Original Article
Rising Incidence of Hepatocellular Carcinoma in the United States
N Engl J Med 1999; 340:745-750March 11, 1999
- Abstract
Background and Methods
Clinical observations have suggested that the number of cases of hepatocellular carcinoma has increased in the United States. We analyzed data from the Surveillance, Epidemiology, and End Results (SEER) data base to determine the age-adjusted incidence of hepatocellular carcinoma from 1976 to 1995, data from the U.S. vital-statistics data base to determine age-adjusted mortality rates from 1981 to 1995, and data from the Department of Veterans Affairs to determine age-adjusted rates of hospitalization for the disease from 1983 to 1997.
Results
The incidence of histologically proved hepatocellular carcinoma increased from 1.4 per 100,000 population (95 percent confidence interval, 1.3 to 1.4) for the period from 1976 to 1980 to 2.4 per 100,000 (95 percent confidence interval, 2.3 to 2.4) for the period from 1991 to 1995. Among black men, the incidence was 6.1 per 100,000 for the period from 1991 to 1995, and among white men, it was 2.8 per 100,000. There was a 41 percent increase in the mortality rate from primary liver cancer and a 46 percent increase in the proportion of hospitalizations attributable to this disease during the periods studied. The incidence increased significantly among younger persons (40 to 60 years old) during the period from 1991 to 1995 as compared with earlier periods.
Conclusions
An increase in the number of cases of hepatocellular carcinoma has occurred in the United States over the past two decades. The age-specific incidence of this cancer has progressively shifted toward younger people.
Media in This Article
Figure 2
Age-Adjusted Rates of Death from Primary Liver Cancer among Black Men and Women and White Men and Women in the United States, 1981–1995.Figure 1
Age-Adjusted Incidence of Hepatocellular Carcinoma among Black Men and Women and White Men and Women in the United States, 1976–1995.Article Activity
- Article
Hepatocellular carcinoma is the most common primary cancer of the liver. The disease has a dismal five-year survival rate of less than 5 percent.1,2 Hepatocellular carcinoma is an infrequent cancer in developed countries.2 However, its incidence has substantially increased in Japan3 during the past three decades, and slight increases have been reported in the United Kingdom and France.4,5 In the United States, the incidence of hepatocellular carcinoma was relatively stable and low from 1970 to 1986 (2.1 to 2.5 cases per 100,000 population).2 A recent report suggested that the rate of death from primary liver cancer has increased,6 but no published studies have analyzed epidemiologic trends of hepatocellular carcinoma in the United States. We analyzed these trends over time using information from three large independent data bases that deal with different aspects of the epidemiology of hepatocellular carcinoma in the United States.
Methods
Data Sources
We used three data bases to analyze trends in the incidence of, mortality from, and rate of hospitalization for hepatocellular carcinoma. Data on incidence were obtained from the nine population-based cancer registries that constitute the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. These registries account for approximately 14 percent of the U.S. population and include the states of Connecticut, Hawaii, New Mexico, and Utah and the metropolitan areas of San Francisco–Oakland, Detroit, Seattle, and Atlanta.7 In this data base, the cancers are coded according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)8 and the International Classification of Diseases for Oncology (ICD-O).9
Data on mortality are accumulated yearly by the National Center for Health Statistics as part of the U.S. vital-statistics data base. Each annual data set is compiled from all death certificates (range, 1.9 million to 2 million) issued in the United States. Data on mortality were obtained for the years 1979 through 199510 and included the age, sex, race or ethnic group, and cause of death of each decedent. Since 1979 the causes of death have been coded according to the ICD-9-CM.
The Patient Treatment File, which is the computerized data base of the Department of Veterans Affairs (VA), was used to provide data on hospitalization for primary liver cancer. The Patient Treatment File contains the records of all inpatients at all 172 VA hospitals. Each annual file, from 1970 to 1997, contains the records of approximately 1 million hospitalizations of 600,000 patients. Since 1981, discharge diagnoses have been coded according to the ICD-9-CM. We analyzed data collected from 1983 to 1997. Data were analyzed according to age and race or ethnic group but not sex, because 98 percent of hospitalized veterans are men.
Diagnostic Codes
We included data on patients with a diagnosis of primary liver cancer (ICD-9-CM code 155.0) from the U.S. vital-statistics data base as well as from the VA data base. We included data on patients in the SEER data base only if the patients had a confirmed histologic diagnosis of hepatocellular carcinoma (ICD-O code 8170).
Statistical Analysis
For each year, the number of hospital discharges of patients with primary liver cancer was broken down according to race or ethnic group and 10-year age groups. The total number of discharges for all diagnoses was also broken down according to race or ethnic group and age. To calculate proportional hospitalization rates for each five-year period analyzed, we divided the number of age-specific hospitalizations for primary liver cancer by the total number of all hospitalizations during a particular five-year period. The numbers of age-specific discharges for each of the five consecutive years were added up, and these race-specific and age-specific rates were then adjusted according to the method of direct standardization to reflect the age distribution of all hospitalized veterans in 1990.11 The age-adjusted rates of consecutive five-year periods were expressed as proportional rates per 10,000 hospitalizations. We used a similar method to calculate age-adjusted mortality rates and age-adjusted incidence, except that the denominator was 100,000 persons.
We calculated the standard error of the age-adjusted rates according to a method suggested by Breslow and Day.12 To calculate the 95 percent confidence interval for each rate, we multiplied the standard error by 1.96 and then added or subtracted this value from the rate. Any two rates whose confidence intervals did not overlap were considered significantly different.
To examine the age distribution of the patients with cancer, we plotted the age-specific incidence of hepatocellular carcinoma according to data obtained from the SEER data base for each five-year period from 1981 to 1995. We subsequently performed a birth-cohort analysis in which the age-specific incidence of hepatocellular carcinoma according to the year of birth was calculated for the entire population included in the SEER data base.
Results
Incidence
In the SEER data base, 73.5 percent of all primary liver cancers were histologically confirmed to be hepatocellular carcinoma (ICD-O code 8170). The rates of histologic confirmation were 75 percent for the period from 1986 to 1990 and 78 percent for the period from 1991 to 1995. The incidence of hepatocellular carcinoma increased from 1.4 per 100,000 (95 percent confidence interval, 1.3 to 1.4) for the period from 1976 to 1980 to 2.4 per 100,000 (95 percent confidence interval, 2.3 to 2.4) for the period from 1991 to 1995 (Table 1Table 1
Overall Incidence of Hepatocellular Carcinoma in the United States and Mortality and Hospitalization Rates.). Figure 1Figure 1Age-Adjusted Incidence of Hepatocellular Carcinoma among Black Men and Women and White Men and Women in the United States, 1976–1995. shows the trends in the incidence of hepatocellular carcinoma over time among black men and women and white men and women. Among black men, the incidence increased from 4.0 per 100,000 (95 percent confidence interval, 3.4 to 4.8) for the period from 1976 to 1980 to 6.1 per 100,000 (95 percent confidence interval, 5.4 to 6.9) for the period from 1991 to 1995. Similarly, among white men, the incidence of hepatocellular carcinoma increased from 1.7 per 100,000 (95 percent confidence interval, 1.6 to 1.8) for the period from 1976 to 1980 to 2.8 per 100,000 (95 percent confidence interval, 2.7 to 3.0) for the period from 1991 to 1995. During the same periods, there was a less pronounced increase among white women and black women. Overall, the incidence of hepatocellular carcinoma among men was three times that among women.The age-adjusted incidence in a heterogeneous group that included Hispanics, Asians, Pacific Islanders, and Native Americans, both men and women, was 5.6 per 100,000 for the period 1976 to 1980, 6.1 per 100,000 for the period 1981 to 1985, 7.0 per 100,000 for the period 1986 to 1990, and 7.4 per 100,000 for the period 1991 to 1995. Among all cases of hepatocellular carcinoma in the SEER data base, the proportion represented by this heterogeneous group was 23 percent for the period from 1981 to 1985, 25 percent for the period from 1986 to 1990, and 23 percent for the period from 1991 to 1995. The lack of a reliable population denominator precluded detailed analysis of this heterogeneous group.
Mortality Rates
The trends in the age-adjusted mortality rates for hepatocellular carcinoma (Table 1 and Figure 2Figure 2
Age-Adjusted Rates of Death from Primary Liver Cancer among Black Men and Women and White Men and Women in the United States, 1981–1995.) were virtually identical to the trends in the incidence of the disease. There was a 41 percent increase in the overall mortality rate. The age-adjusted mortality rate among black men increased from 5.3 per 100,000 (95 percent confidence interval, 4.8 to 5.8) for the period from 1981 to 1985 to 6.0 per 100,000 (95 percent confidence interval, 5.5 to 6.4) for the period from 1991 to 1995 (Figure 2). The respective rates among white men also increased significantly, from 2.3 per 100,000 (95 percent confidence interval, 2.2 to 2.4) to 3.4 per 100,000 (95 percent confidence interval, 3.2 to 3.5). There were smaller but still significant increases in mortality rates from liver cancer among both black women and white women.Hospitalization Rates
The age-adjusted proportional rates of hospitalization for primary liver cancer among U.S. veterans remained stationary from 1983 to 1992 (Table 1). However, in the period from 1993 to 1997, the hospitalization rate was 4.1 per 10,000 hospitalizations for all causes (95 percent confidence interval, 3.7 to 4.5), a 46 percent increase over the rate for the period from 1988 to 1992. The actual total number of hospitalizations for primary liver cancer in the VA hospitals ranged from 1368 for the period from 1983 to 1987 to 1474 for the period from 1993 to 1997. The mean annual number of hospitalized veterans, the denominator, declined by 13 percent, from 1,017,976 for the period from 1983 to 1987 to 886,697 for the period from 1993 to 1997.
Age-Specific Incidence
Figure 3Figure 3
Age-Specific Incidence of Hepatocellular Carcinoma (ICD-O Code 8170) among White Men in the SEER Data Base, 1981–1995, According to Age. shows the age-specific incidence of hepatocellular carcinoma among white men for the period from 1981 to 1995. The age-specific incidence increased progressively, reaching a peak at about 80 to 84 years of age for the period from 1981 to 1985. The same trend was observed for the more recent periods, but the peak shifted toward those 75 to 79 years of age. More important, the slopes preceding the peaks significantly shifted toward younger age groups; the age-specific incidence for the period from 1991 to 1995 is significantly to the left of the incidence for the period from 1981 to 1985. Sixty percent of the 95 percent confidence intervals for the rates for the two curves for men from 40 to 85 years of age or older did not overlap and thus were significantly different. For example, the incidence among men who were 65 to 69 years of age was 9.6 per 100,000 (95 percent confidence interval, 8.1 to 11.2) for the period from 1981 to 1985, as compared with 15.2 per 100,000 (95 percent confidence interval, 13.5 to 17.2) during the period from 1991 to 1995. Similar trends were observed when the age-adjusted incidence rates among black men and among all women were plotted (data not shown). For example, among women, beginning at the age of 60, there were significant increases in the incidence of hepatocellular carcinoma for the period from 1991 to 1995 as compared with the period from 1981 to 1985.A birth-cohort analysis of the entire population included in the SEER data base was performed by analyzing age-specific incidence according to the year of birth (data not shown). A birth cohort is a group of people who were all born during the same period. Since data on incidence were available for the period from 1973 to 1995 for persons ranging in age from 20 to more than 85 years, the birth dates for the cohort ranged from 1888 to 1975. For cohorts born in the period from 1888 to 1958, there was a progressive increase in all age-specific rates that reached a peak in cohorts born in the period from 1953 to 1958 and then declined slightly in younger cohorts. However, the rates among these younger cohorts were low (less than 0.2 per 100,000) and hence were relatively unstable.
Discussion
We found a statistically significant increase in the incidence of hepatocellular carcinoma in the United States over the past two decades. The incidence rose from 1.4 per 100,000 during the period from 1976 to 1980 to 2.4 per 100,000 during the period from 1991 to 1995. Men were affected three times as often as women, and blacks were affected twice as often as whites. Older age was associated with a higher risk, but the incidence among younger persons also rose progressively.
We searched three large data bases to obtain independent measures of the frequency of disease: the hospitalization rate, the incidence, and the mortality rate. As would be expected in the analysis of a rapidly fatal cancer, the results of our analyses of these three measures were similar in every important aspect, strengthening the internal validity of the observed trends. Mortality rates on the whole, however, were higher than the incidence of the disease. Differences in the way the diseases are coded by the SEER data base and by the U.S. vital-statistics data base help to explain this paradox. The SEER data on incidence included only tumors histopathologically confirmed to be hepatocellular carcinoma (ICD-O code 8170). Conversely, the diagnostic code for primary liver cancer (ICD-9-CM code 155.0) used by the U.S. vital-statistics data base encompasses other rare malignant liver tumors and, possibly, a few misclassified metastatic tumors.
The advent of precise diagnostic tests may introduce a detection bias whereby increased recognition of the disease, rather than a true increase in its occurrence, accounts for a rising incidence. However, in the case of hepatocellular carcinoma, detection bias is unlikely to account for the observed trends. The SEER data on incidence included only the 73.5 percent of primary liver cancers that were histopathologically confirmed, and this proportion remained largely the same throughout the study period. Moreover, the use of ultrasonography and measurements of serum alpha-fetoprotein, which has been routine since the early 1980s, could not explain the increase in cases of cancer detected between 1985 and 1995.
According to the VA data on hospitalization, the actual number of cases of liver cancer increased only slightly, but the rates of hospitalization for this illness were disproportionately high. With the recent shift from inpatient to ambulatory care, the total number of hospitalizations for all diagnoses has declined. However, for the same reason, the actual number of cases of liver cancer identified in patients during hospitalization may be underestimated, since some patients receive the diagnosis outside the hospital. One should keep these caveats in mind when interpreting data on hospitalization, especially in this era of managed care.
In developed countries, hepatocellular carcinoma predominantly affects the elderly. However, an effect due to an aging population alone cannot explain the rising rates of this cancer. We used age-adjusted rates to control for this variable among different populations. In addition, the rise in the incidence of hepatocellular carcinoma was coupled with a shift in the incidence of the cancer toward younger age groups. This trend is probably the result of environmental risk factors that affect all birth cohorts but that are stronger in cohorts of younger people. In our analysis, the overall incidence of hepatocellular cancer among cohorts born during the period from 1953 to 1958 was low, but the age-specific incidence was higher than the incidence among cohorts born immediately before or after them.
Our data show that approximately a quarter of the cases of hepatocellular cancer occurred among populations that were neither white nor black. This heterogeneous group includes Hispanics, Native Americans, Pacific Islanders, and Asians. Immigrants from areas where liver cancer is endemic, such as Southeast Asia and Africa, constitute an unknown proportion of this group. This group had the highest risk for hepatocellular carcinoma. Among all cases of hepatocellular carcinoma, the proportion represented by this group has remained virtually constant for the past 20 years, making it unlikely that the cases in this group alone caused the observed rise.
The three main risk factors associated with hepatocellular carcinoma in the United States are infection with hepatitis C virus (HCV), infection with hepatitis B virus (HBV), and alcoholic cirrhosis.1,2,13 The incidence of alcoholic liver disease is declining. Data from the National Hospital Discharge Survey show that alcohol-related diagnoses declined slightly from 1972 to 1987,14 and age-adjusted mortality related to alcoholic cirrhosis declined during the same period.15 This leaves HCV and HBV infections as the two biologically plausible culprits behind the rising incidence of hepatocellular carcinoma. The majority of the study population were 12 to 49 years of age during the 1960s and 1970s. This was a time when intravenous drug use, needle sharing, transfusion of unscreened blood and blood products, and unsafe sexual practices, all of which are risk factors for the transmission of HBV and HCV, were widespread. In persons infected with HBV or HCV in whom hepatocellular carcinoma develops, there is a latency period of one to three decades.16-18 Thus, among persons infected with HCV or HBV during the 1960s or 1970s, hepatocellular carcinoma would develop in the 1980s and 1990s, the period when the increase in cases of cancer began to occur. If HCV and HBV infections are to blame for the increase, this fact would explain the sexual and racial differences in the incidence of hepatocellular carcinoma. In the United States, blacks are at greater risk for HBV and HCV infection than whites, and both HBV infection and HCV infection are more common in men than in women.19-21
The rise in hepatocellular carcinoma may continue for more than a few years. There is a large pool of persons infected with HCV, HBV, or both in whom the cancer is in the latency period. In addition, emigration from areas where hepatocellular carcinoma is endemic, such as Southeast Asia and parts of Africa, where perinatal HBV infection and exposure to environmental carcinogens such as aflatoxin are common, is likely to continue. The incidence of HCV infection remained steady throughout the 1980s (about 150,000 cases annually)20 before declining by half during the early 1990s. The incidence of HBV infection reached a peak of 11.5 per 100,000 population in 1985 before declining to a rate of 6.3 per 100,000 in 1992. In approximately 85 percent of adults infected with HCV and 5 percent of those infected with HBV, the infection becomes chronic.20,22 Cirrhosis is estimated to develop during the first 10 years after transfusion in at least 20 percent of patients with post-transfusion chronic HCV infection. Once cirrhosis is established, carcinoma develops at a rate of 1 to 4 percent per year, which means that after 20 years hepatocellular carcinoma will develop in 1.9 to 6.7 percent of all patients with chronic HCV infection.23-25 These projections are important, because approximately 3.9 million persons in the United States are infected with HCV.19 By contrast, the seroprevalence of HBV in the United States is low, with an estimated 1 million to 1.25 million persons, or 0.9 percent of blacks and 0.2 percent of whites, harboring a silent HBV infection.20,22 According to a consensus report of the National Institutes of Health, the annual probability of liver cancer among patients with HBV-related chronic hepatitis is 0.5 percent and that among patients with cirrhosis is 2.4 percent.25
For patients who harbor chronic HCV or HBV infection, attention must be focused on the prevention of cirrhosis. Controlled trials in Japan26 and France27 indicate that interferon therapy in patients with HCV-related cirrhosis, even when complete biochemical and virologic clearing does not occur, is associated with a decreased risk of hepatocellular carcinoma.26,27 Interferon therapy is of moderate benefit in patients with HBV-related chronic hepatitis, with serum HBV DNA levels becoming undetectable in 37 percent of treated patients and hepatitis B surface antigen levels becoming undetectable in 7.8 percent.28 A favorable response to interferon treatment in patients with HBV-related chronic hepatitis probably reduces the risk of hepatocellular carcinoma.29
We are indebted to Fabiola Delcò, M.D., M.P.H., for sharing her expertise on birth-cohort analysis.
Source Information
From the Veterans Affairs Medical Center and the University of New Mexico, Albuquerque.
Address reprint requests to Dr. El-Serag at the Gastroenterology Section, Veterans Affairs Medical Center 111F, 1501 San Pedro SE, Albuquerque, NM 87108, or at elserag@unm.edu.
- References
References
1
Kew MC. Hepatic tumors and cysts. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathology/diagnosis/management. 6th ed. Vol. 1. Philadelphia: W.B. Saunders, 1998:1364-87.
2
Godley PA, Sandler RS. Liver cancer. In: Everhart JE, ed. Digestive diseases in the United States: epidemiology and impact. Washington, D.C.: Government Printing Office, 1994:227-41. (NIH publication no. 94-1447.)
3
Okuda K ,Fujimoto I ,Hanai A ,Urano Y . Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-4972
Web of Science | Medline4
Taylor-Robinson SD ,Foster GR ,Arora S ,Hargreaves S ,Thomas HC . Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-1143
CrossRef | Web of Science | Medline5
Deuffic S ,Poynard T ,Buffat L ,Valleron AJ . Trends in primary liver cancer. Lancet 1998;351:214-215
CrossRef | Web of Science | Medline6
Landis SH ,Murray T ,Bolden S ,Wingo PA . Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29[Erratum, CA Cancer J Clin 1998;48:192.]
CrossRef | Web of Science | Medline7
Surveillance, Epidemiology, and End Results (SEER) program public-use CD-ROM (1973–1995). Bethesda, Md.: National Cancer Institute, April 1998 (software).
8
Department of Health and Human Services. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. 3rd ed. Vol. 1. Diseases: tabular list. Washington, D.C.: Government Printing Office, March 1989. (DHHS publication no. (PHS) 89-1260.)
9
Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
10
Grant BF, Zobeck T. Liver cirrhosis mortality in the United States, 1972–1986. Surveillance report no. 11. Rockville, Md.: National Institute on Alcohol Abuse and Alcoholism, 1989.
11
Kahn HA, Sempos CT. Statistical methods in epidemiology. Vol. 12 of Monographs in epidemiology and biostatistics. New York: Oxford University Press, 1989:87-95.
12
Breslow NE, Day NE. Statistical methods in cancer research. Vol. 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987:58-61. (IARC scientific publications no. 82.)
13
Takano S ,Yokosuka O ,Imazeki F ,Tagawa M ,Omata M . Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-655
CrossRef | Web of Science | Medline14
Dufour MC. Chronic liver disease and cirrhosis. In: Everhart JE, ed. Digestive diseases in the United States: epidemiology and impact. Washington, D.C.: Government Printing Office, 1994:615-46. (NIH publication no. 94-1447.)
15
Grant BF, Zobeck TS, Pickering RP. Liver cirrhosis mortality in the United States, 1973–1978. Rockville, Md.: National Institute on Alcohol Abuse and Alcoholism, 1990.
16
Sherlock S . Viruses and hepatocellular carcinoma. Gut 1994;35:828-832
CrossRef | Web of Science | Medline17
Yarrish RL ,Werner BG ,Blumberg BS . Association of hepatitis B virus infection with hepatocellular carcinoma in American patients. Int J Cancer 1980;26:711-715
CrossRef | Web of Science | Medline18
Castells L ,Vargas V ,Gonzalez A ,Esteban J ,Esteban R ,Guardia J . Long interval between HCV infection and the development of hepatocellular carcinoma. Liver 1995;15:159-163
Medline19
Alter MJ . Epidemiology of hepatitis C. Hepatology 1997;26:Suppl 1:62S-65S
CrossRef | Web of Science | Medline20
McQuillan GM, Alter MJ, Everhart JE. Viral hepatitis. In: Everhart JE, ed. Digestive diseases in the United States: epidemiology and impact. Washington, D.C.: Government Printing Office, 1994:127-56. (NIH publication no. 94-1447.)
21
Kelen GD ,Green GB ,Purcell RH , et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992;326:1399-1404
Full Text | Web of Science | Medline22
McQuillan GM ,Townsend TR ,Fields HA ,Carroll M ,Leahy M ,Polk BF . Seroepidemiology of hepatitis B virus infection in the United States: 1976 to 1980. Am J Med 1989;87:Suppl 3A:5S-10S
CrossRef | Web of Science | Medline23
Di Bisceglie AM . Hepatitis C and hepatocellular carcinoma. Hepatology 1997;26:Suppl 1:34S-38S
CrossRef | Web of Science | Medline24
Di Bisceglie AM ,Goodman ZD ,Ishak KG ,Hoofnagle JH ,Melpolder JJ ,Alter HJ . Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969-974
CrossRef | Web of Science | Medline25
Di Bisceglie AM ,Rustgi VK ,Hoofnagle JH ,Dusheiko GM ,Lotze MT . NIH conference: hepatocellular carcinoma. Ann Intern Med 1988;108:390-401
Web of Science | Medline26
Nishiguchi S ,Kuroki T ,Nakatani S , et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-1055
CrossRef | Web of Science | Medline27
Serfaty L ,Aumaitre H ,Chazouilleres O , et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440
CrossRef | Web of Science | Medline28
Wong DKH ,Cheung AM ,O'Rourke K ,Naylor CD ,Detsky AS ,Heathcote J . Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993;119:312-323
Web of Science | Medline29
Wong JB ,Koff RS ,Tine F ,Pauker SG . Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1995;122:664-675
Web of Science | Medline
- Citing Articles (1025)
Citing Articles
1
Guibin Wang, Lulu Dong, Yuanyuan Zhang, Yuanyuan Ji, Wenhua Xiang, Min Zhao. (2012) Polysaccharides from Phellinus linteus inhibit cell growth and invasion and induce apoptosis in HepG2 human hepatocellular carcinoma cells. Biologia 67:1, 247-254
CrossRef2
Ann Marie Liapakis, Ira Jacobson. (2012) Telaprevir user's guide. Liver International 32, 17-25
CrossRef3
Shwu-Huey Liu, Yung-Chi Cheng. (2012) Old Formula, New Rx: The Journey of PHY906 as Cancer Adjuvant Therapy. Journal of Ethnopharmacology
CrossRef4
Masaki Kaibori, Noboru Tanigawa, Shuji Kariya, Hiroki Ikeda, Yoshitsugu Nakahashi, Junko Hirohara, Chizu Koreeda, Toshihito Seki, Satoshi Sawada, Kazuichi Okazaki, A-Hon Kwon. (2012) A Prospective Randomized Controlled Trial of Preoperative Whole-Liver Chemolipiodolization for Hepatocellular Carcinoma. Digestive Diseases and Sciences
CrossRef5
Junichi Yamanaka, Jiro Fujimoto. (2012) Sectionectomy of the liver. Journal of Hepato-Biliary-Pancreatic Sciences 19:1, 54-66
CrossRef6
Ju Dong Yang, Bohyun Kim, Schuyler O. Sanderson, Jennifer L. St. Sauver, Barbara P. Yawn, Rachel A. Pedersen, Joseph J. Larson, Terry M. Therneau, Lewis R. Roberts, W. Ray Kim. (2012) Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008. Mayo Clinic Proceedings 87:1, 9-16
CrossRef7
Tae-Jin Song, Yuman Fong, Sung-Jin Cho, Mithat Gönen, Michael Hezel, Scott Tuorto, Sang-Yong Choi, Young-Chul Kim, Sung-Ock Suh, Bum-Hwan Koo, Yang-Seok Chae, William R. Jarnagin, David S. Klimstra. (2012) Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis. Journal of Surgical Oncologyn/a-n/a
CrossRef8
Arndt Weinmann, Ina Maria Niederle, Sandra Koch, Maria Hoppe-Lotichius, Michael Heise, Christoph Düber, Marcus Schuchmann, Gerd Otto, Peter Robert Galle, Marcus-Alexander Wörns. (2012) Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Digestive and Liver Disease
CrossRef9
Jorge A. Marrero. 2012. Hepatocellular Carcinoma. , 1005-1031.
CrossRef10
Peter Greaves. 2012. Liver and Pancreas. , 433-535.
CrossRef11
Kohei Harada, Toru Mizuguchi, Yoshimi Katagiri, Masaki Kawamoto, Yukio Nakamura, Makoto Meguro, Shigenori Ota, Shigeru Sasaki, Koji Miyanishi, Tomoko Sonoda, Mitsuru Mori, Yasuhisa Shinomura, Junji Kato, Koichi Hirata. (2011) Area between the hepatic and heart curves of 99mTc-galactosyl-human serum albumin scintigraphy represents liver function and disease progression for preoperative evaluation in hepatocellular carcinoma patients. Journal of Hepato-Biliary-Pancreatic Sciences
CrossRef12
Jama M. Darling, Stanley M. Lemon, Michael W. Fried. 2011. Hepatitis C. , 582-652.
CrossRef13
Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, Simon D. Taylor-Robinson. 2011. The view from the United Kingdom. , 24-28.
CrossRef14
Ming Kuang, Xiao-Yan Xie, Cheng Huang, Ye Wang, Man-Xia Lin, Zuo-Feng Xu, Guang-Jian Liu, Ming-De Lu. (2011) Long-Term Outcome of Percutaneous Ablation in Very Early-Stage Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 15:12, 2165-2171
CrossRef15
Fahad Alsohaibani, Geoffrey Porter, Hamad Al-Ashgar, Mark Walsh, Robert Berry, Michele Molinari, Kevork Minas Peltekian. (2011) Comparison of Cancer Care for Hepatocellular Carcinoma at Two Tertiary-Care Referral Centers from High and Low Endemic Regions for Viral Hepatitis. Journal of Gastrointestinal Cancer 42:4, 228-235
CrossRef16
Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Yasuhiro Sone, Yuji Kaneoka, Atsuyuki Maeda. (2011) Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan. Journal of Gastroenterology and Hepatology 26:12, 1765-1771
CrossRef17
Yun Ku Cho, Jin Wook Chung, Yoonjung Kim, Hyun Je Cho, Soo Hyun Yang. (2011) Radiofrequency ablation of high-grade dysplastic nodules. Hepatology 54:6, 2005-2011
CrossRef18
Meng-Hsing Ho, Chih-Yung Yu, Kuo-Piao Chung, Teng-Wei Chen, Heng-Cheng Chu, Chih-Kung Lin, Chung-Bao Hsieh. (2011) Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology 18:13, 3632-3639
CrossRef19
David H. Thiel, Guiliano Ramadori. (2011) Non-Viral Causes of Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 42:4, 191-194
CrossRef20
Tzu-Ting Huang, Meng-Chi Yen, Chi-Chen Lin, Tzu-Yang Weng, Yi-Ling Chen, Chiu-Mei Lin, Ming-Derg Lai. (2011) Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Science 102:12, 2214-2220
CrossRef21
I.A. Hanouneh, C. Macaron, R. Lopez, F. Aucejo, N.N. Zein. (2011) Rate of Tumor Growth Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation in Patients Beyond Milan or UCSF Criteria. Transplantation Proceedings 43:10, 3813-3818
CrossRef22
Oidov Baatarkhuu, Do Young Kim, Pagbajabyn Nymadawa, Seung Up Kim, Kwang-Hyub Han, Jazag Amarsanaa, Dagvasumberel Gonchigsuren, Ravjir Sanduijav, Zundui Lkhagvasuren, Naran Khorolsuren, Ravjir Oyungerel, Sang Hoon Ahn. (2011) Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study. Hepatology International
CrossRef23
Andrew V. Stachulski, Chandrakala Pidathala, Eleanor C. Row, Raman Sharma, Neil G. Berry, Alexandre S. Lawrenson, Shelley L. Moores, Mazhar Iqbal, Joanne Bentley, Sarah A. Allman, Geoffrey Edwards, Alison Helm, Jennifer Hellier, Brent E. Korba, J. Edward Semple, Jean-Francois Rossignol. (2011) Thiazolides as Novel Antiviral Agents. 2. Inhibition of Hepatitis C Virus Replication. Journal of Medicinal Chemistry111121131258005
CrossRef24
Goh Eun Chung, Won Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong Min Lee, Jae Young Lee, Se Hyung Kim, Donghee Kim, Hyo-Suk Lee. (2011) Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Journal of Gastroenterology and Hepatology 26:11, 1638-1645
CrossRef25
Masaki Kaibori, Sang Kil Ha-Kawa, Minoru Maehara, Morihiko Ishizaki, Kosuke Matsui, Satoshi Sawada, A-Hon Kwon. (2011) Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Annals of Nuclear Medicine 25:9, 593-602
CrossRef26
Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer, Jessica A. Davila, Peter A. Richardson, Hashem B. El–Serag. (2011) Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 9:11, 989-994
CrossRef27
P.S. Sreejith, Russel Royna Mascarenhas, R.J. Praseeja, V.V. Asha. (2011) The apoptosis inducing effect of Glycosmis pentaphylla (Retz.) Correa and its influence on gene expression in hepatocellular carcinoma cell line, Hep3 B. Journal of Ethnopharmacology
CrossRef28
James M. Wilson, Oleg A. Shchelochkov, Renata C. Gallagher, Mark L. Batshaw. (2011) Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency. Molecular Genetics and Metabolism
CrossRef29
Lixia Zha, Lulu Fan, Guoping Sun, Hua Wang, Tai Ma, Fei Zhong, Wei Wei. (2011) Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. Journal of Pineal Researchno-no
CrossRef30
Yan Li, Zhao-You Tang, Jin-Xuan Hou. (2011) Hepatocellular carcinoma: insight from animal models. Nature Reviews Gastroenterology & Hepatology
CrossRef31
Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, Yuya Seko, Norihiro Imai, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji, Hiromitsu Kumada. (2011) Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma. The American Journal of Gastroenterology
CrossRef32
Marcela Salomao, Helen Remotti, Roger Vaughan, Abby B. Siegel, Jay H. Lefkowitch, Roger Klein Moreira. (2011) The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Human Pathology
CrossRef33
Didier Samuel, Massimo Colombo, Hachem El-Serag, Rodolphe Sobesky, Nigel Heaton. (2011) Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transplantation 17:S2, S6-S13
CrossRef34
Philip Y. Wong, Victor Xia, David K. Imagawa, John Hoefs, Ke-Qin Hu. (2011) Clinical Presentation of Hepatocellular Carcinoma (HCC) in Asian-Americans Versus Non-Asian-Americans. Journal of Immigrant and Minority Health 13:5, 842-848
CrossRef35
Philip J. Johnson. (2011) Hepatobiliary tumours. Medicine 39:10, 630-633
CrossRef36
Krit Kitisin, Vignesh Packiam, Jennifer Steel, Abhinav Humar, T. Clark Gamblin, David A. Geller, J. Wallis Marsh, Allan Tsung. (2011) Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB 13:10, 712-722
CrossRef37
Le Li, Jialin Zhang, Xiaohua Liu, Xiaohang Li, Baoping Jiao, Tieli Kang. (2011) Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: A meta-analysis. Journal of Gastroenterology and Hepatologyno-no
CrossRef38
Sadahisa Ogasawara, Fumihiko Kanai, Shuntaro Obi, Shinpei Sato, Taketo Yamaguchi, Ryosaku Azemoto, Hideaki Mizumoto, Youhei Koushima, Naoki Morimoto, Nobuto Hirata, Takeshi Toriyabe, Yusuke Shinozaki, Yoshihiko Ooka, Rintaro Mikata, Tetsuhiro Chiba, Shinichiro Okabe, Fumio Imazeki, Masaharu Yoshikawa, Osamu Yokosuka. (2011) Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatology International 5:3, 850-856
CrossRef39
Kenneth S. H. Chok, See Ching Chan, Tan To Cheung, Albert C. Y. Chan, Sheung Tat Fan, Chung Mau Lo. (2011) Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation. World Journal of Surgery 35:9, 2058-2062
CrossRef40
Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, Markus Peck-Radosavljevic, Christian Müller. (2011) Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?. Wiener klinische Wochenschrift 123:17-18, 542-551
CrossRef41
Katrin Hoffmann, Ulf Hinz, Norbert Hillebrand, Boris A. Radeleff, Tom M. Ganten, Peter Schirmacher, Jan Schmidt, Markus W. Büchler, Peter Schemmer. (2011) Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis. Clinical Transplantation 25:5, E541-E551
CrossRef42
Julia O’Brien, Lawrie W. Powell. (2011) Non-alcoholic fatty liver disease: is iron relevant?. Hepatology International
CrossRef43
Marievelisse Soto-Salgado, Erick Suárez, Ana P. Ortiz, Sandra Adrovet, Edmir Marrero, Marytere Meléndez, Héctor M. Colón, Carmen Albizu, María del C. Santos, Esther Torres, Cynthia M. Pérez. (2011) Knowledge of Viral Hepatitis Among Puerto Rican Adults: Implications for Prevention. Journal of Community Health 36:4, 565-573
CrossRef44
Toru Mizuguchi, Masaki Kawamoto, Makoto Meguro, Yukio Nakamura, Kohei Harada, Kazuharu Kukita, Koichi Hirata. (2011) Prognostic Impact of Preoperative the Branched-Chain Amino Acid to the Tyrosine Ratio in Hepatocellular Carcinoma Patients after Initial Hepatectomy. Journal of Gastrointestinal Surgery 15:8, 1433-1439
CrossRef45
AnnMarie Liapakis, Ira Jacobson. (2011) Telaprevir User’s Guide. Clinics in Liver Disease 15:3, 555-571
CrossRef46
Lantu Gou, Wei Wang, Aiping Tong, Yuqin Yao, Yan Zhou, Cheng Yi, Jinliang Yang. (2011) Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma. Journal of Molecular Medicine 89:8, 817-827
CrossRef47
Daniel A. Anaya, Natasha S. Becker, Peter Richardson, Neena S. Abraham. (2011) Use of Administrative Data to Identify Colorectal Liver Metastasis. Journal of Surgical Research
CrossRef48
ShiHai Zhang, Jing Zhou, CuiLing Zhang, HuiWen Wu, Yi Wang, JianMin Bian, Jun Guo, XiangYang Wu. (2011) Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production. Medical Oncology
CrossRef49
Weijing Sun, Davendra Sohal, Daniel G. Haller, Kristine Mykulowycz, Mark Rosen, Michael C. Soulen, Millie Caparro, Ursina R. Teitelbaum, Bruce Giantonio, Peter J. O'Dwyer, Abraham Shaked, Rajender Reddy, Kim Olthoff. (2011) Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. Cancer 117:14, 3187-3192
CrossRef50
Danielle Rand, Vivian Ortiz, Yanan Liu, Zoltan Derdak, Jack R. Wands, Milan Tatíček, Christoph Rose-Petruck. (2011) Nanomaterials for X-ray Imaging: Gold Nanoparticle Enhancement of X-ray Scatter Imaging of Hepatocellular Carcinoma. Nano Letters 11:7, 2678-2683
CrossRef51
D Lu, C Han, T Wu. (2011) Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis. Oncogene
CrossRef52
Jeong Han Kim, Hyung Joon Yim, Kwang Gyun Lee, Seung Young Kim, Eun Suk Jung, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun, Ho Sang Ryu. (2011) Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study. Hepatology International
CrossRef53
Hidetsugu Nakayama, Shinji Sugahara, Kuniaki Fukuda, Masato Abei, Junichi Shoda, Hideyuki Sakurai, Koji Tsuboi, Yasushi Matsuzaki, Koichi Tokuuye. (2011) Proton Beam Therapy for Hepatocellular Carcinoma Located Adjacent to the Alimentary Tract. International Journal of Radiation Oncology*Biology*Physics 80:4, 992-995
CrossRef54
David A. Bush, Zeid Kayali, Roger Grove, Jerry D. Slater. (2011) The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 117:13, 3053-3059
CrossRef55
David Kershenobich, Homie A. Razavi, Juan Francisco Sánchez-Avila, Fernando Bessone, Henrique S. Coelho, Lucy Dagher, Fernando L. Gonçales, Jorge F. Quiroz, Federico Rodriguez-Perez, Barbara Rosado, Carolyn Wallace, Francesco Negro, Marcelo Silva. (2011) Trends and projections of hepatitis C virus epidemiology in Latin America. Liver International 31, 18-29
CrossRef56
Klaus J. Schmitz, Georgios C. Sotiropoulos, Hideo A. Baba, Kurt W. Schmid, Doris Müller, Andreas Paul, Thomas Auer, Gabriele Gamerith, Judith Loeffler-Ragg. (2011) AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases. Liver International 31:6, 810-816
CrossRef57
H.-H. Thein, S. R. Walter, H. F. Gidding, J. Amin, M. G. Law, J. George, G. J. Dore. (2011) Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. Journal of Viral Hepatitis 18:7, e232-e241
CrossRef58
R. Anaparthy, J. A. Talwalkar, M. Yin, L. R. Roberts, J. L. Fidler, R. L. Ehman. (2011) Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. Alimentary Pharmacology & Therapeutics 34:1, 83-91
CrossRef59
Zhi-ming Wu, Chun Dai, Ying Huang, Cui-fang Zheng, Qiong-zhu Dong, Guan Wang, Xiao-wen Li, Xiao-fei Zhang, Bin Li, Gang Chen. (2011) Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacologica Sinica 32:7, 939-946
CrossRef60
Hirotaka Tashiro, Hiroshi Aikata, Koji Waki, Hironobu Amano, Akihiko Oshita, Tsuyoshi Kobayashi, Yoshisato Tanimoto, Shintaro Kuroda, Hirofumi Tazawa, Kazuaki Chayama, Toshimasa Asahara, Hideki Ohdan. (2011) Treatment strategy for early hepatocellular carcinomas: Comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection. Journal of Surgical Oncology 104:1, 3-9
CrossRef61
Xiao-Ni Ma, Xiao-Yun Liu, Yue-Feng Yang, Feng-Jun Xiao, Qing-Fang Li, Jun Yan, Qun-Wei Zhang, Li-Sheng Wang, Xue-Yan Li, Hua Wang. (2011) Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism. Biochemical and Biophysical Research Communications 410:4, 803-808
CrossRef62
Jacobson, Ira M., McHutchison, John G., Dusheiko, Geoffrey, Di Bisceglie, Adrian M., Reddy, K. Rajender, Bzowej, Natalie H., Marcellin, Patrick, Muir, Andrew J., Ferenci, Peter, Flisiak, Robert, George, Jacob, Rizzetto, Mario, Shouval, Daniel, Sola, Ricard, Terg, Ruben A., Yoshida, Eric M., Adda, Nathalie, Bengtsson, Leif, Sankoh, Abdul J., Kieffer, Tara L., George, Shelley, Kauffman, Robert S., M.D., Stefan Zeuzem. (2011) Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection. New England Journal of Medicine 364:25, 2405-2416
Full Text63
R.A. Adair, A.L. Young, G.J. Toogood. (2011) Advances in hepatobiliary surgery. Trends in Anaesthesia and Critical Care 1:3, 141-146
CrossRef64
M. Atif, M. Fakhar-e-Alam, S. S. Z. Zaidi, R. Suleman. (2011) Study of the efficacy of photofrin®-Mediated PDT on human hepatocellular carcinoma (HepG2) cell line. Laser Physics 21:6, 1135-1144
CrossRef65
Kazuhiro Kasai, Akira Ushio, Yukiho Kasai, Kei Sawara, Yasuhiro Miyamoto, Kanta Oikawa, Hidekatsu Kuroda, Yasuhiro Takikawa, Kazuyuki Suzuki. (2011) Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma. International Journal of Clinical Oncology 16:3, 221-229
CrossRef66
Joshua J Shaw, Shimul A Shah. (2011) Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?. Expert Review of Gastroenterology & Hepatology 5:3, 365-370
CrossRef67
Rita Golfieri, Matteo Renzulli, Vincenzo Lucidi, Beniamino Corcioni, Franco Trevisani, Luigi Bolondi. (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. European Radiology 21:6, 1233-1242
CrossRef68
Jeong Min Lee, Byung Ihn Choi. (2011) Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdominal Imaging 36:3, 282-289
CrossRef69
Ahmed O. Kaseb, Manal M. Hassan, E Lin, Lianchun Xiao, Vikas Kumar, Priyanka Pathak, Richard Lozano, Asif Rashid, James L. Abbruzzese, Jeffrey S. Morris. (2011) V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer 117:11, 2478-2488
CrossRef70
Marshall J. Orloff, Jon I. Isenberg, Henry O. Wheeler, Kevin S. Haynes, Horacio Jinich-Brook, Roderick Rapier, Florin Vaida, Robert J. Hye, Susan L. Orloff. (2011) Hepatocellular carcinoma in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. The American Journal of Surgery
CrossRef71
Prashant Bhangui, Eric Vibert, Pietro Majno, Chady Salloum, Paola Andreani, Joao Zocrato, Philippe Ichai, Faouzi Saliba, Rene Adam, Denis Castaing, Daniel Azoulay. (2011) Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation. Hepatology 53:5, 1570-1579
CrossRef72
Ponni V. Perumalswami, Thomas D. Schiano. (2011) The Management of Hospitalized Patients with Cirrhosis: The Mount Sinai Experience and a Guide for Hospitalists. Digestive Diseases and Sciences 56:5, 1266-1281
CrossRef73
Mary Jane Burton, Imran Sunesara, Alan Penman, Huan Pham, Nora Oliver, Casey A. Young, Novell McGloster, Brendan M. McGuire. (2011) Comparing the Aspartate Aminotransferase (AST) to Platelet Ratio Index (APRI) Between African American and White Veterans with Chronic Hepatitis C. Southern Medical Journal 104:5, 309-314
CrossRef74
Xin Li, Liang Zhang, Weijun Fan, Ming Zhao, Ligang Wang, Tian Tang, Hua Jiang, Jianlei Zhang, Yanfeng Liu. (2011) Comparison of microwave ablation and multipolar radiofrequency ablation, both using a pair of internally cooled interstitial applicators: Results in ex vivo porcine livers. International Journal of Hyperthermia 27:3, 240-248
CrossRef75
Yao-Li Chen, Chih-Jan Ko, Su-Yu Chien, Li-Sheng Chen, Mei-Ling Chen, Chin-Wen Chi, Hung-Wen Lai. (2011) Tumor size as a prognostic factor in resected small hepatocellular carcinoma: A controversy revisited. Journal of Gastroenterology and Hepatology 26:5, 851-857
CrossRef76
Morris Sherman. 2011. Primary Malignant Neoplasms of the Liver. , 681-703.
CrossRef77
Kyung Ah Kim, Myeong-Jin Kim, Jin-Young Choi, Yong Eun Chung. (2011) Development of hepatocellular carcinomas in patients with absence of tumors on a prior ultrasound examination. European Journal of Radiology
CrossRef78
Irene Bargellini, Rodolfo Sacco, Elena Bozzi, Marco Bertini, Barbara Ginanni, Antonio Romano, Antonio Cicorelli, Emanuele Tumino, Graziana Federici, Roberto Cioni, Salvatore Metrangolo, Michele Bertoni, Giampaolo Bresci, Giuseppe Parisi, Emanuele Altomare, Alfonso Capria, Carlo Bartolozzi. (2011) Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. European Journal of Radiology
CrossRef79
H.C. Addley, N. Griffin, A.S. Shaw, L. Mannelli, R.A. Parker, S. Aitken, H. Wood, S. Davies, G.J. Alexander, D.J. Lomas. (2011) Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clinical Radiology 66:4, 349-356
CrossRef80
Mosaad A. Abdel-Wahhab, Khaled Gamil, Ahmed A. El-Kady, Aziza A. El-Nekeety, Khayria M. Naguib. (2011) Therapeutic Effects of Korean Red Ginseng Extract in Egyptian Patients with Chronic Liver Diseases. Journal of Ginseng Research 35:1, 69-79
CrossRef81
Roberto S Oliveri, Jørn Wetterslev, Christian Gluud, Roberto S Oliveri. 2011. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. .
CrossRef82
Masaki Kaibori, Morihiko Ishizaki, Kosuke Matsui, Hiroaki Kitade, Yoichi Matsui, A-Hon Kwon. (2011) Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 26:3, 536-543
CrossRef83
Jennifer R Kramer, Fasiha Kanwal, Peter Richardson, Thomas P Giordano, Laura A Petersen, Hashem B El-Serag. (2011) Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study. The American Journal of Gastroenterology 106:3, 483-491
CrossRef84
Hidenori Shiraha, Shin-ichi Nishina, Kazuhide Yamamoto. (2011) Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma. Journal of Cellular Biochemistry 112:3, 745-749
CrossRef85
Shimul A. Shah, Jillian K. Smith, YouFu Li, Sing Chau Ng, James E. Carroll, Jennifer F. Tseng. (2011) Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer 117:5, 1019-1026
CrossRef86
Kuo-Feng Hsu, Chi-Hung Chu, De-Chuan Chan, Jyh-Cherng Yu, Ming-Lang Shih, Huan-Fa Hsieh, Tsai-Yuan Hsieh, Chih-Yung Yu, Chung-Bao Hsieh. (2011) Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. European Journal of Radiology
CrossRef87
Jeffrey A. Kolthammer, David J. Corn, Nathan Tenley, Chunying Wu, Haibin Tian, Yanming Wang, Zhenghong Lee. (2011) PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline. European Journal of Nuclear Medicine and Molecular Imaging
CrossRef88
Haiqing Ma, Xiaoting Liang, Yibing Chen, Ke Pan, Jiancong Sun, Hui Wang, Qijing Wang, Yongqiang Li, Jingjing Zhao, Jianjun Li, Minshan Chen, Jianchuan Xia. (2011) Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma. International Journal of Cancer 128:4, 771-777
CrossRef89
Wei-Ting Chen, Mark Lee Fernandes, Chen-Chun Lin, Shi-Ming Lin. (2011) Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program. Journal of Surgical Oncology 103:2, 133-139
CrossRef90
Nicolas Salem, Yu Kuang, David Corn, Bernadette Erokwu, Jeffrey A. Kolthammer, Haibin Tian, Chunying Wu, Fangjing Wang, Yanming Wang, Zhenghong Lee. (2011) [(Methyl)1-11C]-Acetate Metabolism in Hepatocellular Carcinoma. Molecular Imaging and Biology 13:1, 140-151
CrossRef91
Georgios Tsoulfas, Tatsuo Kawai, Nahel Elias, S. C. Ko, Polyxeni Agorastou, A. Benedict Cosimi, Martin Hertl. (2011) Long-term experience with liver transplantation for hepatocellular carcinoma. Journal of Gastroenterology 46:2, 249-256
CrossRef92
Lopa Mishra. (2011) Health care reform: How personalized medicine could help bundling of care for liver diseases. Hepatology 53:2, 379-381
CrossRef93
Caroline Hora, Pamela Romanque, Jean-François F. Dufour. (2011) Effect of sorafenib on murine liver regeneration. Hepatology 53:2, 577-586
CrossRef94
Patrizia Ferroni, Antonella Spila, Roberta D'Alessandro, Francesca Martini, Francesca Iacovone, Giuseppe M. Ettorre, Giovanni Vennarecci, Roberto Santoro, Claudio Puoti, Fiorella Guadagni. (2011) Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer. Clinica Chimica Acta 412:5-6, 450-454
CrossRef95
R. Lord, A. Suddle, P. J. Ross. (2011) Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies. International Journal of Clinical Practice 65:2, 182-188
CrossRef96
Changhai Lu, Malcolm M.Q. Xing, Wen Zhong. (2011) Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage. Nanomedicine: Nanotechnology, Biology and Medicine 7:1, 80-87
CrossRef97
Pratima Sharma, Sameer D. Saini, Latoya B. Kuhn, Joel H. Rubenstein, Darrell S. Pardi, Jorge A. Marrero, Philip S. Schoenfeld. (2011) Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among Gastroenterologists. Digestive Diseases and Sciences 56:2, 569-577
CrossRef98
Masakazu Hirakawa, Kengo Yoshimitsu, Hiroyuki Irie, Tsuyoshi Tajima, Akihiro Nishie, Yoshiki Asayama, Kousei Ishigami, Daisuke Kakihara, Akinobu Taketomi, Shin-ichi Aishima, Hiroshi Honda. (2011) Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. Japanese Journal of Radiology 29:2, 129-137
CrossRef99
Ourania M. Andrisani, Leo Studach, Philippe Merle. (2011) Gene signatures in hepatocellular carcinoma (HCC). Seminars in Cancer Biology 21:1, 4-9
CrossRef100
Jiwei Huang, Roberto Hernandez-Alejandro, Kristopher P. Croome, Lvnan Yan, Hong Wu, Zheyu Chen, Pankaj Prasoon, Yong Zeng. (2011) Radiofrequency Ablation Versus Surgical Resection for Hepatocellular Carcinoma in Childs A Cirrhotics—a Retrospective Study of 1,061 Cases. Journal of Gastrointestinal Surgery 15:2, 311-320
CrossRef101
Yuji Kondo, Shuichiro Shiina, Ryosuke Tateishi, Toru Arano, Koji Uchino, Kennichiro Enooku, Eriko Goto, Hayato Nakagawa, Ryota Masuzaki, Yoshinari Asaoka, Hajime Fujie, Tadashi Goto, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike. (2011) Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis. Liver International 31:2, 197-205
CrossRef102
Zhi-yong Huang, Gen Chen, Xiao-yi Hao, Rong-yao Cai, Yin-feng Zhao, Xiao-ping Chen. (2011) Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors. Langenbeck's Archives of Surgery 396:2, 193-199
CrossRef103
Leong U. Tiong, John W. Finnie, John B. Field, Guy J. Maddern. (2011) Bimodal Electric Tissue Ablation (BETA)—Effect of Reversing the Polarity of the Direct Current on the Size of Ablation. Journal of Surgical Research
CrossRef104
Rafael Calama Sainz, Margarida Tome, M. Sánchez-González, J. Miina., K. Spanos, Marc Palahi. (2011) Modelling Non-Wood Forest Products in Europe: a review. Forest Systems 3:4,
CrossRef105
Kazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, Tomoyuki Nagai, Chie Tatsumi, Taisuke Ueda, Satoshi Kitai, Emi Ishikawa, Norihisa Yada, Tatsuo Inoue, Satoru Hagiwara, Yasunori Minami, Hobyung Chung, Toshiharu Sakurai. (2011) Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma. Digestive Diseases 29:3, 321-325
CrossRef106
Shinn-Jang Hwang, Shou-Dong Lee. (2011) Hepatic steatosis and hepatitis C: Still unhappy bedfellows?. Journal of Gastroenterology and Hepatology 26, 96-101
CrossRef107
Massimo Iavarone, Massimo Colombo. (2011) HBV-related HCC, clinical issues and therapy. Digestive and Liver Disease 43, S32-S39
CrossRef108
Rahul Deshpande, Derek O'Reilly, David Sherlock. (2011) Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. International Journal of Hepatology 2011, 1-9
CrossRef109
Wagida A. Anwar. (2011) Genetic Toxicology Research in Developing Countries: Challenges and Possibilities—Egypt as an Example. Genes and Environment 33:4, 149-159
CrossRef110
Naoki Hotta, Seigo Yamada, Kenichi Murase, Kazuo Masuko. (2011) Usefulness of Real-Time 4D Ultrasonography during Radiofrequency Ablation in a Case of Hepatocellular Carcinoma. Case Reports in Gastroenterology 5:1, 82-87
CrossRef111
Yoon Kyung Park, Kang Mo Kim, Young-Joo Lee, Ki-Hun Kim, Sung-Gyu Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh. (2011) Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?. Journal of Korean Medical Science 26:2, 214
CrossRef112
Nancy E. Kemeny, Lawrence Schwartz, Mithat Gönen, Adam Yopp, David Gultekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter Allen, William R. Jarnagin. (2011) Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?. Oncology 80:3-4, 153-159
CrossRef113
Shawn S. Groth, Beth A. Virnig, Waddah B. Al-Refaie, Stephanie L. Jarosek, Eric H. Jensen, Todd M. Tuttle. (2011) Appendiceal carcinoid tumors: Predictors of lymph node metastasis and the impact of right hemicolectomy on survival. Journal of Surgical Oncology 103:1, 39-45
CrossRef114
Dong-Won Ahn, Ju Hyun Shim, Jung-Hwan Yoon, Chung Yong Kim, Hyo-Suk Lee, Yeong Tae Kim, Yoon Jun Kim. (2011) Treatment and clinical outcome of needle-track seeding from hepatocellular carcinoma. The Korean Journal of Hepatology 17:2, 106
CrossRef115
De-Xin Lin, Qi-Yu Zhang, Xuan Li, Qi-Wen Ye, Fen Lin, Lin-Li Li. (2011) An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Journal of Cancer Research and Clinical Oncology 137:1, 139-149
CrossRef116
Nishant Merchant, Calvin S. David, Steven C. Cunningham. (2011) Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. International Journal of Hepatology 2011, 1-7
CrossRef117
Seiji Ishiguro, Manami Inoue, Yasuhito Tanaka, Masashi Mizokami, Motoki Iwasaki, Shoichiro Tsugane. (2011) Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population-based cohort study (JPHC Study). Cancer Letters 300:2, 173-179
CrossRef118
Kerstin Schütte, Lars Zimmermann, Jan Bornschein, Antal Csepregi, Ricarda Rühl, Jens Ricke, Peter Malfertheiner. (2011) Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis. Digestion 83:4, 275-282
CrossRef119
Philip A. Philip, Michelle R. Mahoney, Kyle D. Holen, Donald W. Northfelt, Henry C. Pitot, Joel Picus, Patrick J. Flynn, Charles Erlichman. (2011) Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer. Cancern/a-n/a
CrossRef120
Dong-Jun Yoo, Kang Mo Kim, Young-Joo Jin, Ju Hyun Shim, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Jae-Lyun Lee, Yoon-Koo Kang, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh. (2011) Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?. Journal of Gastroenterology and Hepatology 26:1, 145-154
CrossRef121
Pierre Bedossa, Valérie Paradis. 2011. Hepatocellular Carcinoma. , 489-501.
CrossRef122
Norio Iizuka, Masaaki Oka, Isao Sakaida, Toyoki Moribe, Toshiaki Miura, Naoki Kimura, Shigeru Tamatsukuri, Hideo Ishitsuka, Koichi Uchida, Shuji Terai, Satoyoshi Yamashita, Kiwamu Okita, Koichiro Sakata, Yoshiyasu Karino, Joji Toyota, Eiji Ando, Tatsuya Ide, Michio Sata, Ryoichi Tsunedomi, Masahito Tsutsui, Michihisa Iida, Yoshihiro Tokuhisa, Kazuhiko Sakamoto, Takao Tamesa, Yusuke Fujita, Yoshihiko Hamamoto. (2011) Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. Clinica Chimica Acta 412:1-2, 152-158
CrossRef123
Naoki Fujita, Yoshiyuki Takei. 2011. Iron overload in nonalcoholic steatohepatitis. , 105-132.
CrossRef124
Jendana Chanyaputhipong, Su-Chong Albert Low, Pierce K. H. Chow. (2011) Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. International Journal of Hepatology 2011, 1-13
CrossRef125
Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo. (2011) Laser Ablation for Small Hepatocellular Carcinoma. Radiology Research and Practice 2011, 1-8
CrossRef126
Gitonga Munene, Jean-Nicolas Vauthey, Elijah Dixon. (2011) Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. International Journal of Hepatology 2011, 1-4
CrossRef127
Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues. (2011) Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study. International Journal of Hepatology 2011, 1-7
CrossRef128
Thomas Gamstätter, Arndt Weinmann, Simin Schadmand-Fischer, Pia R. Spies, Ina M. Niederle, Marcus Schuchmann, Peter R. Galle, Marcus-Alexander Wörns. (2011) AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the Literature. Onkologie 34:10, 538-542
CrossRef129
Jos F. van Pelt, Hannah van Malenstein, Frederik Nevens, Chris Verslype. (2011) Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma. ISRN Pathology 2011, 1-10
CrossRef130
Mohamed Azab, Samy Zaki, Anwar G. El-Shetey, Mohamed F. Abdel-Moty, Nabil M.G. Alnoomani, Ahmad A. Gomaa, Sabry Abdel-Fatah, Sayed Mohiy, Faried Atia. (2011) Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma. Arab Journal of Gastroenterology 12:3, 113
CrossRef131
Min-Shan Chen, Zhen-Wei Peng, Li Xu, Yao-Jun Zhang, Hui-Hong Liang, Jin-Qing Li. (2011) Role of Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: Experience of a Cancer Center in China. Oncology 81:s1, 100-104
CrossRef132
Florie Borel, Ruiqi Han, Allerdien Visser, Harald Petry, Sander J.H. van Deventer, Peter L.M. Jansen, Pavlina Konstantinova. (2011) ATP-Binding Cassette Transporter Genes Up-Regulation in Untreated Hepatocellular Carcinoma is Mediated by Cellular microRNAs. Hepatologyn/a-n/a
CrossRef133
Gavin Low, Edward Leen. 2011. Focal liver lesions/echo enhancing agents and the liver. , 138-166.
CrossRef134
Nishant Poddar, Boris Avezbakiyev, Zili He, Ming Jiang, Arash Gohari, Jen Chen Wang. (2010) Hepatocellular Carcinoma Presenting as an Incidental Isolated Malignant Portal Vein Thrombosis. Journal of Gastrointestinal Cancer
CrossRef135
Lu Wu, Ye-Fa Yang, Nai-Jian Ge, Shu-Qun Shen, Jun Liang, Yi Wang, Wei-Ping Zhou, Feng Shen, Meng-Chao Wu. (2010) Hepatic Arterial Iodine-131–Labeled Metuximab Injection Combined with Chemoembolization for Unresectable Hepatocellular Carcinoma: Interim Safety and Survival Data from 110 Patients. Cancer Biotherapy & Radiopharmaceuticals 25:6, 657-663
CrossRef136
B Sangro, G Mazzolini, M Ruiz, J Ruiz, J Quiroga, I Herrero, C Qian, A Benito, J Larrache, C Olagüe, J Boan, I Peñuelas, B Sádaba, J Prieto. (2010) A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Therapy 17:12, 837-843
CrossRef137
Jiwei Huang, Lvnan Yan, Zheyu Cheng, Hong Wu, Liang Du, Jinzhou Wang, Yinglong Xu, Yong Zeng. (2010) A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria. Annals of Surgery 252:6, 903-912
CrossRef138
Spiros G. Delis, Andreas Bakoyiannis, Nikos Tassopoulos, Kostas Athanassiou, Dimitrios Kelekis, Juan Madariaga, Christos Dervenis. (2010) Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surgical Oncology 19:4, 200-207
CrossRef139
Agneta Norén, Jozef Urdzik, Frans Duraj, Charlotte Ebeling Barbier, Britt-Mari Karlson, Ulf Haglund. (2010) Longterm follow-up after transarterial chemotherapy for hepatocellular carcinoma in a Scandinavian centre. HPB 12:9, 637-643
CrossRef140
Jeremy F. L. Cobbold, Quentin M. Anstee, Simon D. Taylor-Robinson. (2010) The importance of fatty liver disease in clinical practice. Proceedings of the Nutrition Society 69:04, 518-527
CrossRef141
Jian-Min Wu, Nicholas J. Skill, Mary A. Maluccio. (2010) Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB 12:9, 625-636
CrossRef142
Jeffery S. Russell, Rajiv Sawhney, Alexander Monto, Sujal Nanavati, J. Ben Davoren, Rizwan Aslam, Carlos U. Corvera. (2010) Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center. The American Journal of Surgery 200:5, 659-664
CrossRef143
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. (2010) Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacologica Sinica 31:11, 1409-1420
CrossRef144
Natalie M. Johnson, Guoqing Qian, Li Xu, Danielle Tietze, Alicia Marroquin-Cardona, Abraham Robinson, Melanie Rodriguez, Linda Kaufman, Kyle Cunningham, James Wittmer, Fernando Guerra, Kirby C. Donnelly, Jonathan H. Williams, Jia-Sheng Wang, Timothy D. Phillips. (2010) Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Science of The Total Environment 408:23, 6027-6031
CrossRef145
Chuanxing Li, Fujun Zhang, Weidong Zhang, Liang Zhang, Zilin Huang, Peihong Wu. (2010) Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 136:11, 1633-1640
CrossRef146
Yuki Fujiwara, Hiroaki Shiba, Kenei Furukawa, Tomonori Iida, Taro Sakamoto, Takeshi Gocho, Shigeki Wakiyama, Shoichi Hirohara, Yuichi Ishida, Takeyuki Misawa, Toya Ohashi, Katsuhiko Yanaga. (2010) Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 17:6, 892-897
CrossRef147
Tomokazu Kawaoka, Hiroshi Aikata, Shintaro Takaki, Yoshimasa Hashimoto, Yoshio Katamura, Akira Hiramatsu, Koji Waki, Shoichi Takahashi, Koji Kamada, Mikiya Kitamoto, Toshio Nakanishi, Masaki Ishikawa, Masashi Hieda, Hideaki Kakizawa, Junko Tanaka, Kazuaki Chayama. (2010) Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems. Hepatology Research 40:11, 1082-1091
CrossRef148
Amelia J. Hessheimer, Alejandro Forner, María Varela, Jordi Bruix. (2010) Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 22:10, 1239-1244
CrossRef149
Rohit Loomba, Hwai-I. Yang, Jun Su, David Brenner, Uchenna Iloeje, Chien-Jen Chen. (2010) Obesity and Alcohol Synergize to Increase the Risk of Incident Hepatocellular Carcinoma in Men. Clinical Gastroenterology and Hepatology 8:10, 891-898.e2
CrossRef150
Haruo Watanabe, Masayuki Kanematsu, Teruhiko Kitagawa, Yuriko Suzuki, Hiroshi Kondo, Satoshi Goshima, Kimihiro Kajita, Kyongtae T. Bae, Yoshinobu Hirose, Seiki Miotani, Xiangrong Zhou, Hiroshi Fujita. (2010) MR elastography of the liver at 3 T with cine-tagging and bending energy analysis: preliminary results. European Radiology 20:10, 2381-2389
CrossRef151
Masaki Kaibori, Morihiko Ishizaki, Kosuke Matsui, A-Hon Kwon. (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. Journal of Surgical Oncology 102:5, 462-468
CrossRef152
Peter Gassmann, Tilmann Spieker, Joerg Haier, Fabian Schmidt, Wolf Arif Mardin, Norbert Senninger. (2010) Prognostic Impact of Underlying Liver Fibrosis and Cirrhosis After Curative Resection of Hepatocellular Carcinoma. World Journal of Surgery 34:10, 2442-2451
CrossRef153
Chien Peter Chen, Daphne Haas-Kogan. (2010) Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics. Expert Review of Molecular Diagnostics 10:7, 883-895
CrossRef154
Meredith E. Giuliani, Jennifer Knox, Laura A. Dawson. (2010) Malignant Intracardiac Thrombus from Hepatocellular Carcinoma Treated with External Beam Radiation Therapy. Journal of Palliative Medicine 13:10, 1293-1295
CrossRef155
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Massimiliano Berretta, Alessandro Cappellani, Mariano Malaguarnera. (2010) Serum Markers of Hepatocellular Carcinoma. Digestive Diseases and Sciences 55:10, 2744-2755
CrossRef156
Willscott E. Naugler, Amnon Sonnenberg. (2010) Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transplantation 16:10, 1186-1194
CrossRef157
Yusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada. (2010) New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatology Research 40:10, 1006-1014
CrossRef158
Xiaozhou Ma, Ronald S. Arellano, Debra A. Gervais, Peter F. Hahn, Peter R. Mueller, Dushyant V. Sahani. (2010) Success of Image-guided Biopsy for Small (≤ 3 cm) Focal Liver Lesions in Cirrhotic and Noncirrhotic Individuals. Journal of Vascular and Interventional Radiology 21:10, 1539-1547
CrossRef159
Andrew Kennedy, Douglas Coldwell, Bruno Sangro, Harpreet Wasan, Riad Salem. (2010) Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver Tumors. American Journal of Clinical Oncology1
CrossRef160
Thomas J. Byrne. 2010. Liver Mass Found on Abdominal Imaging. , 95-104.
CrossRef161
George P. Kim, Michelle R. Mahoney, Daniel Szydlo, Tony S. K. Mok, Robert Marshke, Kyle Holen, Joel Picus, Michael Boyer, Henry C. Pitot, Joseph Rubin, Philip A. Philip, Anna Nowak, John J. Wright, Charles Erlichman. (2010) An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Investigational New Drugs
CrossRef162
Hideki Ohnishi, Kohsaku Sakaguchi, Kazuhiro Nouso, Yoshiyuki Kobayashi, Shinichiro Nakamura, Hironori Tanaka, Yasuhiro Miyake, Bon Shoji, Shouta Iwadou, Yasushi Shiratori. (2010) Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma. Hepatology International 4:3, 562-568
CrossRef163
Lorenzo Cereser, Alessandro Furlan, Daniele Bagatto, Rossano Girometti, Giuseppe Como, Claudio Avellini, Maria Orsaria, Chiara Zuiani, Massimo Bazzocchi. (2010) Comparison of Portal Venous and Delayed Phases of Gadolinium-Enhanced Magnetic Resonance Imaging Study of Cirrhotic Liver for the Detection of Contrast Washout of Hypervascular Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 34:5, 706-711
CrossRef164
Chuanxing Li, Weidong Zhang, Rong Zhang, Liang Zhang, Peihong Wu, Fujun Zhang. (2010) Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. European Journal of Cancer 46:13, 2513-2521
CrossRef165
Xuekang Yang, Desheng Wang, Wei Dong, Zhenshun Song, Kefeng Dou. (2010) Inhibition of Na+/H+ exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Letters 295:2, 198-204
CrossRef166
R. Vilana, A. Forner, Á. García, C. Ayuso, C. Bru. (2010) Carcinoma hepatocelular: diagnóstico, estadificación y estrategia terapéutica. Radiología 52:5, 385-398
CrossRef167
Hidekatsu Kuroda, Akira Ushio, Yasuhiro Miyamoto, Kei Sawara, Kanta Oikawa, Kazuhiro Kasai, Ryujin Endo, Yasuhiro Takikawa, Akinobu Kato, Kazuyuki Suzuki. (2010) Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one-year prospective trial. Journal of Gastroenterology and Hepatology 25:9, 1550-1555
CrossRef168
Balkrishan Sharma, Radhika Srinivasan, Yogesh Kumar Chawla, Shweta Kapil, Nitin Saini, Bhupesh Singla, Anuradha Chakraborthy, Naveen Kalra, Ajay Duseja, Radha Krishan Dhiman. (2010) Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. Hepatology International 4:3, 569-576
CrossRef169
Lifang Fan, Mylinh T Mac, David P Frishberg, Xuemo Fan, Deepti Dhall, Bonnie L Balzer, Stephen A Geller, Hanlin L Wang. (2010) Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 25:9, 1556-1561
CrossRef170
Chin-Ta Lin, Kuo-Feng Hsu, Teng-Wei Chen, Jyh-Cherng Yu, De-Chuan Chan, Chih-Yung Yu, Tsai-Yuan Hsieh, Hsiu-Lung Fan, Shih-Ming Kuo, Kuo-Piao Chung, Chung-Bao Hsieh. (2010) Comparing Hepatic Resection and Transarterial Chemoembolization for Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma: Change for Treatment of Choice?. World Journal of Surgery 34:9, 2155-2161
CrossRef171
Terence C. Chua, Akshat Saxena, Francis Chu, Winston Liauw, Jing Zhao, David L. Morris. (2010) Clinicopathological Determinants of Survival After Hepatic Resection of Hepatocellular Carcinoma in 97 Patients—Experience From an Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery 14:9, 1370-1380
CrossRef172
K.-W. Huang, H.-L. Wu, H.-L. Lin, P.-C. Liang, P.-J. Chen, S.-H. Chen, H.-I. Lee, P.-Y. Su, W.-H. Wu, P.-H. Lee, L.-H. Hwang, D.-S. Chen. (2010) Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model. Proceedings of the National Academy of Sciences 107:33, 14769-14774
CrossRef173
Asra S. Khan, Hero K. Hussain, Timothy D. Johnson, William J. Weadock, Shawn J. Pelletier, Jorge A. Marrero. (2010) Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. Journal of Magnetic Resonance Imaging 32:2, 360-366
CrossRef174
Zobair M. Younossi, Maria Stepanova. (2010) Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States. Clinical Gastroenterology and Hepatology 8:8, 718-723
CrossRef175
Tatehiro Kagawa, Jun Koizumi, Sei-ichiro Kojima, Naruhiko Nagata, Makoto Numata, Norihito Watanabe, Tetsu Watanabe, Tetsuya Mine. (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma. Cancer 116:15, 3638-3644
CrossRef176
Shilpa Lingala, Yi-Yao Cui, Xiaoli Chen, Boris H. Ruebner, Xiao-Feng Qian, Mark A. Zern, Jian Wu. (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Experimental and Molecular Pathology 89:1, 27-35
CrossRef177
Thomas A. Aloia, Richard Knight, A. Osama Gaber, R. Mark Ghobrial, John A. Goss. (2010) Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transplantation 16:8, 950-959
CrossRef178
Peter Abrams, J. Wallis Marsh. (2010) Current Approach to Hepatocellular Carcinoma. Surgical Clinics of North America 90:4, 803-816
CrossRef179
George V. Papatheodoridis, Pietro Lampertico, Spilios Manolakopoulos, Anna Lok. (2010) Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review. Journal of Hepatology 53:2, 348-356
CrossRef180
Tomokazu Kawaoka, Hiroshi Aikata, Yoshio Katamura, Shintaro Takaki, Koji Waki, Akira Hiramatsu, Shoichi Takahashi, Masashi Hieda, Hideaki Kakizawa, Kazuaki Chayama. (2010) Hypersensitivity Reactions to Transcatheter Chemoembolization with Cisplatin and Lipiodol Suspension for Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 21:8, 1219-1225
CrossRef181
Jia-Yin Zhou, Damon W. K. Wong, Feng Ding, Sudhakar K. Venkatesh, Qi Tian, Ying-Yi Qi, Wei Xiong, Jimmy J. Liu, Wee-Kheng Leow. (2010) Liver tumour segmentation using contrast-enhanced multi-detector CT data: performance benchmarking of three semiautomated methods. European Radiology 20:7, 1738-1748
CrossRef182
H. Yanai, K. Nakamura, S. Hijioka, A. Kamei, T. Ikari, Y. Ishikawa, E. Shinozaki, N. Mizunuma, K. Hatake, A. Miyajima. (2010) Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. Journal of Biochemistry 148:1, 85-92
CrossRef183
Takanori Sakaguchi, Shohachi Suzuki, Yoshifumi Morita, Kousuke Oishi, Atsushi Suzuki, Kazuhiko Fukumoto, Keisuke Inaba, Satoshi Nakamura, Hiroyuki Konno. (2010) Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria. Surgery Today 40:7, 638-645
CrossRef184
Hiroyuki Kirikoshi, Satoru Saito, Norio Ueno, Kaori Suzuki, Hirokazu Takahashi, Masato Yoneda, Koji Fujita, Atsushi Nakajima. (2010) Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapy. Journal of Medical Ultrasonics 37:3, 137-141
CrossRef185
Abby B. Siegel, Sonja K. Olsen, Arthur Magun, Robert S. Brown. (2010) Sorafenib: Where do we go from here?. Hepatology 52:1, 360-369
CrossRef186
Chia-Yang Hsu, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Che-Chuan Loong, Yi-You Chiou, Jen-Huey Chiang, Pui-Ching Lee, Teh-Ia Huo, Shou-Dong Lee. (2010) A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system. Journal of Hepatology 53:1, 108-117
CrossRef187
Rohit Sharma, John F. Gibbs. (2010) Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome. Journal of Surgical Oncology 101:8, 745-754
CrossRef188
Guido Bonomo, Vittorio Pedicini, Lorenzo Monfardini, Paolo Della Vigna, Dario Poretti, Gianluigi Orgera, Franco Orsi. (2010) Bland Embolization in Patients with Unresectable Hepatocellular Carcinoma Using Precise, Tightly Size-Calibrated, Anti-Inflammatory Microparticles: First Clinical Experience and One-Year Follow-Up. CardioVascular and Interventional Radiology 33:3, 552-559
CrossRef189
János Fehér, Gabriella Lengyel. (2010) Hepatocellularis carcinoma: előfordulás, kórokok, biomarkerek. Orvosi Hetilap 151:23, 933-940
CrossRef190
Abdel-Rahman El-Zayadi, Hanaa M. Badran, Sherine Shawky, Sally Emara, Ashraf El-Bareedy, Mohammed Sobhi. (2010) Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients. Hepatology International 4:2, 500-506
CrossRef191
Alejandro Forner, Carlos Rodríguez De Lope, María Reig, Jordi Bruix. (2010) Tratamiento del carcinoma hepatocelular avanzado. Gastroenterología y Hepatología 33:6, 461-468
CrossRef192
Mustafa S. Ascha, Ibrahim A. Hanouneh, Rocio Lopez, Tarek Abu-Rajab Tamimi, Ariel F. Feldstein, Nizar N. Zein. (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:6, 1972-1978
CrossRef193
Junfang Ji, Lei Zhao, Anuradha Budhu, Marshonna Forgues, Hu-Liang Jia, Lun-Xiu Qin, Qing-Hai Ye, Jinming Yu, Xuetao Shi, Zhao-You Tang, Xin Wei Wang. (2010) Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinoma. Journal of Hepatology 52:5, 690-697
CrossRef194
Richard S. Finn. (2010) Drug therapy: Sorafenib. Hepatology 51:5, 1843-1849
CrossRef195
Brad Q. Starley, Christopher J. Calcagno, Stephen A. Harrison. (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 51:5, 1820-1832
CrossRef196
William R. Jarnagin. (2010) Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation. Annals of Surgical Oncology 17:5, 1226-1233
CrossRef197
Bernardino Rampone, Beniamino Schiavone, Giuseppe Confuorto. (2010) Current Management of Hepatocellular Cancer. Current Oncology Reports 12:3, 186-192
CrossRef198
Chang Moo Kang, Gi Hong Choi, Dong Hyun Kim, Sae Byeol Choi, Kyung Sik Kim, Jin Sub Choi, Woo Jung Lee. (2010) Revisiting the Role of Nonanatomic Resection of Small (≤4 cm) and Single Hepatocellular Carcinoma in Patients With Well-Preserved Liver Function. Journal of Surgical Research 160:1, 81-89
CrossRef199
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. (2010) Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 25:5, 951-956
CrossRef200
S. Jelic, G. C. Sotiropoulos, . (2010) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21:Supplement 5, v59-v64
CrossRef201
Kyle A. Perry, C. Kristian Enestvedt, Luke W. Hosack, Thai H. Pham, Brian S. Diggs, Swee Teh, Susan Orloff, Shelly Winn, John G. Hunter, Brett C. Sheppard. (2010) Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. Surgical Endoscopy 24:5, 1151-1157
CrossRef202
Hiroji Shinkawa, Takahiro Uenishi, Shigekazu Takemura, Kazuki Ohba, Masao Ogawa, Tsuyoshi Ichikawa, Shintaro Kodai, Takatsugu Yamamoto, Hiromu Tanaka, Shoji Kubo. (2010) Risk factors for postoperative recurrence of non-B non-C hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 17:3, 291-295
CrossRef203
Ana-Carolina Cardoso, Rami Moucari, Claudio Figueiredo-Mendes, Marie-Pierre Ripault, Nathalie Giuily, Corinne Castelnau, Nathalie Boyer, Tarik Asselah, Michelle Martinot-Peignoux, Sarah Maylin, Roberto J. Carvalho-Filho, Dominique Valla, Pierre Bedossa, Patrick Marcellin. (2010) Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis. Journal of Hepatology 52:5, 652-657
CrossRef204
Markus Frieser, Deike Strobel, Stefan Schaber, Thaddaeus Till Wissniowski, Thomas Bernatik, Steffen Adis, Eckhart Georg Hahn, Johannes Marcus Hänsler. (2010) Getaktete Dreifachapplikation mit perfundierten Nadelapplikatoren bei Radiofrequenzablation: In - vitro -Versuch an der Rinderleber / Pulsed radiofrequency ablation using perfused needle applicators in an in vitro trial on bovine liver. Biomedizinische Technik/Biomedical Engineering 55:2, 101-107
CrossRef205
Shuji Kanmura, Hirofumi Uto, Yuko Sato, Koutarou Kumagai, Fumisato Sasaki, Akihiro Moriuchi, Makoto Oketani, Akio Ido, Kenji Nagata, Katsuhiro Hayashi, Sherri O. Stuver, Hirohito Tsubouchi. (2010) The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. Journal of Gastroenterology 45:4, 459-467
CrossRef206
Anoop P Ayyappan, Kartik S Jhaveri. (2010) CT and MRI of hepatocellular carcinoma: an update. Expert Review of Anticancer Therapy 10:4, 507-519
CrossRef207
Nader N. Massarweh, James O. Park, Farhood Farjah, Raymond S.W. Yeung, Rebecca Gaston Symons, Thomas L. Vaughan, Laura-Mae Baldwin, David R. Flum. (2010) Trends in the Utilization and Impact of Radiofrequency Ablation for Hepatocellular Carcinoma. Journal of the American College of Surgeons 210:4, 441-448
CrossRef208
Jesper B. Andersen, Roberto Loi, Andrea Perra, Valentina M. Factor, Giovanna M. Ledda-Columbano, Amedeo Columbano, Snorri S. Thorgeirsson. (2010) Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 51:4, 1401-1409
CrossRef209
Higinia R. Cárdenes, Tracy R. Price, Susan M. Perkins, Mary Maluccio, P. Kwo, T. E. Breen, Mark A. Henderson, Tracey E. Schefter, Kathy Tudor, Jill Deluca, Peter A. S. Johnstone. (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clinical and Translational Oncology 12:3, 218-225
CrossRef210
Nabil M. Abdel-Hamid, Mohamed A. Morsy. (2010) Novel Biochemical Pathways for 5-Fluorouracil in Managing Experimental Hepatocellular Carcinoma in Rats. Journal of Membrane Biology 234:1, 29-34
CrossRef211
Tao Zhang, Xin Ding, Dong Wei, Peng Cheng, Xiaomei Su, Huanyi Liu, Daoyuan Wang, Hui Gao. (2010) Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials. Anti-Cancer Drugs 21:3, 326-332
CrossRef212
Hans-Udo Kasper, Christopher Bangard, Axel Gossmann, Hans Peter Dienes, Dirk Ludger Stippel. (2010) Pathomorphological changes after radiofrequency ablation in the liver. Pathology International 60:3, 149-155
CrossRef213
Z.-W. Peng, M.-S. Chen, H.-H. Liang, H.-J. Gao, Y.-J. Zhang, J.-Q. Li, Y.-Q. Zhang, W.Y. Lau. (2010) A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 36:3, 257-263
CrossRef214
Mostafa Hashim, Ahmed A. S. Salem. (2010) Simultaneous Treatment of Unresectable Hepatocelluar Carcinoma and Hepatic Artery Aneurysm, Case Report. Journal of Gastrointestinal Cancer 41:1, 13-16
CrossRef215
Jennifer Altomonte, Sabrina Marozin, Roland M Schmid, Oliver Ebert. (2010) Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma. Molecular Therapy 18:2, 275-284
CrossRef216
Mosaad A. Abdel-Wahhab, Nabila S. Hassan, Ahmed A. El-Kady, Yasser A. Khadrawy, Aziza A. El-Nekeety, Sherif R. Mohamed, Hafiza A. Sharaf, Fathia A. Mannaa. (2010) Red ginseng extract protects against aflatoxin B1 and fumonisins-induced hepatic pre-cancerous lesions in rats. Food and Chemical Toxicology 48:2, 733-742
CrossRef217
Gary L. Davis, Miriam J. Alter, Hashem El–Serag, Thierry Poynard, Linda W. Jennings. (2010) Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression. Gastroenterology 138:2, 513-521.e6
CrossRef218
R. CABRERA, D. R. NELSON. (2010) Review article: the management of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 31:4, 461-476
CrossRef219
Augusto Villanueva, Beatriz Minguez, Alejandro Forner, Maria Reig, Josep M. Llovet. (2010) Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy. Annual Review of Medicine 61:1, 317-328
CrossRef220
U. Bork, M. Koch, M.W. Büchler, J. Weitz. (2010) Hepatobiliäre Tumorchirurgie. Der Chirurg 81:2, 111-116
CrossRef221
Ritesh Rathore, Howard Safran, Greg Soares, Greg Dubel, Brendan McNulty, Sun Ahn, David Iannitti, Teresa Kennedy. (2010) Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Advanced Hepatocellular Cancer. American Journal of Clinical Oncology 33:1, 43-46
CrossRef222
Min-Hua Wang, Yuan Ji, Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, Jian Zhou, Meng-Su Zeng, Ai-Hong Bi, Yun-Shan Tan. (2010) Impact Factors for Microinvasion in Patients With Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume. International Journal of Radiation Oncology*Biology*Physics 76:2, 467-476
CrossRef223
Matthew M Yeh, Hubert Darius-J Daniel, Michael Torbenson. (2010) Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers. Modern Pathology 23:2, 276-283
CrossRef224
S. Esneault, C. Lafon, J.-L. Dillenseger. (2010) Liver Vessels Segmentation Using a Hybrid Geometrical Moments/Graph Cuts Method. IEEE Transactions on Biomedical Engineering 57:2, 276-283
CrossRef225
Ching-Yih Lin, Chang-Sheng Kuo, Chin-Li Lu, Meng-Ying Wu, Rwei-Fen Syu Huang. (2010) Elevated Serum Vitamin B 12 Levels in Association With Tumor Markers as the Prognostic Factors Predictive for Poor Survival in Patients With Hepatocellular Carcinoma. Nutrition and Cancer 62:2, 190-197
CrossRef226
Jung Ho Han, Dong Gyu Kim, Jung Cheol Park, Hyun-Tai Chung, Sun Ha Paek, Young Seob Chung. (2010) Little Response of Cerebral Metastasis from Hepatocellular Carcinoma to Any Treatments. Journal of Korean Neurosurgical Society 47:5, 325
CrossRef227
Jiunn-Chang Lin, Yung-Luen Shih, Pei-Ju Chien, Chien-Liang Liu, Jie-Jen Lee, Tsan-Pai Liu, Wen-Ching Ko, Chwen-Ming Shih. (2010) Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. Human Immunology 71:1, 58-62
CrossRef228
Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber. (2010) Hepatocellular Carcinoma: Current Management. Current Problems in Surgery 47:1, 10-67
CrossRef229
Yu-Jia Chang, Chong-Chi Chiu, Chih-Hsiung Wu, Jane An, Cheng-Chia Wu, Tsan-Zon Liu, Po-Li Wei, Ming-Te Huang. (2010) Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma. Annals of Surgical Oncology 17:6, 1703
CrossRef230
Yun Kyung Kang, Seong Woo Hong, Hyucksang Lee, Woo Ho Kim. (2010) Prognostic implications of ezrin expression in human hepatocellular carcinoma. Molecular Carcinogenesisn/a-n/a
CrossRef231
M. J. Thun, J. O. DeLancey, M. M. Center, A. Jemal, E. M. Ward. (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31:1, 100-110
CrossRef232
R. Vilana, A. Forner, Á. García, C. Ayuso, C. Bru. (2010) Hepatocellular Carcinoma: Diagnosis, staging, and treatment strategy. Radiología (English Edition) 52:5, 385-398
CrossRef233
Srinath Chinnakotla, Gary L. Davis, Sugam Vasani, Peter Kim, Koji Tomiyama, Edmund Sanchez, Nicholas Onaca, Robert Goldstein, Marlon Levy, Göran B. Klintmalm. (2009) Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation 15:12, 1834-1842
CrossRef234
L. Macarini, P. Milillo, A. Cascavilla, G. Scalzo, L. Stoppino, R. Vinci, G. Moretti, G. Ettorre. (2009) MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. La radiologia medica 114:8, 1267-1282
CrossRef235
Wei-Wen Su, Chien-Hung Chen, Hans Hsienhong Lin, Sheng-Shun Yang, Ting-Tsung Chang, Ken-Sheng Cheng, Jaw-Ching Wu, Shun-Sheng Wu, Chuan-Mo Lee, Chi-Sin Changchien, Chien-Jen Chen, Jin-Chuan Sheu, Ding-Shinn Chen, Sheng-Nan Lu. (2009) Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas. Hepatology International 3:4, 537-543
CrossRef236
Pablo Muriel. (2009) Role of free radicals in liver diseases. Hepatology International 3:4, 526-536
CrossRef237
P. Merle, F. Mornex, C. Trepo. (2009) Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy. Cancer Letters 286:1, 129-133
CrossRef238
Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Jen-Huey Chiang, Han-Chieh Lin, Pui-Ching Lee, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee. (2009) Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Renal Insufficiency. Journal of Clinical Gastroenterology1
CrossRef239
Niraj J. Gusani, Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-OʼCarroll, Hua Cheng, Jaffer A. Ajani. (2009) New Pharmacological Developments in the Treatment of Hepatocellular Cancer. Drugs 69:18, 2533-2540
CrossRef240
G. Morris-Stiff, D. Gomez, N. de Liguori Carino, K.R. Prasad. (2009) Surgical management of hepatocellular carcinoma: Is the jury still out?. Surgical Oncology 18:4, 298-321
CrossRef241
Alyson McIntosh, Klaus D. Hagspiel, Abdullah M. Al-Osaimi, Patrick Northup, Stephen Caldwell, Carl Berg, J. Fritz Angle, Curtis Argo, Geoffrey Weiss, Tyvin A. Rich. (2009) Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. Cancer 115:21, 5117-5125
CrossRef242
Spiros G. Delis, Andreas Bakoyiannis, Nikos Tassopoulos, Kostas Athanassiou, Aristotelis Kechagias, Dimitrios Kelekis, Juan Madariaga, Christos Dervenis. (2009) Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB 11:7, 551-558
CrossRef243
B. A. KONKLE, C. KESSLER, L. ALEDORT, J. ANDERSEN, P. FOGARTY, P. KOUIDES, D. QUON, M. RAGNI, A. ZAKARIJA, B. EWENSTEIN. (2009) Emerging clinical concerns in the ageing haemophilia patient. Haemophilia 15:6, 1197-1209
CrossRef244
Junichi Yamanaka, Toshihiro Okada, Shinichi Saito, Yuichi Kondo, Yasuhiko Yoshida, Kazuhiro Suzumura, Tadamichi Hirano, Yuji Iimuro, Jiro Fujimoto. (2009) Minimally invasive laparoscopic liver resection: 3D MDCT simulation for preoperative planning. Journal of Hepato-Biliary-Pancreatic Surgery 16:6, 808-815
CrossRef245
Laura E. Moreno Luna, Paul Y. Kwo, Lewis R. Roberts, Teresa A. Mettler, Denise N. Gansen, James C. Andrews, Gregory A. Wiseman, Vijay Laxmi Misra. (2009) Liver transplantation after radioembolization in a patient with unresectable HCC. Nature Reviews Gastroenterology & Hepatology 6:11, 679-683
CrossRef246
Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip. (2009) Vascular endothelial growth factor in the management of hepatocellular carcinoma. Cancer 115:21, 4895-4906
CrossRef247
W. Ray Kim, Norah A. Terrault, Rachel A. Pedersen, Terry M. Therneau, Erick Edwards, Andrew A. Hindman, Carol L. Brosgart. (2009) Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States. Gastroenterology 137:5, 1680-1686
CrossRef248
Takahide Uehara, Masashi Hirooka, Yoshiyasu Kisaka, Masanori Abe, Yoichi Hiasa, Morikazu Onji. (2009) Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients. Hepatology Research 39:10, 954-962
CrossRef249
Hye Jin Kim, Ji Hoon Shin, Tae-Hyung Kim, Eun Young Kim, Young Soo Park, Chan-Sik Park, Ho-Young Song. (2009) Efficacy of Transarterial Embolization with Arsenic Trioxide Oil Emulsion in a Rabbit VX2 Liver Tumor Model. Journal of Vascular and Interventional Radiology 20:10, 1365-1370
CrossRef250
Aya Kamaya, Katherine E. Maturen, Grace A. Tye, Yueyi I. Liu, Naveen N. Parti, Terry S. Desser. (2009) Hypervascular Liver Lesions. Seminars in Ultrasound, CT, and MRI 30:5, 387-407
CrossRef251
Evangelia M Fatourou, John S Koskinas. (2009) Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Review of Anticancer Therapy 9:10, 1499-1510
CrossRef252
Paul Marotta, Dietrich Hueppe, Elmar Zehnter, Paul Kwo, Ira Jacobson. (2009) Efficacy of Chronic Hepatitis C Therapy in Community-Based Trials. Clinical Gastroenterology and Hepatology 7:10, 1028-1036
CrossRef253
Jia Zhou, Tong Ding, Weidong Pan, Ling-yan Zhu, Lian Li, Limin Zheng. (2009) Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. International Journal of Cancer 125:7, 1640-1648
CrossRef254
Katsuhiro Ogawa. (2009) Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathology International 59:9, 605-622
CrossRef255
Tomohiro Iguchi, Shinichi Aishima, Kensaku Sanefuji, Nobuhiro Fujita, Keishi Sugimachi, Tomonobu Gion, Akinobu Taketomi, Ken Shirabe, Yoshihiko Maehara, Masazumi Tsuneyoshi. (2009) Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in Japan. Annals of Surgical Oncology 16:9, 2539-2546
CrossRef256
Ira M. Jacobson. (2009) Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy. Clinical Gastroenterology and Hepatology 7:9, 921-930
CrossRef257
W. R. Jarnagin, L. H. Schwartz, D. H. Gultekin, M. Gonen, D. Haviland, J. Shia, M. D'Angelica, Y. Fong, R. DeMatteo, A. Tse, L. H. Blumgart, N. Kemeny. (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Annals of Oncology 20:9, 1589-1595
CrossRef258
Jordi Rimola, Alejandro Forner, Maria Reig, Ramon Vilana, Carlos Rodríguez de Lope, Carmen Ayuso, Jordi Bruix. (2009) Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:3, 791-798
CrossRef259
Arumugam Geetha, Panneerselvam Saranya, Sam Annie Jeyachristy, Rajagopal Surendran, Arunachalam Sundaram. (2009) Relevance of Non-ceruloplasmin Copper to Oxidative Stress in Patients with Hepatocellular Carcinoma. Biological Trace Element Research 130:3, 229-240
CrossRef260
Michele Molinari, Scott Helton. (2009) Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis. The American Journal of Surgery 198:3, 396-406
CrossRef261
Katsunori Imai, Toru Beppu, Yoshiharu Nakayama, Takatoshi Ishiko, Kei Horino, Hiroyuki Komori, Toshiro Masuda, Hiromitsu Hayashi, Hirohisa Okabe, Yoshihumi Baba, Masayuki Watanabe, Hiroshi Takamori, Kazuo Awai, Yasuyuki Yamashita, Hideo Baba. (2009) Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy. Journal of Surgical Oncology 100:2, 121-126
CrossRef262
Dong Yeok Shin, Chung Ho Ryu, Won Sup Lee, Dong Chul Kim, Seok Hyun Kim, Young-Sool Hah, Sung Joong Lee, Sung Chul Shin, Ho Sung Kang, Yung Hyun Choi. (2009) Induction of Apoptosis and Inhibition of Invasion in Human Hepatoma Cells by Anthocyanins from Meoru. Annals of the New York Academy of Sciences 1171:1, 137-148
CrossRef263
Shawn J. Pelletier, Sherry Fu, Veena Thyagarajan, Carlos Romero-Marrero, Mashal J. Batheja, Jeffrey D. Punch, John C. Magee, Anna S. Lok, Robert J. Fontana, Jorge A. Marrero. (2009) An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transplantation 15:8, 859-868
CrossRef264
Toyoki Moribe, Norio Iizuka, Toshiaki Miura, Naoki Kimura, Shigeru Tamatsukuri, Hideo Ishitsuka, Yoshihiko Hamamoto, Kazuhiko Sakamoto, Takao Tamesa, Masaaki Oka. (2009) Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. International Journal of Cancer 125:2, 388-397
CrossRef265
Konrad Schoppmeyer, Sebastian Weis, Joachim Mössner, Wolfgang E. Fleig, Konrad Schoppmeyer. 2009. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. .
CrossRef266
Steven C. Cunningham, Susan Tsai, Hugo P. Marques, Paulo Mira, Andrew Cameron, Eduardo Barroso, Benjamin Philosophe, Timothy M. Pawlik. (2009) Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis. Annals of Surgical Oncology 16:7, 1820-1831
CrossRef267
Kouichi Momiyama, Hidenari Nagai, Yasukiyo Sumino. (2009) Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy. Cancer Chemotherapy and Pharmacology 64:2, 271-277
CrossRef268
Jin-Ming Hwang, Shao-Hsuan Kao, Yi-Hsien Hsieh, Kuen-Lin Li, Pei-Hsi Wang, Li-Song Hsu, Jer-Yuh Liu. (2009) Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells. Molecular and Cellular Biochemistry 327:1-2, 135-144
CrossRef269
Jennifer Guy, Hal F. Yee. (2009) Health disparities in liver disease: Time to take notice and take action. Hepatology 50:1, 309-313
CrossRef270
Shahid M. Malik, Parijat A. Gupte, Michael E. de Vera, Jawad Ahmad. (2009) Liver Transplantation in Patients With Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 7:7, 800-806
CrossRef271
F. Muscari, B. Foppa, N. Kamar, J. M. Peron, J. Selves, B. Suc. (2009) Liberal selection criteria for liver transplantation for hepatocellular carcinoma. British Journal of Surgery 96:7, 785-791
CrossRef272
Hyo-Cheol Kim, Jin Wook Chung, Jae Hyung Park, Sangbu An, Kyu Ri Son, Nak Jong Seong, Hwan Jun Jae. (2009) Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Prospective Assessment of the Right Inferior Phrenic Artery with C-arm CT. Journal of Vascular and Interventional Radiology 20:7, 888-895
CrossRef273
Won Kim, Jung-Hwan Yoon, Jung-Ryul Kim, In-Jin Jang, Yung-Jue Bang, Yoon-Jun Kim, Hyo-Suk Lee. (2009) Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 64:3, 497-507
CrossRef274
Grace M. Lau, Gillian M. Lau, Guo-Liang Yu, Irwin H. Gelman, Alan Gutowski, David Hangauer, Jane W. S. Fang. (2009) Expression of Src and FAK in Hepatocellular Carcinoma and the Effect of Src Inhibitors on Hepatocellular Carcinoma In Vitro. Digestive Diseases and Sciences 54:7, 1465-1474
CrossRef275
Jorge A. Marrero, Ziding Feng, Yinghui Wang, Mindie H. Nguyen, Alex S. Befeler, Lewis R. Roberts, K. Rajender Reddy, Denise Harnois, Josep M. Llovet, Daniel Normolle, Jackie Dalhgren, David Chia, Anna S. Lok, Paul D. Wagner, Sudhir Srivastava, Myron Schwartz. (2009) α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma. Gastroenterology 137:1, 110-118
CrossRef276
Katjana Daskalow, David Pfander, Wilko Weichert, Nadine Rohwer, Armin Thelen, Peter Neuhaus, Sven Jonas, Bertram Wiedenmann, Christoph Benckert, Thorsten Cramer. (2009) Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochemistry and Cell Biology 132:1, 21-31
CrossRef277
Masaki Kaibori, Morihiko Ishizaki, Takamichi Saito, Kosuke Matsui, A.-Hon Kwon, Yasuo Kamiyama. (2009) Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas. The American Journal of Surgery 198:1, 39-45
CrossRef278
Tomokazu Kawaoka, Hiroshi Aikata, Shintaro Takaki, Yoshio Katamura, Akira Hiramatsu, Koji Waki, Shoichi Takahashi, Masashi Hieda, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama. (2009) Transarterial Infusion Chemotherapy Using Cisplatin-Lipiodol Suspension With or Without Embolization for Unresectable Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 32:4, 687-694
CrossRef279
Geoffrey C. Nguyen, Nimisha P. Thuluvath, Dorry L. Segev, Paul J. Thuluvath. (2009) Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transplantation 15:7, 776-781
CrossRef280
Deepak Amarapurkar, Kwang-Hyub Han, Henry Lik-Yuen Chan, Yoshiyuki Ueno, . (2009) Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Journal of Gastroenterology and Hepatology 24:6, 955-961
CrossRef281
Ja Kyung Kim, Hye Young Chang, Jung Min Lee, Oidov Baatarkhuu, Young Joon Yoon, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Chae Yoon Chon, Sang Hoon Ahn. (2009) Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. Journal of Medical Virology 81:6, 1002-1008
CrossRef282
Tony MOK, Tsai-Shen YANG, Yee CHAO, Cheng-Hsu WANG, Mei-Ching LIU, Yoon Koo KANG, Won Ki KANG, Jun Suk KIM, Yajie WANG, Thomas LEUNG. (2009) Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 5:2, 95-100
CrossRef283
Gopalakrishnan Ramakrishnan, Sundaram Jagan, Sattu Kamaraj, Pandi Anandakumar, Thiruvengadam Devaki. (2009) Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Investigational New Drugs 27:3, 233-240
CrossRef284
S. Jelic, . (2009) Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20:Supplement 4, iv41-iv45
CrossRef285
Christopher B. O'Brien. (2009) The Hospitalized Patient with Abnormal Liver Function Tests. Clinics in Liver Disease 13:2, 179-192
CrossRef286
Higinia R. Cárdenes. (2009) Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results. Clinical and Translational Oncology 11:5, 276-283
CrossRef287
Hyoung Su Kim, Ji Won Park, Ji Sun Jang, Ha Jung Kim, Woon Geon Shin, Kyung Ho Kim, Jin Heon Lee, Hak Yang Kim, Myoung Kuk Jang. (2009) Prognostic Values of α-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 43:5, 482-488
CrossRef288
Kang Mo Kim, Jong Hoon Kim, Ik Soo Park, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Young-Suk Lim, Han Chu Lee, Young Hwa Chung, Yung Sang Lee, Dong Jin Suh. (2009) Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. Journal of Gastroenterology and Hepatology 24:5, 806-814
CrossRef289
Jorge A. Marrero, Theodore Welling. (2009) Modern Diagnosis and Management of Hepatocellular Carcinoma. Clinics in Liver Disease 13:2, 233-247
CrossRef290
Zheng Wang, Jian Zhou, Jia Fan, Chang-Jun Tan, Shuang-Jian Qiu, Yao Yu, Xiao-Wu Huang, Zhao-You Tang. (2009) Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 135:5, 715-722
CrossRef291
Jorge André de Segadas-Soares, Cristiane A. Villela-Nogueira, Renata M. Perez, Letícia C. Nabuco, Carlos Eduardo Brandão-Mello, Henrique Sérgio M. Coelho. (2009) Is the Rapid Virologic Response a Positive Predictive Factor of Sustained Virologic Response in all Pretreatment Status Genotype 1 Hepatitis C Patients Treated With Peginterferon-α2b and Ribavirin?. Journal of Clinical Gastroenterology 43:4, 362-366
CrossRef292
Yasuhiro Asahina, Hiroyuki Nakanishi, Namiki Izumi. (2009) LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA. Digestive Endoscopy 21:2, 67-72
CrossRef293
Shuai Li, Hanjiang Fu, Yulan Wang, Yi Tie, Ruiyun Xing, Jie Zhu, Zhixian Sun, Lixin Wei, Xiaofei Zheng. (2009) MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 49:4, 1194-1202
CrossRef294
G. Ramakrishnan, L. Lo Muzio, C. M. Elinos-Báez, S. Jagan, T. A. Augustine, S. Kamaraj, P. Anandakumar, T. Devaki. (2009) Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Proliferation 42:2, 229-240
CrossRef295
Richard S Finn, Andrew X Zhu. (2009) Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Review of Anticancer Therapy 9:4, 503-509
CrossRef296
Xiao-Yu Yin, Ming-De Lu. (2009) Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 3:2, 121-130
CrossRef297
Yu-Jing Zhang, Haiyang Li, Hui-Chen Wu, Jing Shen, Lin Wang, Ming-Whei Yu, Po-Huang Lee, I. Bernard Weinstein, Regina M. Santella. (2009) Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma. Cancer Letters 275:2, 277-284
CrossRef298
Hedwig P. van de Nieuwenhof, Leon F.A.G. Massuger, Irene A.M. van der Avoort, Ruud L.M. Bekkers, Mariel Casparie, Wim Abma, Léon C.L.T. van Kempen, Joanne A. de Hullu. (2009) Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. European Journal of Cancer 45:5, 851-856
CrossRef299
Giuseppe Cabibbo, Federica Latteri, Michela Antonucci, Antonio Craxì. (2009) Multimodal approaches to the treatment of hepatocellular carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 6:3, 159-169
CrossRef300
Mikio Tezuka, Keiji Hayashi, Yoichi Okada, Tetsuya Irie, Hiroyasu Ina. (2009) Therapeutic Results of Computed-Tomography-Guided Transcatheter Arterial Chemoembolization for Local Recurrence of Hepatocellular Carcinoma After Initial Transcatheter Arterial Chemoembolization: The Results of 85 Recurrent Tumors in 35 Patients. Digestive Diseases and Sciences 54:3, 661-669
CrossRef301
Valérie Paradis, Stéphane Zalinski, Emna Chelbi, Nathalie Guedj, Françoise Degos, Valérie Vilgrain, Pierre Bedossa, Jacques Belghiti. (2009) Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis. Hepatology 49:3, 851-859
CrossRef302
Zhong-Zhe Lin, Hey-Chi Hsu, Chih-Hung Hsu, Pei-Yen Yeh, Chi-Ying F. Huang, Yung-Feng Huang, Te-Jung Chen, Sung-Hsin Kuo, Chiun Hsu, Fu-Chang Hu, Yung-Ming Jeng, Ying Chung, Ann-Lii Cheng. (2009) The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Journal of Hepatology 50:3, 518-527
CrossRef303
Simon C.H. Yu, Joyce W.Y. Hui, Edwin P. Hui, Frankie Mo, Paul S.F. Lee, John Wong, Kit F. Lee, Paul B.S. Lai, Winnie Yeo. (2009) Embolization Efficacy and Treatment Effectiveness of Transarterial Therapy for Unresectable Hepatocellular Carcinoma: A Case-Controlled Comparison of Transarterial Ethanol Ablation with Lipiodol–Ethanol Mixture versus Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology 20:3, 352-359
CrossRef304
H. Richly, B. Schultheis, I.A. Adamietz, P. Kupsch, M. Grubert, R.A. Hilger, M. Ludwig, E. Brendel, O. Christensen, D. Strumberg. (2009) Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial. European Journal of Cancer 45:4, 579-587
CrossRef305
Ganesaratnam K. Balendiran, Hans-Joerg Martin, Yasser El-Hawari, Edmund Maser. (2009) Cancer biomarker AKR1B10 and carbonyl metabolism. Chemico-Biological Interactions 178:1-3, 134-137
CrossRef306
Alejandro Forner, Carmen Ayuso, María Isabel Real, Javier Sastre, Ricardo Robles, Bruno Sangro, María Varela, Manuel de la Mata, María Buti, Luís Martí-Bonmatí, Concepció Bru, Josep Tabernero, Josep M Llovet, Jordi Bruix. (2009) Diagnóstico y tratamiento del carcinoma hepatocelular. Medicina Clínica 132:7, 272-287
CrossRef307
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. (2009) Development of novel treatments for hepatitis C. The Lancet Infectious Diseases 9:2, 108-117
CrossRef308
Hee Sun Park, Jeong-Min Lee, Se Hyung Kim, Samuel Chang, Soo Jin Kim, Joon Koo Han, Byung Ihn Choi. (2009) Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: Value of SPIO-enhanced MR imaging at 3.0 Tesla. Journal of Magnetic Resonance Imaging 29:2, 328-335
CrossRef309
Tomokazu Kawaoka, Hiroshi Aikata, Shintaro Takaki, Kiminori Uka, Takahiro Azakami, Hiromi Saneto, Soo Cheol Jeong, Yoshiiku Kawakami, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Yutaka Hirokawa, Kazuaki Chayama. (2009) FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatology Research 39:2, 134-142
CrossRef310
Yun Ku Cho, Jae Kyun Kim, Mi Young Kim, Hyunchul Rhim, Joon Koo Han. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:2, 453-459
CrossRef311
Toru Mizuguchi, Minoru Nagayama, Makoto Meguro, Toshihito Shibata, Shinsuke Kaji, Takayuki Nobuoka, Yasutoshi Kimura, Tomohisa Furuhata, Koichi Hirata. (2009) Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy. Journal of Gastrointestinal Surgery 13:2, 325-333
CrossRef312
Luciana O.O. Kikuchi, Denise C. Paranaguá-Vezozzo, Aline L. Chagas, Evandro S. Mello, Venancio A.F. Alves, Alberto Q. Farias, Ricardo Pietrobon, Flair J. Carrilho. (2009) Nodules Less Than 20 mm and Vascular Invasion are Predictors of Survival in Small Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 43:2, 191-195
CrossRef313
Daniel H. Palmer, Rachel S. Midgley, Noweeda Mirza, Elizabeth E. Torr, Forhad Ahmed, Jane C. Steele, Neil M. Steven, David J. Kerr, Lawrence S. Young, David H. Adams. (2009) A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology 49:1, 124-132
CrossRef314
Suzanne C. Schiffman, Charles E. Woodall, David A. Kooby, Robert C.G. Martin, Charles A. Staley, Vasili Egnatashvili, Kelly M. McMasters, Charles R. Scoggins. (2009) Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: A multicenter analysis. Journal of Surgical Oncologyn/a-n/a
CrossRef315
Moira Marcolongo, Bradford Young, Francesca Dal Pero, Giovanna Fattovich, Laura Peraro, Maria Guido, Giada Sebastiani, Giorgio Palù, Alfredo Alberti. (2009) A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology 50:4, 1038
CrossRef316
Ryosuke Tateishi, Shuichiro Shiina, Takamasa Ohki, Takahisa Sato, Ryota Masuzaki, Jun Imamura, Eriko Goto, Tadashi Goto, Hideo Yoshida, Shuntaro Obi, Shinpei Sato, Fumihiko Kanai, Haruhiko Yoshida, Masao Omata. (2009) Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. Journal of Gastroenterology 44:S19, 142-146
CrossRef317
Alejandro Forner, María Reig, Jordi Bruix. (2009) α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star. Gastroenterology 137:1, 26
CrossRef318
Taro Yamashita, Masao Honda, Hajime Takatori, Ryuhei Nishino, Hiroshi Minato, Hiroyuki Takamura, Tetsuo Ohta, Shuichi Kaneko. (2009) Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. Journal of Hepatology 50:1, 100-110
CrossRef319
H. PATEL, E. J. HEATHCOTE. (2009) When to treat and the benefits of treating hepatitis C in patients with haemophilia. Haemophilia 15:1, 20-32
CrossRef320
Sung Hoon Kim, Young-Hwa Chung, Soo Hyun Yang, Jeong A Kim, Myoung Kuk Jang, Sung Eun Kim, Danbi Lee, Sae Hwan Lee, Don Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh. (2009) Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization. The Korean Journal of Hepatology 15:3, 320
CrossRef321
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher. (2009) Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 87:1, 143-152
CrossRef322
Yoshiyasu Kisaka, Masashi Hirooka, Yohei Koizumi, Masanori Abe, Bunzo Matsuura, Yoichi Hiasa, Morikazu Onji. (2009) Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. Journal of Clinical UltrasoundNA-NA
CrossRef323
Jie Jin, Haiyan You, Bin Yu, Yun Deng, Ning Tang, Genfu Yao, Huiqun Shu, Shengli Yang, Wenxin Qin. (2009) Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochemical and Biophysical Research Communications 379:1, 86-91
CrossRef324
Il Han Song. (2009) Molecular targeting for treatment of advanced hepatocellular carcinoma. The Korean Journal of Hepatology 15:3, 299
CrossRef325
Hiroki Sakaguchi, Shuichi Seki, Kunihiko Tsuji, Kenichi Teramoto, Masatoshi Suzuki, Kiyohide Kioka, Norio Isoda, Kenichi Ido, . (2009) Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study. Hepatology Research 39:1, 47-52
CrossRef326
Adrian P. Martin. (2009) Management of hepatocellular carcinoma in the age of liver transplantation. International Journal of Surgery 7:4, 324-329
CrossRef327
Jiang Jingting, Wu Changping, Xu Ning, Zhu yibei, Wu Jun, Ji Mei, Xu Bin, Nilsson-Ehle Peter, Zhang Xueguan. (2009) Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 23:4, 213-218
CrossRef328
Shuichiro Shiina. (2009) Image-guided percutaneous ablation therapies for hepatocellular carcinoma. Journal of Gastroenterology 44:S19, 122-131
CrossRef329
Jennifer Altomonte, Rickmer Braren, Stephan Schulz, Sabrina Marozin, Ernst J. Rummeny, Roland M. Schmid, Oliver Ebert. (2008) Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats. Hepatology 48:6, 1864-1873
CrossRef330
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian Zhou, Jian-Hua Wang, Bin-Liang Wang, Wei Guo. (2008) Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Science 99:12, 2510-2517
CrossRef331
Norah A. Terrault, Kelly Im, Ross Boylan, Peter Bacchetti, David E. Kleiner, Robert J. Fontana, Jay H. Hoofnagle, Steven H. Belle. (2008) Fibrosis Progression in African Americans and Caucasian Americans With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 6:12, 1403-1411
CrossRef332
Frédéric Borie, Anne-Marie Bouvier, Astrid Herrero, Jean Faivre, Guy Launoy, Patricia Delafosse, Michel Velten, Antoine Buemi, Jun Peng, Pascale Grosclaude, Brigitte Trétarre. (2008) Treatment and prognosis of hepatocellular carcinoma: A population based study in France. Journal of Surgical Oncology 98:7, 505-509
CrossRef333
Larisa Stojanovič, Tomaž Lunder, Mario Poljak, Tomaž Marš, Boštjan Mlakar, Mojca Matičič. (2008) Lack of evidence for hepatitis C virus infection in association with lichen planus. International Journal of Dermatology 47:12, 1250-1256
CrossRef334
M. CHAPARRO, L. GONZÁLEZ MORENO, M. TRAPERO-MARUGÁN, J. MEDINA, R. MORENO-OTERO. (2008) Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Alimentary Pharmacology & Therapeutics 28:11-12, 1269-1277
CrossRef335
Shigeru Saito, Hidenori Ojima, Hitoshi Ichikawa, Setsuo Hirohashi, Tadashi Kondo. (2008) Molecular background of α-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Science 99:12, 2402-2409
CrossRef336
Tatsuya Orimo, Hidenori Ojima, Nobuyoshi Hiraoka, Shigeru Saito, Tomoo Kosuge, Tatsuhiko Kakisaka, Hideki Yokoo, Kazuaki Nakanishi, Toshiya Kamiyama, Satoru Todo, Setsuo Hirohashi, Tadashi Kondo. (2008) Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology 48:6, 1851-1863
CrossRef337
Daniel Lavanchy. (2008) Chronic viral hepatitis as a public health issue in the world. Best Practice & Research Clinical Gastroenterology 22:6, 991-1008
CrossRef338
Ryota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Masao Omata. (2008) Hepatocellular carcinoma in viral hepatitis: Improving standard therapy. Best Practice & Research Clinical Gastroenterology 22:6, 1137-1151
CrossRef339
Jun Imamura, Ryosuke Tateishi, Shuichiro Shiina, Eriko Goto, Takahisa Sato, Takamasa Ohki, Ryota Masuzaki, Tadashi Goto, Hideo Yoshida, Fumihiko Kanai, Keisuke Hamamura, Shuntaro Obi, Haruhiko Yoshida, Masao Omata. (2008) Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 103:12, 3057-3062
CrossRef340
Kimberly B. Higginbotham, Richard Lozano, Thomas Brown, Yehuda Z. Patt, Takashi Arima, James L. Abbruzzese, Melanie B. Thomas. (2008) A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 134:12, 1325-1335
CrossRef341
Simon S Lo, Higinia R Cardenes, Bin S Teh, Achilles J Fakiris, Mark A Henderson, Lech Papiez, Ronald C McGarry, Jian Z Wang, Kaile Li, Nina A Mayr, Robert D Timmerman. (2008) Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Review of Anticancer Therapy 8:12, 1939-1951
CrossRef342
Jin-Ping Lai, James R Thompson, Dalbir S Sandhu, Lewis R Roberts. (2008) Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncology 4:6, 803-814
CrossRef343
Ping Gao, Rui Wang, Jian-Jun Shen, Fang Lin, Xi Wang, Ke Dong, Hui-Zhong Zhang. (2008) Hypoxia-inducible enhancer/α-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cancer Science 99:11, 2209-2217
CrossRef344
Bruno M Strebel, Jean-François Dufour. (2008) Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease. Expert Review of Anticancer Therapy 8:11, 1743-1749
CrossRef345
Masaki Kaibori, Sang Kil Ha-Kawa, Morihiko Ishizaki, Kosuke Matsui, Takamichi Saito, A-Hon Kwon, Yasuo Kamiyama. (2008) HA/GSA-Rmax Ratio as a Predictor of Postoperative Liver Failure. World Journal of Surgery 32:11, 2410-2418
CrossRef346
Yusuke Kawamura, Kenji Ikeda, Yasuji Arase, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada. (2008) Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. Journal of Gastroenterology and Hepatology 23:11, 1739-1746
CrossRef347
Patricia Roxburgh, T. R. Jeffry Evans. (2008) Systemic therapy of hepatocellular carcinoma: Are we making progress?. Advances in Therapy 25:11, 1089-1104
CrossRef348
Young-Suk Lim, W. Ray Kim. (2008) The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease. Clinics in Liver Disease 12:4, 733-746
CrossRef349
Lan-Tu Gou, Ai-Ping Tong, Li-Juan Chen, Ming-Hai Tang, Bin Chen, Shu-Fang Liang, Canhua Huang, Yu-Quan Wei. (2008) Comparative plasma membrane-associated proteomics of immortalized human hepatocytes. Biochemistry (Moscow) 73:11, 1200-1206
CrossRef350
J Altomonte, L Wu, M Meseck, L Chen, O Ebert, A Garcia-Sastre, J Fallon, J Mandeli, S L C Woo. (2008) Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells. Cancer Gene Therapy
CrossRef351
Josep M. Llovet, Jordi Bruix. (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:4, 1312-1327
CrossRef352
Gaia Pocobelli, Linda S. Cook, Rollin Brant, Samuel S. Lee. (2008) Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis. Liver International 28:9, 1272-1279
CrossRef353
Maria Pleguezuelo, Laura Marelli, Maria Misseri, Giacomo Germani, Vincenza Calvaruso, Elias Xiruochakis, Manousou Pinelopi, Andrew K Burroughs. (2008) TACE versus TAE as therapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy 8:10, 1623-1641
CrossRef354
Francisco A Durazo, Lawrence M Blatt, William G Corey, Jiing-Huey Lin, Steven Han, Sammy Saab, Ronald W Busuttil, Myron J Tong. (2008) Des-γ-carboxyprothrombin, α-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:10, 1541-1548
CrossRef355
Wei Cui, Shirley X. Hu, Zhen-Ya Tang, Ke-Qin Hu. (2008) In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anti-Cancer Drugs 19:9, 891-897
CrossRef356
Takahiro Uenishi, Shuhei Nishiguchi, Shogo Tanaka, Takatsugu Yamamoto, Shigekazu Takemura, Shoji Kubo. (2008) Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Journal of Surgical Oncology 98:5, 358-362
CrossRef357
S A McDonald, S J Hutchinson, S M Bird, C Robertson, P R Mills, J F Dillon, D J Goldberg. (2008) A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland. British Journal of Cancer 99:5, 805-810
CrossRef358
Chang-Sheng Kuo, Ching-Yih Lin, Meng-Ying Wu, Chin-Li Lu, Rwei-Fen Huang. (2008) Relationship between folate status and tumour progression in patients with hepatocellular carcinoma. British Journal of Nutrition 100:03,
CrossRef359
M. Gambarin-Gelwan, I. M. Jacobson. (2008) Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C. Journal of Viral Hepatitis 15:9, 623-633
CrossRef360
Stephanie Ma, Kwok Wah Chan, Xin-Yuan Guan. (2008) In Search of Liver Cancer Stem Cells. Stem Cell Reviews 4:3, 179-192
CrossRef361
Kyoko Ito, Yoshio Yamaoka, Hiroyoshi Ota, Hala El-Zimaity, David Y. Graham. (2008) Adherence, Internalization, and Persistence of Helicobacter pylori in Hepatocytes. Digestive Diseases and Sciences 53:9, 2541-2549
CrossRef362
Firdous A. Siddiqui, Murray N. Ehrinpreis, James Janisse, Ravi Dhar, Elizabeth May, Milton G. Mutchnick. (2008) Demographics of a large cohort of urban chronic hepatitis C patients. Hepatology International 2:3, 376-381
CrossRef363
Daris Ferrari, Giuseppe Di Maria, Nicola Fazio, Carla Codecà, Jessica Fiore, Andrea Luciani, Sabina Oldani, Marco Maggioni, Paolo Foa. (2008) Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy. Anti-Cancer Drugs 19:8, 837-840
CrossRef364
He Yuanlong, Jin Haifeng, Zhang Xiaoyin, Song Jialin, Liu Jie, Yan Li, Xie Huahong, Song Jiugang, Pan Yanglin, Wu Kaichun, Ding Jie, Fan Daiming. (2008) The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells. Cancer Letters 268:1, 110-119
CrossRef365
Belinda Knight, Janina E.E. Tirnitz–Parker, John K. Olynyk. (2008) C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice. Gastroenterology 135:3, 969-979.e1
CrossRef366
G VAINER, E PIKARSKY, Y BENNERIAH. (2008) Contradictory functions of NF-κB in liver physiology and cancer. Cancer Letters 267:2, 182-188
CrossRef367
J. M. Llovet, A. Lok. (2008) Hepatitis B Virus Genotype and Mutants: Risk Factors for Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute 100:16, 1121-1123
CrossRef368
Hidenori Toyoda, Takashi Kumada, Yuji Kaneoka, Yukio Osaki, Toru Kimura, Akira Arimoto, Hiroko Oka, Osamu Yamazaki, Takao Manabe, Fumihiro Urano, Hobyung Chung, Masatoshi Kudo, Takashi Matsunaga. (2008) Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. Journal of Hepatology 49:2, 223-232
CrossRef369
Andrea E. Reid. (2008) Viral hepatitis in African Americans. Current Hepatitis Reports 7:3, 120-126
CrossRef370
Kun Yan, Min Hua Chen, Wei Yang, Yan Bin Wang, Wen Gao, Chun Yi Hao, Bao Cai Xing, Xin Fu Huang. (2008) Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors. European Journal of Radiology 67:2, 336-347
CrossRef371
Adam C. Randolph, Erin M. Tharalson, Nooman Gilani. (2008) Spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies. European Journal of Gastroenterology & Hepatology 20:8, 804-809
CrossRef372
William B. Bunn. (2008) Risk and Burden Associated With the Acquisition of Viral Hepatitis A and B in the Corporate Traveler. Journal of Occupational and Environmental Medicine 50:8, 935-944
CrossRef373
R.V. Tse, Chandan Guha, L.A. Dawson. (2008) Conformal radiotherapy for hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 67:2, 113-123
CrossRef374
Wojciech Blonski, K. Rajender Reddy. (2008) Hepatitis C Virus Infection and Hepatocellular Carcinoma. Clinics in Liver Disease 12:3, 661-674
CrossRef375
Katsutoshi Sugimoto, Fuminori Moriyasu, Naohisa Kamiyama, Ryo Metoki, Masahiko Yamada, Yasuharu Imai, Hiroko Iijima. (2008) Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography. Hepatology Research 38:8, 790-799
CrossRef376
David A. Kooby, Vasili Egnatashvili, Michael Graiser, Keith A. Delman, John Kauh, William C. Wood, Charles A. Staley III. (2008) Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center. Journal of Surgical Oncology 98:2, 81-88
CrossRef377
Llovet, Josep M., Ricci, Sergio, Mazzaferro, Vincenzo, Hilgard, Philip, Gane, Edward, Blanc, Jean-Frédéric, de Oliveira, Andre Cosme, Santoro, Armando, Raoul, Jean-Luc, Forner, Alejandro, Schwartz, Myron, Porta, Camillo, Zeuzem, Stefan, Bolondi, Luigi, Greten, Tim F., Galle, Peter R., Seitz, Jean-François, Borbath, Ivan, Häussinger, Dieter, Giannaris, Tom, Shan, Minghua, Moscovici, Marius, Voliotis, Dimitris, Bruix, Jordi, . (2008) Sorafenib in Advanced Hepatocellular Carcinoma. New England Journal of Medicine 359:4, 378-390
Full Text378
Markus Weber, Pierre-Alain Clavien. (2008) Hepatocellular carcinoma and liver transplantation: Entering the area after the Milan and University of California at San Francisco criteria?. Liver Transplantation 14:7, 911-914
CrossRef379
Cristina Bosetti, Fabio Levi, Paolo Boffetta, Franca Lucchini, Eva Negri, Carlo La Vecchia. (2008) Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004. Hepatology 48:1, 137-145
CrossRef380
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura, Masaru Miyazaki. (2008) Clinical significance of -fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:7pt2, e189-e197
CrossRef381
Daiki Okamura, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Atsushi Kato, Masaru Miyazaki. (2008) Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection. Modern Pathology 21:7, 847-855
CrossRef382
S. Herber, S. Biesterfeld, U. Franz, J. Schneider, J. Thies, M. Schuchmann, C. Düber, M. B. Pitton, G. Otto. (2008) Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome. CardioVascular and Interventional Radiology 31:4, 768-777
CrossRef383
Junji Furuse. (2008) Growth factors as therapeutic targets in HCC. Critical Reviews in Oncology/Hematology 67:1, 8-15
CrossRef384
S. W. Moore, A. Davidson, G. P. Hadley, M. Kruger, J. Poole, D. Stones, L. Wainwright, G. Wessels. (2008) Malignant Liver Tumors in South African Children: A National Audit. World Journal of Surgery 32:7, 1389-1395
CrossRef385
Ke-Qin Hu. (2008) Hepatitis B Virus (HBV) Infection in Asian and Pacific Islander Americans (APIAs): How Can We Do Better for This Special Population. The American Journal of Gastroenterology 103:7, 1824-1833
CrossRef386
Vincent Wai-To Lam, Kelvin Kwok-Chai Ng, Kenneth Siu-Ho Chok, Tan-To Cheung, Jimmy Yuen, Helen Tung, Wai-Kuen Tso, Sheung-Tat Fan, Ronnie T.P. Poon. (2008) Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of the American College of Surgeons 207:1, 20-29
CrossRef387
Zhen-Wei Peng, Yao-Jun Zhang, Min-Shan Chen, Hui-Hong Liang, Jin-Qing Li, Ya-Qi Zhang, Wan Y. Lau. (2008) Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surgical Oncology 17:1, 23-31
CrossRef388
Yuichi Torisu, Akira Watanabe, Aya Nonaka, Yutaka Midorikawa, Masatoshi Makuuchi, Takahiro Shimamura, Haruhiko Sugimura, Atsushi Niida, Tetsu Akiyama, Hiroko Iwanari, Tatsuhiko Kodama, Mikio Zeniya, Hiroyuki Aburatani. (2008) Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by β-catenin/TCF. Cancer Science 99:6, 1139-1146
CrossRef389
Victor W Xia, Masahiko Taniguchi, Randolph H Steadman. (2008) The changing face of patients presenting for liver transplantation. Current Opinion in Organ Transplantation 13:3, 280-284
CrossRef390
Yixing Jiang, Eric T Kimchi, Alberto J Montero, Kevin F Staveley-O’Carroll, Jaffer A Ajani. (2008) Upper gastrointestinal tumors: current status and future perspectives. Expert Review of Anticancer Therapy 8:6, 975-991
CrossRef391
A James Hanje, Francis Y Yao. (2008) Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation. Current Opinion in Organ Transplantation 13:3, 234-240
CrossRef392
Hans Christian Spangenberg, Robert Thimme, Hubert E Blum. (2008) Advances in prevention and diagnosis of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2:3, 425-433
CrossRef393
Van Thi Thuy Nguyen, Karina Razali, Janaki Amin, Matthew G Law, Gregory J Dore. (2008) Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. Journal of Gastroenterology and Hepatology 23:6, 922-929
CrossRef394
Jennifer J. Knox, Sharlene Gill, Timothy W. Synold, James J. Biagi, Pierre Major, Ron Feld, Christine Cripps, Nancy Wainman, Elizabeth Eisenhauer, Lesley Seymour. (2008) A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168). Investigational New Drugs 26:3, 265-272
CrossRef395
M. Del Gaudio, G. Ercolani, M. Ravaioli, M. Cescon, A. Lauro, M. Vivarelli, M. Zanello, A. Cucchetti, G. Vetrone, F. Tuci, G. Ramacciato, G. L. Grazi, A. D. Pinna. (2008) Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience. American Journal of Transplantation 8:6, 1177-1185
CrossRef396
Roderich E. Schwarz, David D. Smith. (2008) Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. The American Journal of Surgery 195:6, 829-836
CrossRef397
Shujing Liu, Mei Yu, Ying He, Lin Xiao, Fang Wang, Changcheng Song, Shuhan Sun, Changquan Ling, Zhiheng Xu. (2008) Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47:6, 1964-1973
CrossRef398
N SUKSUMEK, K LEELAWAT, S LEELAWAT, B RUSSELL, U LEKUTHAI. (2008) TaqMan real-time PCR assay for specific detection of Opisthorchis viverrini DNA in Thai patients with hepatocellular carcinoma and cholangiocarcinoma. Experimental Parasitology 119:2, 217-224
CrossRef399
J. M. Llovet, A. M. Di Bisceglie, J. Bruix, B. S. Kramer, R. Lencioni, A. X. Zhu, M. Sherman, M. Schwartz, M. Lotze, J. Talwalkar, G. J. Gores, . (2008) Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute 100:10, 698-711
CrossRef400
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote. (2008) Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors. Gastroenterology 134:6, 1699-1714
CrossRef401
Pamela A. Norton, Mary Ann Comunale, Jonathan Krakover, Lucy Rodemich, Natalie Pirog, Anthony D'Amelio, Ramila Philip, Anand S. Mehta, Timothy M. Block. (2008) N-linked glycosylation of the liver cancer biomarker GP73. Journal of Cellular Biochemistry 104:1, 136-149
CrossRef402
P. Wang, Z.Q. Meng, Z. Chen, J.H. Lin, B. Ping, L.F. Wang, B.H. Wang, L.M. Liu. (2008) Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome—A study based on 3011 patients in China. European Journal of Surgical Oncology (EJSO) 34:5, 541-546
CrossRef403
Sonia Pascual, Javier Irurzun, Pedro Zapater, José Such, Laura Sempere, Fernando Carnicer, Jose María Palazón, Pedro De La Iglesia, Santiago Gil, Francisco De España, Miguel Perez-Mateo. (2008) Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver International 28:5, 682-689
CrossRef404
Byung Jae Youn, Jin Wook Chung, Kyu Ri Son, Hyo-Cheol Kim, Hwan Jun Jae, Jeong Min Lee, In Chan Song, In-One Kim, Jae Hyung Park. (2008) Diffusion-Weighted MR. Academic Radiology 15:5, 593-600
CrossRef405
Nikhil B. Amesur, Albert B. Zajko, Brian I. Carr. (2008) Chemo-embolization for Unresectable Hepatocellular Carcinoma with Different Sizes of Embolization Particles. Digestive Diseases and Sciences 53:5, 1400-1404
CrossRef406
Ghassan K. Abou-Alfa, Alan P. Venook. (2008) The impact of new data in the treatment of advanced hepatocellular carcinoma. Current Oncology Reports 10:3, 199-205
CrossRef407
Reiji Teramoto, Hirotaka Minagawa, Masao Honda, Kenji Miyazaki, Yo Tabuse, Ken'ichi Kamijo, Teruyuki Ueda, Shuichi Kaneko. (2008) Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784:5, 764-772
CrossRef408
Travis Kidner, Menghua Dai, Prasad S. Adusumilli, Yuman Fong. (2008) Advances in Experimental and Translational Research in the Treatment of Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 17:2, 377-389
CrossRef409
W. Ray Kim, Steven L. Flamm, Adrian M. Di Bisceglie, Henry C. Bodenheimer. (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:4, 1363-1370
CrossRef410
Sunil Krishnan, Laura A. Dawson, Jinsil Seong, Yasuyuki Akine, Sam Beddar, Tina M. Briere, Christopher H. Crane, Francoise Mornex. (2008) Radiotherapy for Hepatocellular Carcinoma: An Overview. Annals of Surgical Oncology 15:4, 1015-1024
CrossRef411
Jong Doo Lee, Won Jun Kang, Mijin Yun. (2008) Primary Cancer of the Liver and Biliary Duct. PET Clinics 3:2, 169-186
CrossRef412
Ryosuke Tateishi, Haruhiko Yoshida, Yutaka Matsuyama, Norio Mine, Yuji Kondo, Masao Omata. (2008) Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. Hepatology International 2:1, 17-30
CrossRef413
Geoffrey C. Nguyen, Paul J. Thuluvath. (2008) Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. Hepatology 47:3, 1058-1066
CrossRef414
Simon Chun Ho Yu, Thomas Wai Tong Leung, Wan Yee Lau, Nelson Lee, Edwin Pun Hui, Winnie Yeo, Paul Bo San Lai, Tony Shu Kam Mok. (2008) A Comparison of Three Transarterial Lipiodol-Based Formulations for Hepatocellular Carcinoma: In Vivo Biodistribution Study in Humans. CardioVascular and Interventional Radiology 31:2, 289-298
CrossRef415
Judith I. Tsui, Sue Currie, Hui Shen, Edmund J. Bini, Norbert Brau, Teresa L. Wright, . (2008) Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results from the VA HCV-001 Study. Digestive Diseases and Sciences 53:3, 809-814
CrossRef416
Vincent Wai-To Lam, Kelvin K. Ng, Kenneth Siu-Ho Chok, Tan-To Cheung, Jimmy Yuen, Helen Tung, Wai-Kuen Tso, Sheung-Tat Fan, Ronnie T. P. Poon. (2008) Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic Factors. Annals of Surgical Oncology 15:3, 782-790
CrossRef417
Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uchiyama, Yo-Ichi Yamashita, Yoshihiko Maehara. (2008) Liver transplantation for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 15:2, 124-130
CrossRef418
G.-Y. Chau, W.-Y. Lui, C.-W. Chi, Y.-P. Chau, A.-F. Li, H.-L. Kao, C.-W. Wu. (2008) Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. European Journal of Surgical Oncology (EJSO) 34:3, 333-338
CrossRef419
Katsutoshi Sugimoto, Fuminori Moriyasu, Naohisa Kamiyama, Masahiko Yamada, Hiroko Iijima. (2008) Correlation between parametric imaging using contrast ultrasound and the histological differentiation of hepatocellular carcinoma. Hepatology Research 38:3, 273-280
CrossRef420
John P. Duffy, Jonathan R. Hiatt, Ronald W. Busuttil. (2008) Surgical Resection of Hepatocellular Carcinoma. The Cancer Journal 14:2, 100-110
CrossRef421
Shirit Einav, Ella H. Sklan, Hyang Mi Moon, Elizabeth Gehrig, Ping Liu, Ying Hao, Anson W. Lowe, Jeffrey S. Glenn. (2008) The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection. Hepatology 47:3, 827-835
CrossRef422
Carla W. Brady, Alastair D. Smith, Karen M. Stechuchak, Cynthia J. Coffman, Janet E. Tuttle-Newhall, Dawn Provenzale, Andrew J. Muir. (2008) Frequency and predictors ofde novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. Liver Transplantation 14:2, 228-234
CrossRef423
Michael J. Bates, Emily Farkas, David Taylor, P. Michael McFadden. (2008) Pulmonary Resection of Metastatic Hepatocellular Carcinoma After Liver Transplantation. The Annals of Thoracic Surgery 85:2, 412-415
CrossRef424
Nyingi Kemmer, Guy Neff, Michelle Secic, Victoria Zacharias, Tiffany Kaiser, Joseph Buell. (2008) Ethnic Differences in Hepatocellular Carcinoma: Implications for Liver Transplantation. Digestive Diseases and Sciences 53:2, 551-555
CrossRef425
Fabio Puglisi, Giuseppe Aprile, Gianpiero Fasola. (2008) Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology. Anti-Cancer Drugs 19:2, 221-233
CrossRef426
Chun-Ming Wong, Irene O. L. Ng. (2008) Molecular pathogenesis of hepatocellular carcinoma. Liver International 28:2, 160-174
CrossRef427
Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, Lewis R Roberts. (2008) Treatment options for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2:1, 81-92
CrossRef428
Jun-Yi Lei, Jiaoti Huang. (2008) Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma. Expert Opinion on Medical Diagnostics 2:2, 151-159
CrossRef429
C. Garnier, C. Lafon, J.-L. Dillenseger. (2008) 3-D Modeling of the Thermal Coagulation Necrosis Induced by an Interstitial Ultrasonic Transducer. IEEE Transactions on Biomedical Engineering 55:2, 833-837
CrossRef430
Roberto Mazzanti, Laura Gramantieri, Luigi Bolondi. (2008) Hepatocellular carcinoma: Epidemiology and clinical aspects. Molecular Aspects of Medicine 29:1-2, 130-143
CrossRef431
Andrew X. Zhu. (2008) Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer 112:2, 250-259
CrossRef432
Alejandro Forner, Jordi Bruix. (2008) Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care. Hepatology 47:1, 5-7
CrossRef433
Junji Shiraishi, Katsutoshi Sugimoto, Fuminori Moriyasu, Naohisa Kamiyama, Kunio Doi. (2008) Computer-aided diagnosis for the classification of focal liver lesions by use of contrast-enhanced ultrasonography. Medical Physics 35:5, 1734
CrossRef434
Javier Martín-Renedo, José L. Mauriz, Francisco Jorquera, Olga Ruiz-Andrés, Paquita González, Javier González-Gallego. (2008) Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. Journal of Pineal Research 45:4, 532
CrossRef435
Grace C.H. Yang, Liang-Che Tao. 2008. Liver and Pancreas. , 873-913.
CrossRef436
Jennifer Altomonte, Lan Wu, Li Chen, Marcia Meseck, Oliver Ebert, Adolfo García-Sastre, John Fallon, Savio LC Woo. (2008) Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo. Molecular Therapy 16:1, 146-153
CrossRef437
T. Albrecht. (2008) HCC-Screening. Der Radiologe 48:1, 33-38
CrossRef438
Klaus Juergen Schmitz, Jeremias Wohlschlaeger, Hauke Lang, Georgios Charalambos Sotiropoulos, Massimo Malago, Karen Steveling, Henning Reis, Vito Rosario Cicinnati, Kurt Werner Schmid, Hideo Andreas Baba. (2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. Journal of Hepatology 48:1, 83-90
CrossRef439
Atsuya Takeda, Masahiko Takahashi, Etsuo Kunieda, Toshiaki Takeda, Naoko Sanuki, Yuji Koike, Kazuhiro Atsukawa, Toshio Ohashi, Hidetsugu Saito, Naoyuki Shigematsu, Atsushi Kubo. (2008) Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatology Research 38:1, 60-69
CrossRef440
D. Gomez, S. Farid, H. Z. Malik, A. L. Young, G. J. Toogood, J. P. A. Lodge, K. R. Prasad. (2008) Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma. World Journal of Surgery 32:8, 1757
CrossRef441
Se Hyung Kim, Byung Ihn Choi, Jae Young Lee, Soo Jin Kim, Young Ho So, Hyo Won Eun, Jeong Min Lee, Joon Koo Han. (2008) Diagnostic Accuracy of Multi-/Single-Detector Row CT and Contrast-Enhanced MRI in the Detection of Hepatocellular Carcinomas Meeting the Milan Criteria before Liver Transplantation. Intervirology 51:1, 52-60
CrossRef442
Hui Xu, Jing-Xia Xie, Xuan Li, Zheng-Han Yang, Zhuo-Zhao Zheng, Bin Wang, Zheng Wang. (2008) Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model. Journal of Magnetic Resonance Imaging 27:1, 102-109
CrossRef443
Simon C.H. Yu, Edwin P. Hui, John Wong, Herman Wong, Frankie Mo, Simon S.M. Ho, Yuen Y. Wong, Winnie Yeo, Paul B.S. Lai, Anthony T.C. Chan, Tony S.K. Mok. (2008) Transarterial Ethanol Ablation of Hepatocellular Carcinoma with Lipiodol–Ethanol Mixture: Phase II Study. Journal of Vascular and Interventional Radiology 19:1, 95-103
CrossRef444
Gregory C. Connolly, Rui Chen, Ollivier Hyrien, Parvez Mantry, Adel Bozorgzadeh, Peter Abt, Alok A. Khorana. (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thrombosis Research 122:3, 299-306
CrossRef445
Sung-Soo Han, Jung-Sun Kim, Bong-Ky Park, Hwa-Seung Yoo. (2007) A case report on regression of hepatocellular carcinoma treated with herbal medicine. Oriental Pharmacy and Experimental Medicine 7:4, 436-440
CrossRef446
S. K. Ramaiah, S. Rittling. (2007) Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer. Toxicological Sciences 103:1, 4-13
CrossRef447
Hirokazu Uyama, Hiroaki Nagano, Hideji Nakamura, Takamichi Murakami, Hironobu Nakamura, Morito Monden, Norio Hayashi. (2007) New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy. Hepatology Research 37:12, 1018-1025
CrossRef448
Nishita Kothary, Joshua L. Weintraub, Jonathan Susman, John H. Rundback. (2007) Transarterial Chemoembolization for Primary Hepatocellular Carcinoma in Patients at High Risk. Journal of Vascular and Interventional Radiology 18:12, 1517-1526
CrossRef449
Ivan Borbath, Isabelle A. Leclercq, Jorge Abarca-Quinones, Christine Desaeger, Valérie Lebrun, Pierre Moulin, Christine Sempoux, Yves Horsmans. (2007) Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide. Cancer Science 98:12, 1831-1839
CrossRef450
Christopher J. Sonnenday, Justin B. Dimick, Richard D. Schulick, Michael A. Choti. (2007) Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 11:12, 1636-1646
CrossRef451
Todd C Schirmang, Damian E Dupuy. (2007) Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip™ radiofrequency ablation system. Expert Review of Medical Devices 4:6, 803-814
CrossRef452
Kojiro Taura, Iwao Ikai, Etsuro Hatano, Kentaro Yasuchika, Akio Nakajima, Masaharu Tada, Satoru Seo, Takafumi Machimoto, Shinji Uemoto. (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: An analysis of 293 patients. Surgery 142:5, 685-694
CrossRef453
Maya Gambarin-Gelwan. (2007) Hepatitis B in Pregnancy. Clinics in Liver Disease 11:4, 945-963
CrossRef454
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth C. Yanek, Robert A. Fisher. (2007) Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 84:10, 1262-1271
CrossRef455
N. SNOWBERGER, S. CHINNAKOTLA, R. M. LEPE, J. PEATTIE, R. GOLDSTEIN, G. B. KLINTMALM, G. L. DAVIS. (2007) Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Alimentary Pharmacology & Therapeutics 26:9, 1187-1194
CrossRef456
M. Rasool Aljabiri, Francesca Lodato, Andrew K. Burroughs. (2007) Surveillance and diagnosis for hepatocellular carcinoma. Liver Transplantation 13:S2, S2-S12
CrossRef457
Leslie R. Rowe, Sean J. Mulvihill, Lyska Emerson, Evelyn V. Gopez. (2007) Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma. Diagnostic Cytopathology 35:11, 717-721
CrossRef458
Josep M. Llovet. (2007) Clinical and molecular classification of hepatocellular carcinoma. Liver Transplantation 13:S2, S13-S16
CrossRef459
Laura M. Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. (2007) Emerging Approaches in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 41:9, 839-854
CrossRef460
Rohit Satoskar, Donald M Jensen. (2007) Retreatment of chronic hepatitis C in previous non-responders and relapsers. Expert Opinion on Pharmacotherapy 8:15, 2491-2503
CrossRef461
Yong Beom Cho, Kuhn Uk Lee, Kyung-Suk Suh, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Seokyung Hahn, Byung-Joo Park. (2007) Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. Journal of Gastroenterology and Hepatology 22:10, 1643-1649
CrossRef462
R. Konopke, A. Bunk, S. Kersting. (2007) The Role of Contrast-Enhanced Ultrasound for Focal Liver Lesion Detection: An Overview. Ultrasound in Medicine & Biology 33:10, 1515-1526
CrossRef463
Janaki Amin, Dianne O'Connell, Mark Bartlett, Elizabeth Tracey, John Kaldor, Matthew Law, Gregory Dore. (2007) Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study. Australian and New Zealand Journal of Public Health 31:5, 475-482
CrossRef464
Sakae Nagaoka, Takafumi Yoshida, Junji Akiyoshi, Jun Akiba, Takuji Torimura, Hisashi Adachi, Junichi Kurogi, Nobuyoshi Tajiri, Kinya Inoue, Takashi Niizeki, Hironori Koga, Tsutomu Imaizumi, Masamichi Kojiro, Michio Sata. (2007) Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver International 27:8, 1091-1097
CrossRef465
Norbert Bräu, Rena K. Fox, Peiying Xiao, Kristen Marks, Zeenat Naqvi, Lynn E. Taylor, Anita Trikha, Morris Sherman, Mark S. Sulkowski, Douglas T. Dieterich, Michael O. Rigsby, Teresa L. Wright, Maria D. Hernandez, Mamta K. Jain, Gajendra K. Khatri, Richard K. Sterling, Maurizio Bonacini, Catherine A. Martyn, Ayse Aytaman, Josep M. Llovet, Sheldon T. Brown, Edmund J. Bini. (2007) Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study. Journal of Hepatology 47:4, 527-537
CrossRef466
Ira M. Jacobson, Robert S. Brown, Bradley Freilich, Nezam Afdhal, Paul Y. Kwo, John Santoro, Scott Becker, Adil E. Wakil, David Pound, Eliot Godofsky, Robert Strauss, David Bernstein, Steven Flamm, Mary Pat Pauly, Pabak Mukhopadhyay, Louis H. Griffel, Clifford A. Brass, . (2007) Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial. Hepatology 46:4, 971-981
CrossRef467
Mercedes Iñarrairaegui, Bruno Sangro. (2007) Diagnóstico del hepatocarcinoma de pequeño tamaño. Gastroenterología y Hepatología 30:8, 498-505
CrossRef468
O. F. M. Couto, I. Dvorchik, B. I. Carr. (2007) Causes of Death in Patients with Unresectable Hepatocellular Carcinoma. Digestive Diseases and Sciences 52:11, 3285-3289
CrossRef469
M. Ulcickas Yood, C. P. Quesenberry, D. Guo, K. Wells, J. Shan, L. Sanders, M. L. Skovron, U. Iloeje, C. Caldwell, M. M. Manos. (2007) Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. Journal of Viral Hepatitis 0:0, 070924202706001-???
CrossRef470
John F. Perry, Barbara Charlton, David J. Koorey, Richard C. Waugh, P. James Gallagher, Michael D. Crawford, Deborah J. Verran, Geoffrey W. McCaughan, Simone I. Strasser. (2007) Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International 0:0, 070908015728001-???
CrossRef471
Yangchao Chen, Marie Chia-mi Lin, Hua Wang, Chu-yan Chan, Lei Jiang, Sai Ming Ngai, Jun Yu, Ming-liang He, Pang-Chui Shaw, David T. Yew, Joseph J. Sung, Hsiang-fu Kung. (2007) Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. PROTEOMICS 7:17, 3097-3104
CrossRef472
John P. Duffy, Andrew Vardanian, Elizabeth Benjamin, Melissa Watson, Douglas G. Farmer, Rafik M. Ghobrial, Gerald Lipshutz, Hasan Yersiz, David S. K. Lu, Charles Lassman, Myron J. Tong, Jonathan R. Hiatt, Ronald W. Busuttil. (2007) Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded. Annals of Surgery 246:3, 502-511
CrossRef473
Francis Y. Yao. (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S267-S274
CrossRef474
Yu-Lueng Shih, Chung-Bao Hsieh, Hung-Cheng Lai, Ming-De Yan, Tsai-Yuan Hsieh, You-Chen Chao, Ya-Wen Lin. (2007) SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. International Journal of Cancer 121:5, 1028-1035
CrossRef475
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas Bak, Jeffrey Campsen, Franklin Wright, Tracy Steinberg, William Bennett, Igal Kam. (2007) Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transplant International 20:9, 747-753
CrossRef476
Takuya Komura, Eishiro Mizukoshi, Yuki Kita, Masaru Sakurai, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Tetsuo Ohta, Koichi Shimizu, Yasunari Nakamoto, Masao Honda, Toshinari Takamura, Shuichi Kaneko. (2007) Impact of Diabetes on Recurrence of Hepatocellular Carcinoma after Surgical Treatment in Patients With Viral Hepatitis. The American Journal of Gastroenterology 102:9, 1939-1946
CrossRef477
Namiki Izumi, Yasuhiro Asahina, Kaoru Tsuchiya, Masayuki Kurosaki, Hiroyuki Nakanishi, Takatoshi Kitamura, Masakatsu Uchihara, Schozo Miyake. (2007) Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival. Hepatology Research 37:s2 Fourth JSH S, S254-S263
CrossRef478
Hashem B. El-Serag. (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatology Research 37:s2 Fourth JSH S, S88-S94
CrossRef479
L.A. Kondili, A. Lala, B. Gunson, S. Hubscher, S. Olliff, E. Elias, S. Bramhall, D. Mutimer. (2007) Primary hepatocellular cancer in the explanted liver: Outcome of transplantation and risk factors for HCC recurrence. European Journal of Surgical Oncology (EJSO) 33:7, 868-873
CrossRef480
Geoffrey C. Nguyen, Dorry L. Segev, Paul J. Thuluvath. (2007) Nationwide Increase in Hospitalizations and Hepatitis C Among Inpatients With Cirrhosis and Sequelae of Portal Hypertension. Clinical Gastroenterology and Hepatology 5:9, 1092-1099
CrossRef481
Alastair L. Young, Hassan Z. Malik, Mohammed Abu-Hilal, J. Ashley Guthrie, Judy Wyatt, K. Rajendra Prasad, Giles J. Toogood, J. Peter A. Lodge. (2007) Large Hepatocellular Carcinoma: Time to Stop Preoperative Biopsy. Journal of the American College of Surgeons 205:3, 453-462
CrossRef482
Shuichiro Shiina. (2007) Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S223-S229
CrossRef483
V. Schmitz, T. Sauerbruch. (2007) Früherkennung des hepatozellulären Karzinoms. Der Gastroenterologe 2:5, 356-364
CrossRef484
Sean D. Monahan, Vladimir M. Subbotin, Vladimir G. Budker, Paul M. Slattum, Zane C. Neal, Hans Herweijer, Jon A. Wolff. (2007) Rapidly Reversible Hydrophobization: An Approach to High First-Pass Drug Extraction. Chemistry & Biology 14:9, 1065-1077
CrossRef485
Patricia M. Lopez, Pruthvi Patel, Pablo Uva, Augusto Villanueva, Josep M. Llovet. (2007) Current management of liver cancer. European Journal of Cancer Supplements 5:5, 444-446
CrossRef486
Alexandre Sherlley Casimiro Onofre, Natalia Pomjanski, Birgit Buckstegge, Alfred Böcking. (2007) Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies. Cancer 111:4, 259-268
CrossRef487
Hugo R. Rosen, Scott J. Weston, KyungAh Im, Huiying Yang, James R. Burton, Henry Erlich, Jared Klarquist, Steven H. Belle, . (2007) Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy. Hepatology 46:2, 350-358
CrossRef488
Riccardo Capocaccia, Milena Sant, Franco Berrino, Arianna Simonetti, Valentina Santi, Franco Trevisani, . (2007) Hepatocellular Carcinoma: Trends of Incidence and Survival in Europe and the United States at the End of the 20th Century. The American Journal of Gastroenterology 102:8, 1661-1670
CrossRef489
Pankaj Singh, Richard A. Erickson, Phalguni Mukhopadhyay, Shanthi Gopal, Alex Kiss, Ahmed Khan, T. Ulf Westblom. (2007) EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointestinal Endoscopy 66:2, 265-273
CrossRef490
L. Gellert, B. Jalaludin, M. Levy. (2007) Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Internal Medicine Journal 37:8, 516-522
CrossRef491
Jessica Zucman-Rossi, Pierre Laurent-Puig. (2007) Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics 8:8, 997-1003
CrossRef492
George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B. McDonald, Laura Beretta, Sum P. Lee. (2007) Incidence and Predictors of Hepatocellular Carcinoma in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 5:8, 938-945.e4
CrossRef493
H. SHEN, D. AGARWAL, R. QI, N. CHALASANI, S. LIANGPUNSAKUL, L. LUMENG, H. YOO, P. KWO. (2007) Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Alimentary Pharmacology & Therapeutics 26:3, 393-400
CrossRef494
D. Koorey. (2007) Hepatocellular carcinoma: prevention, detection and treatment
?
CrossRef495
Paul J. Thuluvath. (2007) EUS-guided FNA could be another important tool for the early diagnosis of hepatocellular carcinoma. Gastrointestinal Endoscopy 66:2, 274-276
CrossRef496
Stephanie Roessler, Anuradha Budhu, Xin Wei Wang. (2007) Future of molecular profiling of human hepatocellular carcinoma. Future Oncology 3:4, 429-439
CrossRef497
Fanyin Meng, Roger Henson, Hania Wehbe–Janek, Kalpana Ghoshal, Samson T. Jacob, Tushar Patel. (2007) MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology 133:2, 647-658
CrossRef498
Vinod K. Rustgi. (2007) The epidemiology of hepatitis C infection in the United States. Journal of Gastroenterology 42:7, 513-521
CrossRef499
Konrad Schoppmeyer, Anna Dorothea ADW Wagner, Joachim Mössner, Wolfgang E. Fleig, Konrad Schoppmeyer. 2007. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. .
CrossRef500
M.A. Kern, K. Breuhahn, M. Schuchmann, P. Schirmacher. (2007) Molekulare Pathogenese des hepatozellulären Karzinoms. Der Pathologe 28:4, 261-268
CrossRef501
Myron Schwartz, Sasan Roayaie, Manousos Konstadoulakis. (2007) Strategies for the management of hepatocellular carcinoma. Nature Clinical Practice Oncology 4:7, 424-432
CrossRef502
Leonidas Christou, Georgios Pappas, Matthew E. Falagas. (2007) Bacterial Infection-Related Morbidity and Mortality in Cirrhosis. The American Journal of Gastroenterology 102:7, 1510-1517
CrossRef503
Peter Ferenci, Stefan Ferenci, Christian Datz, Ingo Rezman, Wilhelm Oberaigner, Reinhild Strauss. (2007) Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. Journal of Hepatology 47:1, 31-36
CrossRef504
I. Borbath, I. Leclercq, P. Moulin, C. Sempoux, Y. Horsmans. (2007) The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver. European Journal of Cancer 43:11, 1755-1763
CrossRef505
Naoki Hotta, Minoru Ayada, Akihiko Okumura, Tetsuya Ishikawa, Shinichi Kakumu. (2007) Usefulness of live 3D echocardiography during radiofrequency ablation in a case of hepatocellular carcinoma. Clinical Imaging 31:4, 283-286
CrossRef506
George Lau, Patrick Marcellin, Marion Peters. (2007) Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies. Hepatology International 1:2, 316-325
CrossRef507
Yukihiro Koike, Haruhiko Yoshida, Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Masatoshi Akamatsu, Ryosuke Tateishi, Tomonori Fujishima, Yujin Hoshida, Miho Kanda, Takashi Ishikawa, Yasushi Shiratori, Masao Omata. (2007) Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion. Hepatology International 1:2, 295-301
CrossRef508
Teh-Ia Huo, Cheng-Yuan Hsia, Chi-Jen Chu, Yi-Hsiang Huang, Wing-Yiu Lui, Jaw-Ching Wu, Pui-Ching Lee, Chin-Wen Chi, Shou-Dong Lee. (2007) The predictive ability of serum α-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Journal of Surgical Oncology 95:8, 645-651
CrossRef509
Joel R. Pekow, Atul K. Bhan, Hui Zheng, Raymond T. Chung. (2007) Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109:12, 2490-2496
CrossRef510
Arief Suriawinata, Swan N. Thung. (2007) Hepatitis C virus and malignancy. Hepatology Research 37:6, 397-401
CrossRef511
Linda L WONG, Naoky TSAI. (2007) Hepatocellular carcinoma in Filipinos. Asia-Pacific Journal of Clinical Oncology 3:2, 84-88
CrossRef512
Hashem B. El–Serag, K. Lenhard Rudolph. (2007) Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology 132:7, 2557-2576
CrossRef513
E Sirach, C Bureau, J M Péron, L Pradayrol, J P Vinel, L Buscail, P Cordelier. (2007) KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Cell Death and Differentiation 14:6, 1202-1210
CrossRef514
N. Girard, F. Mornex, C. Trepo, P. Merle. (2007) Place de la radiothérapie dans la stratégie de traitement du carcinome hépatocellulaire. Oncologie 9:6, 482-486
CrossRef515
Junichi Yamanaka, Shinichi Saito, Jiro Fujimoto. (2007) Impact of Preoperative Planning Using Virtual Segmental Volumetry on Liver Resection for Hepatocellular Carcinoma. World Journal of Surgery 31:6, 1251-1257
CrossRef516
Ellen T. Chang, Theresa H. M. Keegan, Scarlett L. Gomez, Gem M. Le, Christina A. Clarke, Samuel K. S. So, Sally L. Glaser. (2007) The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 109:10, 2100-2108
CrossRef517
Matthew M. Yeh, Anne M. Larson, Jean S. Campbell, Nelson Fausto, Stephen J. Rulyak, Paul E. Swanson. (2007) The Expression of Transforming Growth Factor-?? in Cirrhosis, Dysplastic Nodules, and Hepatocellular Carcinoma. The American Journal of Surgical Pathology 31:5, 681-689
CrossRef518
Yuichiro Otsuka, John P. Duffy, Sammy Saab, Douglas G. Farmer, Rafik M. Ghobrial, Jonathan R. Hiatt, Ronald W. Busuttil. (2007) Postresection hepatic failure: Successful treatment with liver transplantation. Liver Transplantation 13:5, 672-679
CrossRef519
Laura M Kulik. (2007) Advancements in hepatocellular carcinoma. Current Opinion in Gastroenterology 23:3, 268-274
CrossRef520
Shimul A. Shah, Alice C. Wei, Sean P. Cleary, Ilun Yang, Ian D. McGilvray, Steven Gallinger, David R. Grant, Paul D. Greig. (2007) Prognosis and Results After Resection of Very Large (≥10 cm) Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 11:5, 589-595
CrossRef521
S P Hussain, J Schwank, F Staib, X W Wang, C C Harris. (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:15, 2166-2176
CrossRef522
Lennox J. Jeffers. (2007) Treating hepatitis C in African Americans. Liver International 27:3, 313-322
CrossRef523
Takamasa Ohki, Ryosuke Tateishi, Shuichiro Shiina, Takahisa Sato, Ryota Masuzaki, Hideo Yoshida, Fumihiko Kanai, Shuntaro Obi, Haruhiko Yoshida, Masao Omata. (2007) Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma. Liver International 27:3, 360-367
CrossRef524
Elisa Wurmbach, Ying-bei Chen, Greg Khitrov, Weijia Zhang, Sasan Roayaie, Myron Schwartz, Isabel Fiel, Swan Thung, Vincenzo Mazzaferro, Jordi Bruix, Erwin Bottinger, Scott Friedman, Samuel Waxman, Josep M. Llovet. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:4, 938-947
CrossRef525
Shuji Kanmura, Hirofumi Uto, Kazunori Kusumoto, Yoichi Ishida, Satoru Hasuike, Kenji Nagata, Katsuhiro Hayashi, Akio Ido, Sherri Oliver Stuver, Hirohito Tsubouchi. (2007) Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology 45:4, 948-956
CrossRef526
George Miller, Lawrence H. Schwartz, Michael D'Angelica. (2007) The Use of Imaging in the Diagnosis and Staging of Hepatobiliary Malignancies. Surgical Oncology Clinics of North America 16:2, 343-368
CrossRef527
Yuqing Liu, Ronnie T.P. Poon, Weibin Shao, Xiaoli Sun, Hui Chen, Tsz Wai Kok, Sheung Tat Fan. (2007) Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Cancer Letters 248:1, 32-40
CrossRef528
Xiaofeng Wu, Jia Fan, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Yao Yu, Yinkun Liu, Zhaoyou Tang. (2007) Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochemical and Biophysical Research Communications 355:4, 866-871
CrossRef529
Valeria R. Mas, Robert A. Fisher, Kellie J. Archer, Kenneth C. Yanek, Bridgette Williams, Catherine I. Dumur, Daniel G. Maluf. (2007) Genes Associated With Progression and Recurrence of Hepatocellular Carcinoma in Hepatitis C Patients Waiting and Undergoing Liver Transplantation: Preliminary Results. Transplantation 83:7, 973-981
CrossRef530
G. Becker, A. Schmitt-Graeff, V. Ertelt, H.E. Blum, H.-P. Allgaier. (2007) CD117 (c-kit) Expression in Human Hepatocellular Carcinoma. Clinical Oncology 19:3, 204-208
CrossRef531
Shimul A. Shah, Sean P. Cleary, Alice C. Wei, Ilun Yang, Bryce R. Taylor, Alan W. Hemming, Bernard Langer, David R. Grant, Paul D. Greig, Steven Gallinger. (2007) Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes. Surgery 141:3, 330-339
CrossRef532
Wei-Dong Jia, Hui-Chuan Sun, Ju-Bo Zhang, Yang Xu, Yong-Bing Qian, Jin-Zhong Pang, Lu Wang, Lun-Xiu Qin, Yin-Kun Liu, Zhao-You Tang. (2007) A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis. Cancer Letters 247:2, 234-242
CrossRef533
J. Louis Hinshaw, Fred T. Lee. (2007) Cryoablation for Liver Cancer. Techniques in Vascular and Interventional Radiology 10:1, 47-57
CrossRef534
Jinsil Seong, Su Jung Shim, Ik Jae Lee, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn. (2007) Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. International Journal of Radiation Oncology*Biology*Physics 67:4, 1037-1042
CrossRef535
Nicholas Onaca, Gary L. Davis, Robert M. Goldstein, Linda W. Jennings, Göran B. Klintmalm. (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transplantation 13:3, 391-399
CrossRef536
Tatsuya Fujikawa, Hidenori Shiraha, Yutaka Nakanishi, Nobuyuki Takaoka, Naoki Ueda, Mayumi Suzuki, Yasushi Shiratori. (2007) Cimetidine inhibits epidermal growth factor-induced cell signaling. Journal of Gastroenterology and Hepatology 22:3, 436-443
CrossRef537
Sameer Parikh, David Hyman. (2007) Hepatocellular Cancer: A Guide for the Internist. The American Journal of Medicine 120:3, 194-202
CrossRef538
Mikio Tezuka, Keiji Hayashi, Kazunori Kubota, Sachiko Sekine, Yoichi Okada, Hiroyasu Ina, Tetsuya Irie. (2007) Growth Rate of Locally Recurrent Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization: Comparing the Growth Rate of Locally Recurrent Tumor with That of Primary Hepatocellular Carcinoma. Digestive Diseases and Sciences 52:3, 783-788
CrossRef539
Harsha Gadadhar Vardhana, Mukta Panda. (2007) Spontaneous Regression of Hepatocellular Carcinoma: Potential Promise for the Future. Southern Medical Journal 100:2, 223-224
CrossRef540
E. Bugianesi. (2007) Non-alcoholic Steatohepatitis and Cancer. Clinics in Liver Disease 11:1, 191-207
CrossRef541
W. Ray Kim. (2007) Epidemiology of hepatitis B in the United States. Current Hepatitis Reports 6:1, 3-8
CrossRef542
Gunda Millonig, Ivo W. Graziadei, Martin C. Freund, Werner Jaschke, Sylvia Stadlmann, Ruth Ladurner, Raimund Margreiter, Wolfgang Vogel. (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation 13:2, 272-279
CrossRef543
Sassan Pazirandeh, Urmila Khettry, Fredric D. Gordon, Robert H. Resnick, Jessica E. Murray, Sunil G. Sheth. (2007) Cyclooxygenase-2 Expression in Hepatocellular Carcinoma, Cirrhosis and Chronic Hepatitis in the United States. Digestive Diseases and Sciences 52:1, 220-227
CrossRef544
Jianzhong Shentu, Bo Zhang, Lingling Fan, Qioajun He, Bo Yang, Zhi Chen. (2007) Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo. Anti-Cancer Drugs 18:1, 47-53
CrossRef545
Norah A. Terrault, Mitchell L. Shiffman, Anna S.F. Lok, Sammy Saab, Lan Tong, Robert S. Brown, Gregory T. Everson, K. Rajender Reddy, Jeffrey H. Fair, Laura M. Kulik, Timothy L. Pruett, Leonard B. Seeff. (2007) Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation. Liver Transplantation 13:1, 122
CrossRef546
Chau-Ting Yeh, Tse-Ching Chen, Ming-Ling Chang, Chao-Wei Hsu, Ta-Sen Yeh, Wei-Chen Lee, Shiu-Feng Huang, Chih-Chieh Tsai. (2007) Identification of NV-F virus DNA in hepatocellular carcinoma. Journal of Medical Virology 79:1, 92-96
CrossRef547
M. Michele Manos, Wendy A. Leyden, Rosemary C. Murphy, Norah A. Terrault, Beth P. Bell. (2007) Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology 47:4, 1150
CrossRef548
Arvind Reddy, Chiranjeev Dash, Apinya Leerapun, Teresa A. Mettler, Linda M. Stadheim, Konstantinos N. Lazaridis, Rosebud O. Roberts, Lewis R. Roberts. (2007) Hypothyroidism: A Possible Risk Factor for Liver Cancer in Patients With No Known Underlying Cause of Liver Disease. Clinical Gastroenterology and Hepatology 5:1, 118-123
CrossRef549
Lukas Jyuhn-Hsiarn Lee, Chien-Hung Chen, Grace Yao, Chih-Wen Chung, Jin-Chuan Sheu, Po-Huang Lee, Yih-Jian Tsai, Jung-Der Wang. (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. Journal of Surgical Oncology 95:1, 34-39
CrossRef550
Gerhild Becker, Hans-Peter Allgaier, Manfred Olschewski, Andreas Zähringer, Hubert Erich Blum, . (2007) Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study. Hepatology 45:1, 9-15
CrossRef551
Michiyasu Yagura, Akihisa Tanaka, Masanobu Iri, Hiroshi Kamitsukasa. (2007) Chronological analysis for the hepatocellular carcinoma development. Kanzo 48:12, 598-603
CrossRef552
Deirdre J. Doyle, Martin E. O'Malley, Hyun-Jung Jang, Kartik Jhaveri. (2007) Value of the Unenhanced Phase for Detection of Hepatocellular Carcinomas 3 cm or Less When Performing Multiphase Computed Tomography in Patients With Cirrhosis. Journal of Computer Assisted Tomography 31:1, 86-92
CrossRef553
Yuko Kono, Olivier Lucidarme, Sang-Hee Choi, Steven C. Rose, Tarek I. Hassanein, Elliot Alpert, Robert F. Mattrey. (2007) Contrast-enhanced Ultrasound as a Predictor of Treatment Efficacy within 2 Weeks after Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 18:1, 57-65
CrossRef554
Ihab R. Kamel, Diane K. Reyes, Eleni Liapi, David A. Bluemke, Jean-Francois H. Geschwind. (2007) Functional MR Imaging Assessment of Tumor Response after 90Y Microsphere Treatment in Patients with Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 18:1, 49-56
CrossRef555
Juan F. Gallegos-Orozco, Hugo E. Vargas. (2007) Should Antihepatitis B Virus Core Positive or Antihepatitis C Virus Core Positive Subjects Be Accepted as Organ Donors for Liver Transplantation?. Journal of Clinical Gastroenterology 41:1, 66-74
CrossRef556
Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko Oka, Fumihiro Urano, Masatoshi Kudo, Takashi Matsunaga. (2006) Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers. Clinical Gastroenterology and Hepatology 4:12, 1528-1536
CrossRef557
Patricia M. Lopez, Augusto Villanueva, Sasan Roayaie, Josep M. Llovet. (2006) Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal. Liver Transplantation 12:12, 1747-1754
CrossRef558
Ryosuke Tateishi, Shuichiro Shiina, Haruhiko Yoshida, Takuma Teratani, Shuntaro Obi, Noriyo Yamashiki, Hideo Yoshida, Masatoshi Akamatsu, Takao Kawabe, Masao Omata. (2006) Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 44:6, 1518-1527
CrossRef559
A. Mathew, L. P. Peiffer, K. Rhoades, T. McGarrity. (2006) Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment. Digestive Diseases and Sciences 51:11, 1956-1961
CrossRef560
Eiji Ando, Ryoko Kuromatsu, Masatoshi Tanaka, Akio Takada, Nobuyoshi Fukushima, Shuji Sumie, Sakae Nagaoka, Jyunji Akiyoshi, Kinya Inoue, Takuji Torimura, Ryukichi Kumashiro, Takato Ueno, Michio Sata. (2006) Surveillance Program for Early Detection of Hepatocellular Carcinoma in Japan. Journal of Clinical Gastroenterology 40:10, 942-948
CrossRef561
Bachir Taouli, Glenn A. Krinsky. (2006) Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Liver Transplantation 12:S2, S1-S7
CrossRef562
G. Giannelli, S. Antonaci. (2006) New frontiers in biomarkers for hepatocellular carcinoma. Digestive and Liver Disease 38:11, 854-859
CrossRef563
Alejandro Forner, Amelia J. Hessheimer, M. Isabel Real, Jordi Bruix. (2006) Treatment of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 60:2, 89-98
CrossRef564
M. Lesurtel, B. Müllhaupt, B. C. Pestalozzi, T. Pfammatter, P.-A. Clavien. (2006) Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis. American Journal of Transplantation 6:11, 2644-2650
CrossRef565
Hui Zhang, Qing-Hai Ye, Ning Ren, Lei Zhao, Yan-Fang Wang, Xin Wu, Hui-Chuan Sun, Lu Wang, Bo-Heng Zhang, Yin-Kun Liu, Zhao-You Tang, Lun-Xiu Qin. (2006) The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 132:11, 709-717
CrossRef566
Sheng-Nan Lu, Wei-Wen Su, Sheng-Shun Yang, Ting-Tsung Chang, Ken-Sheng Cheng, Jaw-Ching Wu, Hans Hsienhong Lin, Shun-Sheng Wu, Chuan-Mo Lee, Chi-Sin Changchien, Chien-Jen Chen, Jin-Chuan Sheu, Ding-Shinn Chen, Chien-Hung Chen. (2006) Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. International Journal of Cancer 119:8, 1946-1952
CrossRef567
I. Kaare Tesdal, Mats Wikström, Christa Flechtenmacher, Thomas Filser, Christoph Dueber. (2006) Percutaneous Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts. CardioVascular and Interventional Radiology 29:5, 778-784
CrossRef568
Richard B. Freeman, Abigail Mithoefer, Robin Ruthazer, Khanh Nguyen, Anthony Schore, Ann Harper, Erick Edwards. (2006) Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transplantation 12:10, 1504-1511
CrossRef569
J.A. Batsis, T.R. Halfdanarson, H. Pitot. (2006) Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice. Digestive and Liver Disease 38:10, 768-771
CrossRef570
L. Castells Fusté. (2006) Virus de la hepatitis B y carcinoma hepatocelular. Gastroenterología y Hepatología 29, 86-92
CrossRef571
A. Forner, M. Varela, J. Bruix. (2006) Hepatocarcinoma y VHC. Gastroenterología y Hepatología 29, 196-199
CrossRef572
Ankit Bharat, Daniel B. Brown, Jeffrey S. Crippin, Jennifer E. Gould, Jeffrey A. Lowell, Surendra Shenoy, Niraj M. Desai, William C. Chapman. (2006) Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival. Journal of the American College of Surgeons 203:4, 411-420
CrossRef573
Tsutomu Masaki, Asahiro Morishita, Kazutaka Kurokohchi, Shigeki Kuriyama. (2006) Multidisciplinary treatment of patients with hepatocellular carcinoma. Expert Review of Anticancer Therapy 6:10, 1377-1384
CrossRef574
Terence C.W. Poon, Nathalie Wong, Paul B.S. Lai, Magnus Rattray, Philip J. Johnson, Joseph J.Y. Sung. (2006) A Tumor Progression Model for Hepatocellular Carcinoma: Bioinformatic Analysis of Genomic Data. Gastroenterology 131:4, 1262-1270
CrossRef575
Yasuhiro Kuramitsu, Kazuyuki Nakamura. (2006) Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkers. PROTEOMICS 6:20, 5650-5661
CrossRef576
Sandro Pignata, Ciro Gallo, Bruno Daniele, Silvana Elba, Antonio Giorgio, Gaetano Capuano, Luigi Elio Adinolfi, Ilario De Sio, Francesco Izzo, Fabio Farinati, Carlo Del Naja, Maria Stanzione, Fabiana Castiglione, Giampiero Marone, Oreste Cuomo, Martina Felder, Giovanni Battista Gaeta, Ermelinda De Maio, Massimo Di Maio, Giuseppe Signoriello, Francesco Perrone. (2006) Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. Critical Reviews in Oncology/Hematology 59:3, 243-249
CrossRef577
Sakae Nagaoka, Satoshi Itano, Masatoshi Ishibashi, Takuji Torimura, Kenkichi Baba, Junji Akiyoshi, Junichi Kurogi, Satoru Matsugaki, Kinya Inoue, Nobuyoshi Tajiri, Akio Takada, Eiji Ando, Ryoko Kuromatsu, Hayato Kaida, Mina Kurogi, Hironori Koga, Ryukichi Kumashiro, Naofumi Hayabuchi, Masamichi Kojiro, Michio Sata. (2006) Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver International 26:7, 781-788
CrossRef578
Nicholas J. Shaheen, Richard A. Hansen, Douglas R. Morgan, Lisa M. Gangarosa, Yehuda Ringel, Michelle T. Thiny, Mark W. Russo, Robert S. Sandler. (2006) The Burden of Gastrointestinal and Liver Diseases, 2006. The American Journal of Gastroenterology 101:9, 2128-2138
CrossRef579
RW Pang, TK Lee, K Man, RT Poon, S-T Fan, Y-L Kwong, E Tse. (2006) PIN1 expression contributes to hepatic carcinogenesis. The Journal of Pathology 210:1, 19-25
CrossRef580
Patrizia Pontisso, Santina Quarta, Cristina Caberlotto, Luca Beneduce, Maria Marino, Elisabetta Bernardinello, Natascia Tono, Giorgio Fassina, Luisa Cavalletto, Angelo Gatta, Liliana Chemello. (2006) Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. International Journal of Cancer 119:4, 735-740
CrossRef581
Wei-Min Tong, Ming-Kei Lee, Dominique Galendo, Zhao-Qi Wang, Kanaga Sabapathy. (2006) Aflatoxin-B exposure does not lead top53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice. International Journal of Cancer 119:4, 745-749
CrossRef582
Erik J. Van Kleek, Jonathan M. Schwartz, Stephen C. Rayhill, Hugo R. Rosen, Scott J. Cotler. (2006) Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 40:7, 643-647
CrossRef583
Weidong Liu, Hideji Nakamura, Tohru Tsujimura, Jidong Cheng, Teruhisa Yamamoto, Yuna Iwamoto, Hiroyasu Imanishi, Soji Shimomura, Tetsuo Yamamoto, Tsutomu Hirasawa, Shuichiro Inagaki, Shuhei Nishiguchi, Toshikazu Hada. (2006) Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor. Cancer Science 97:8, 768-773
CrossRef584
Yu-Lueng Shih, Rong-Yuan Shyu, Chung-Bao Hsieh, Hung-Cheng Lai, Kuo-Yu Liu, Tang-Yuan Chu, Ya-Wen Lin. (2006) Promoter methylation of the secreted frizzled-related protein 1 geneSFRP1 is frequent in hepatocellular carcinoma. Cancer 107:3, 579-590
CrossRef585
Yan Li, Zhao-You Tang, Bo Tian, Sheng-Long Ye, Lun-Xiu Qin, Qiong Xue, Rui-Xia Sun. (2006) Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients. Journal of Cancer Research and Clinical Oncology 132:8, 515-520
CrossRef586
Maria Varela, William Sanchez, Jordi Bruix, Gregory J. Gores. (2006) Hepatocellular carcinoma in the setting of liver transplantation. Liver Transplantation 12:7, 1028-1036
CrossRef587
Patrick Couvreur, Christine Vauthier. (2006) Nanotechnology: Intelligent Design to Treat Complex Disease. Pharmaceutical Research 23:7, 1417-1450
CrossRef588
Robert Suruki, Katsuhiro Hayashi, Kazunori Kusumoto, Hirofumi Uto, Akio Ido, Hirohito Tsubouchi, Sherri O. Stuver. (2006) Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan. International Journal of Cancer 119:1, 192-195
CrossRef589
Masahiro Okamoto, Tohru Utsunomiya, Shigeki Wakiyama, Masaji Hashimoto, Kengo Fukuzawa, Takahiro Ezaki, Taizo Hanai, Hiroshi Inoue, Masaki Mori. (2006) Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive Patients. Annals of Surgical Oncology 13:7, 947-954
CrossRef590
Jean-Claude Trinchet, Nathalie Ganne-Carrié. (2006) Faut-il dépister le carcinome hépatocellulaire ?. Gastroentérologie Clinique et Biologique 30:6-7, 880-886
CrossRef591
Motonari Takashima, Yasuhiro Kuramitsu, Yuichiro Yokoyama, Norio Iizuka, Toshio Harada, Masanori Fujimoto, Isao Sakaida, Kiwamu Okita, Masaaki Oka, Kazuyuki Nakamura. (2006) Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. PROTEOMICS 6:13, 3894-3900
CrossRef592
Dana R. Crawford, Stephanie Ostrowski, Dilip Vakharia, Zoran Ilic, Stewart Sell. (2006) Separate Origins of Hepatitis B Virus Surface Antigen-Negative Foci and Hepatocellular Carcinomas in Transgenic HBsAg (alb/psx) Mice. The American Journal of Pathology 169:1, 223-232
CrossRef593
Michel Doffoël, Ahmed Ananna. (2006) Traitement palliatif du carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 30:6-7, 887-890
CrossRef594
Chao-Shiang Li, Ran-Chou Chen, Jiunn-Ming Lii, Wei-Tsung Chen, Li-Sun Shih, Ting-An Zhang, Hsing-Yang Tu. (2006) Magnetic Resonance Imaging Appearance of Well-differentiated Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 30:4, 597-603
CrossRef595
Christian Müller. (2006) Hepatocellular carcinoma – Rising incidence, changing therapeutic strategies. Wiener Medizinische Wochenschrift 156:13-14, 404-409
CrossRef596
J T Feng, S Shang, L Beretta. (2006) Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene 25:27, 3810-3817
CrossRef597
M Levrero. (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:27, 3834-3847
CrossRef598
L B Seeff, J H Hoofnagle. (2006) Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 25:27, 3771-3777
CrossRef599
J-S Lee, S S Thorgeirsson. (2006) Comparative and integrative functional genomics of HCC. Oncogene 25:27, 3801-3809
CrossRef600
J West, H Wood, R F A Logan, M Quinn, G P Aithal. (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. British Journal of Cancer 94:11, 1751-1758
CrossRef601
Eishiro Mizukoshi, Yasunari Nakamoto, Yohei Marukawa, Kuniaki Arai, Tatsuya Yamashita, Hirokazu Tsuji, Kiyotaka Kuzushima, Masafumi Takiguchi, Shuichi Kaneko. (2006) Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 43:6, 1284-1294
CrossRef602
Valeria R. Mas, Daniel G. Maluf, Catherine I. Dumur, Kellie J. Archer, Kenneth Yanek, Colleen Jackson-Cook, Robert A. Fisher. (2006) Molecular Techniques for Identifying HCC Origin and Biology After Orthotopic Liver Transplantation. Diagnostic Molecular Pathology 15:2, 90-94
CrossRef603
C. D. Howell, L. S. Jeffers, W. Cassidy, K. R. Reddy, S. Hu, J. S. Lee. (2006) Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response. Journal of Viral Hepatitis 13:6, 371-376
CrossRef604
Shimul A. Shah, Jensen C.C. Tan, Ian D. McGilvray, Mark S. Cattral, Sean P. Cleary, Gary A. Levy, Paul D. Greig, David R. Grant. (2006) Accuracy of Staging as a Predictor for Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 81:12, 1633-1639
CrossRef605
Hironori Tanaka, Kazuhiro Nouso, Haruhiko Kobashi, Yoshiyuki Kobayashi, Shin-ichiro Nakamura, Yasuhiro Miyake, Hideki Ohnishi, Kenji Miyoshi, Shouta Iwado, Yoshiaki Iwasaki, Kohsaku Sakaguchi, Yasushi Shiratori. (2006) Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival. Liver International 26:5, 543-551
CrossRef606
Takakazu Furutani, Keisuke Hino, Michiari Okuda, Toshikazu Gondo, Sohji Nishina, Akira Kitase, Masaaki Korenaga, Shu–Yuan Xiao, Steven A. Weinman, Stanley M. Lemon, Isao Sakaida, Kiwamu Okita. (2006) Hepatic Iron Overload Induces Hepatocellular Carcinoma in Transgenic Mice Expressing the Hepatitis C Virus Polyprotein. Gastroenterology 130:7, 2087-2098
CrossRef607
Christoph Eisenbach, Anne Freyse, Catalin M. Lupu, Kilian Weigand, Evelyn Ernst, Birgit Hoyler, Wolfgang Stremmel, Joachim J. Bugert, Jens Encke. (2006) Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse. Vaccine 24:24, 5140-5148
CrossRef608
F. Chu, D.L. Morris. (2006) Single centre experience of liver resection for hepatocellular carcinoma in patients outside transplant criteria. European Journal of Surgical Oncology (EJSO) 32:5, 568-572
CrossRef609
Massimo Malagó, Georgios C. Sotiropoulos, Silvio Nadalin, Camino Valentin-Gamazo, Andreas Paul, Hauke Lang, Arnold Radtke, Fuat Saner, Ernesto Molmenti, Susanne Beckebaum, Guido Gerken, Andrea Frilling, Christoph E. Broelsch. (2006) Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report. Liver Transplantation 12:6, 934-940
CrossRef610
P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET. (2006) Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Alimentary Pharmacology and Therapeutics 23:11, 1535-1547
CrossRef611
Michael A. Kern, Anke M. Haugg, Eva Eiteneuer, Elisabeth Konze, Uta Drebber, Hans P. Dienes, Kai Breuhahn, Peter Schirmacher, Hans U. Kasper. (2006) Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma. Liver International 26:5, 604-612
CrossRef612
Miguel Bruguera, Xavier Forns. (2006) Hepatitis C en España. Medicina Clínica 127:3, 113-117
CrossRef613
Anne M. Covey, Mary A. Maluccio, Johanna Schubert, Leah BenPorat, Lynn A. Brody, Constantinos T. Sofocleous, George I. Getrajdman, Yuman Fong, Karen T. Brown. (2006) Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106:10, 2181-2189
CrossRef614
Jorge A Marrero. (2006) Hepatocellular carcinoma. Current Opinion in Gastroenterology 22:3, 248-253
CrossRef615
Mosaad A. Abdel-Wahhab, Hanaa, H. Ahmed, Mohamad M. Hagazi. (2006) Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts. Journal of Applied Toxicology 26:3, 229-238
CrossRef616
Adnan Said, Michael R Lucey. (2006) Liver transplantation: an update. Current Opinion in Gastroenterology 22:3, 272-278
CrossRef617
X.-P. Chen, F.-Z. Qiu, Z.-D. Wu, Z.-W. Zhang, Z.-Y. Huang, Y.-F Chen. (2006) Long-term outcome of resection of large hepatocellular carcinoma. British Journal of Surgery 93:5, 600-606
CrossRef618
Michael Zimmerman, Ronald W Busuttil. (2006) Long-term efficacy of percutaneous thermal ablation for patients with recurrent hepatocellular carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 3:5, 250-251
CrossRef619
Shuntaro Obi, Haruhiko Yoshida, Risa Toune, Tadao Unuma, Miho Kanda, Shinpei Sato, Ryosuke Tateishi, Takuma Teratani, Shuichiro Shiina, Masao Omata. (2006) Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106:9, 1990-1997
CrossRef620
Mark Branda, Jack R. Wands. (2006) Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 43:5, 891-902
CrossRef621
M. L. Shiffman, S. Saab, S. Feng, M. I. Abecassis, A. G. Tzakis, N. P. Goodrich, D. E. Schaubel. (2006) Liver and Intestine Transplantation in the United States, 1995-2004. American Journal of Transplantation 6:5p2, 1170-1187
CrossRef622
Takuma Teratani, Haruhiko Yoshida, Shuichiro Shiina, Shuntaro Obi, Shinpei Sato, Ryosuke Tateishi, Norio Mine, Yuji Kondo, Takao Kawabe, Masao Omata. (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:5, 1101-1108
CrossRef623
Maria A. Hawkins, Laura A. Dawson. (2006) Radiation therapy for hepatocellular carcinoma. Cancer 106:8, 1653-1663
CrossRef624
Ju-Seog Lee, Jeonghoon Heo, Louis Libbrecht, In-Sun Chu, Pal Kaposi-Novak, Diego F Calvisi, Arsen Mikaelyan, Lewis R Roberts, Anthony J Demetris, Zongtang Sun, Frederik Nevens, Tania Roskams, Snorri S Thorgeirsson. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nature Medicine 12:4, 410-416
CrossRef625
Beicheng Sun, Meizhen Chen, Christina Hawks, Peter J. Hornsby, Xuehao Wang. (2006) Tumorigenic study on hepatocytes coexpressing SV40 with Ras. Molecular Carcinogenesis 45:4, 213-219
CrossRef626
Tushar Patel, Cheryle Dangell, Shail Maheshwari. (2006) Impact of Age on Screening and Surveillance for Primary Liver Cancer. The American Journal of Gastroenterology 101:4, 768-774
CrossRef627
Daniel Cherqui, Alexis Laurent, Claude Tayar, Stephen Chang, Jeanne Tran Van Nhieu, J??r??me Loriau, Mehdi Karoui, Christophe Duvoux, Daniel Dhumeaux, Pierre-Louis Fagniez. (2006) Laparoscopic Liver Resection for Peripheral Hepatocellular Carcinoma in Patients With Chronic Liver Disease. Annals of Surgery 243:4, 499-506
CrossRef628
Lesley De Pietri, Antonio Siniscalchi, Alexia Reggiani, Michele Masetti, Bruno Begliomini, Matteo Gazzi, Giorgio E. Gerunda, Alberto Pasetto. (2006) The Use of Intrathecal Morphine for Postoperative Pain Relief After Liver Resection: A Comparison with Epidural Analgesia. Anesthesia & Analgesia 102:4, 1157-1163
CrossRef629
Hiroto Katoh, Tatsuhiro Shibata, Akiko Kokubu, Hidenori Ojima, Masashi Fukayama, Yae Kanai, Setsuo Hirohashi. (2006) Epigenetic Instability and Chromosomal Instability in Hepatocellular Carcinoma. The American Journal of Pathology 168:4, 1375-1384
CrossRef630
A. Zerbini, M. Pilli, C. Ferrari, G. Missale. (2006) Is there a role for immunotherapy in hepatocellular carcinoma?. Digestive and Liver Disease 38:4, 221-225
CrossRef631
Yasuhiro Kuramitsu, Toshio Harada, Motonari Takashima, Yuuichirou Yokoyama, Isao Hidaka, Norio Iizuka, Tosifusa Toda, Masanori Fujimoto, Xiulian Zhang, Isao Sakaida, Kiwamu Okita, Masaaki Oka, Kazuyuki Nakamura. (2006) Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. ELECTROPHORESIS 27:8, 1651-1658
CrossRef632
William Sanchez, Jayant A. Talwalkar. (2006) Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation. Gastroenterology Clinics of North America 35:1, 201-219
CrossRef633
Tilak U. Shah, Richard C. Semelka, Ertan Pamuklar, Zeynep Firat, Richard D. Gerber, Roshan Shrestha, Mark W. Russo. (2006) The Risk of Hepatocellular Carcinoma in Cirrhotic Patients with Small Liver Nodules on MRI. The American Journal of Gastroenterology 101:3, 533-540
CrossRef634
Hashem B. El–Serag, Howard Hampel, Fariba Javadi. (2006) The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence. Clinical Gastroenterology and Hepatology 4:3, 369-380
CrossRef635
Min-Shan Chen, Jin-Qing Li, Yun Zheng, Rong-Ping Guo, Hui-Hong Liang, Ya-Qi Zhang, Xiao-Jun Lin, Wan Y. Lau. (2006) A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma. Annals of Surgery 243:3, 321-328
CrossRef636
Liang Qiao, Hongxia Zhang, Jun Yu, Rona Francisco, Paul Dent, Matthias P.A. Ebert, Christoph Röcken, Geoffrey Farrell. (2006) Constitutive Activation of NF-κB in Human Hepatocellular Carcinoma: Evidence of a Cytoprotective Role. Human Gene Therapy 17:3, 280-290
CrossRef637
Jonathan M. Schwartz. (2006) TREATMENT OF HEPATOCELLULAR CARCINOMA IN THE UNITED STATES: HOW WELL HAVE WE BEEN DOING?. Evidence-Based Gastroenterology 7:1, 25-26
CrossRef638
Lei Yu, Dana A. Sloane, Chuanfa Guo, Charles D. Howell. (2006) Risk Factors for Primary Hepatocellular Carcinoma in Black and White Americans in 2000. Clinical Gastroenterology and Hepatology 4:3, 355-360
CrossRef639
Bieke Lambert, Klaus Bacher, Luc Defreyne, Hans Vlierberghe, Jae Min Jeong, Rong Fu Wang, Jan Meerbeeck, Peter Smeets, Roberto Troisi, Hubert Thierens, Filip Vos, Christophe Wiele. (2006) 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study. European Journal of Nuclear Medicine and Molecular Imaging 33:3, 344-352
CrossRef640
Chien-Chung Lin, Po-Quang Chen, Wen-Jer Chen, Lih-Huei Chen. (2006) Prognosis Of Operative Treatment for Metastatic Hepatocellular Carcinoma of the Spine. Clinical Orthopaedics and Related Research 443:&NA;, 209-215
CrossRef641
Eishiro Mizukoshi, Yasunari Nakamoto, Hirokazu Tsuji, Tatsuya Yamashita, Shuichi Kaneko. (2006) Identification of α-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. International Journal of Cancer 118:5, 1194-1204
CrossRef642
JEONG HWAN KIM, MOON SEOK CHOI, HYUK LEE, DO YOUNG KIM, JOON HYEOK LEE, KWANG CHEOL KOH, BYUNG CHUL YOO, SEUNG WOON PAIK, JONG CHUL RHEE. (2006) Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. Journal of Gastroenterology and Hepatology 21:3, 588-594
CrossRef643
liang Qiao, Hongxia Zhang, Jun Yu, Rona Francisco, Paul Dent, Matthias P.A. Ebert, Christoph Rocke, Geoffrey Farrell. (2006) Constitutive Activation of NF-B in Human Hepatocellular Carcinoma: Evidence of a Cytoprotective Role. Human Gene Therapy 0:0, 060215071124002
CrossRef644
W. Ray Kim, Terry M. Therneau, Joanne T. Benson, Walter K. Kremers, Charles B. Rosen, Gregory J. Gores, E. Rolland Dickson. (2006) Deaths on the liver transplant waiting list: An analysis of competing risks. Hepatology 43:2, 345-351
CrossRef645
Hong-Mei Zhang, Li-Wang Zhang, Jun Ren, Li Fan, Xiao-Ming Si, Wen-Chao Liu. (2006) Induction of α-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. Cellular Immunology 239:2, 144-150
CrossRef646
Tong Wu. (2006) Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treatment Reviews 32:1, 28-44
CrossRef647
Jin Wook Chung, Hyo-Cheol Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Hwan Jun Jae, Whal Lee, Jae Hyung Park. (2006) Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Prevalence and Causative Factors of Extrahepatic Collateral Arteries in 479 Patients. Korean Journal of Radiology 7:4, 257
CrossRef648
K T Ng, K Man, C K Sun, T K Lee, R T Poon, C-M Lo, S-T Fan. (2006) Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. British Journal of Cancer 95:8, 1050
CrossRef649
Joshua Seinfeld, Aaron Scott Wagner, B. K. Kleinschmidt-DeMasters. (2006) Brain Metastases from Hepatocellular Carcinoma in US Patients. Journal of Neuro-Oncology 76:1, 93-98
CrossRef650
Danny H. F. Chow, Lorraine H. Y. Sinn, Kelvin K. Ng, Chi Ming Lam, Jimmy Yuen, Sheung Tat Fan, Ronnie T. P. Poon. (2006) Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: A comparative study. Journal of Surgical Oncology 94:7, 565
CrossRef651
Y.-H. HUANG, J.-C. WU, S.-C. CHEN, C.-H. CHEN, J.-H. CHIANG, T.-I. HUO, P.-C. LEE, F.-Y. CHANG, S.-D. LEE. (2006) Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Alimentary Pharmacology and Therapeutics 23:1, 129-135
CrossRef652
Maryann Mugo, Ravina Matta, L Romayne Kurukulasuriya, James R. Sowers. (2006) Association of Hepatitis C Virus Infection and Diabetes Mellitus. The Endocrinologist 16:1, 41-48
CrossRef653
David Mondada, Fredrik T. Bosman, Charlotte Fontolliet, Walter K. F. Seelentag. (2006) Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival. Virchows Archiv 448:1, 35-45
CrossRef654
John B Wong. (2006) Hepatitis C. PharmacoEconomics 24:7, 661-672
CrossRef655
B. L. Pearlman. (2006) Hepatitis C Virus Infection in African Americans. Clinical Infectious Diseases 42:1, 82-91
CrossRef656
Tony S.K. Mok, Eve Choi, Daisy Yau, Anandhi Johri, Winnie Yeo, Anthony T.C. Chan, Cesar Wong. (2006) Effects of Patupilone (Epothilone B; EPO906), a Novel Chemotherapeutic Agent, in Hepatocellular Carcinoma: An in vitro Study. Oncology 71:3-4, 292-296
CrossRef657
Stephen A Harrison. (2006) Liver Disease in Patients With Diabetes Mellitus. Journal of Clinical Gastroenterology 40:1, 68-76
CrossRef658
Ming-Yang Lai. (2006) Combined Interferon and Ribavirin Therapy for Chronic Hepatitis C in Taiwan. Intervirology 49:1-2, 91-95
CrossRef659
ERICA VILLA, ANTONELLA GROTTOLA, ALESSANDRA COLANTONI, NICOLA MARIA, PAOLA BUTTAFOCO, ILVA FERRETTI, FEDERICO MANENTI. (2006) Hepatocellular Carcinoma. Annals of the New York Academy of Sciences 963:1, 37
CrossRef660
Hideo Yoshida, Haruhiko Yoshida, Shuichiro Shiina, Masao Omata. (2005) Early liver cancer: concepts, diagnosis, and management. International Journal of Clinical Oncology 10:6, 384-390
CrossRef661
D. Lavanchy. (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. Journal of Clinical Virology 34, S1-S3
CrossRef662
Chris R. Kelsey, Tracey Schefter, S Russell Nash, Paul Russ, Anna E. Bar??n, Chan Zeng, Laurie E. Gaspar. (2005) Retrospective Clinicopathologic Correlation of Gross Tumor Size of Hepatocellular Carcinoma. American Journal of Clinical Oncology 28:6, 576-580
CrossRef663
Zong-Ming E Chen, Kimberley G Crone, Mark A Watson, John D Pfeifer, Hanlin L Wang. (2005) Identification of a Unique Gene Expression Signature That Differentiates Hepatocellular Adenoma From Well-Differentiated Hepatocellular Carcinoma. The American Journal of Surgical Pathology 29:12, 1600-1608
CrossRef664
Nayna Patel, Adrian K. P. Lim, Martin J. K. Blomley, Paul Sidhu, Simon D. Taylor-Robinson. (2005) Screening for Hepatocellular Carcinoma: The Role of Alpha-fetoprotein and Ultrasound with and without Ultrasound Contrast Agents. Ultrasound 13:4, 219-225
CrossRef665
Chian-Feng Chen, Shiou-Hwei Yeh, Ding-Shinn Chen, Pei-Jer Chen, Yuh-Shan Jou. (2005) Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11. Genes, Chromosomes and Cancer 44:3, 320-328
CrossRef666
Anne M. Larson. (2005) The epidemiology of hepatocellular carcinoma in hcv. Current Hepatitis Reports 4:4, 145-152
CrossRef667
Kui-Hin Liau, Leyo Ruo, Jinru Shia, Aasim Padela, Mithat Gonen, William R. Jarnagin, Yuman Fong, Michael I. D'Angelica, Leslie H. Blumgart, Ronald P. DeMatteo. (2005) Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer 104:9, 1948-1955
CrossRef668
Srikanta Dash, Salima Haque, Virendra Joshi, Ramesh Prabhu, Sidhartha Hazari, Cesar Fermin, Robert Garry. (2005) HCV-hepatocellular carcinoma: New findings and hope for effective treatment. Microscopy Research and Technique 68:3-4, 130-148
CrossRef669
Ju-Tao Feng, Yin-Kun Liu, Hai-Yan Song, Zhi Dai, Lun-Xiu Qin, Mohamad Radwan Almofti, Cai-Yun Fang, Hao-Jie Lu, Peng-Yuan Yang, Zhao-You Tang. (2005) Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. PROTEOMICS 5:17, 4581-4588
CrossRef670
E. BUGIANESI. (2005) Review article: steatosis, the metabolic syndrome and cancer. Alimentary Pharmacology and Therapeutics 22:s2, 40-43
CrossRef671
Jamie Berkes, Scott J. Cotler. (2005) Global epidemiology of hcv infection. Current Hepatitis Reports 4:4, 125-130
CrossRef672
Murat Aladag, Cemal Camci, Ye Huang, Harlan Wright, Sayed Rizvi, Ahmet Gurakar, Kenneth Stokes, Anthony Sebastian. (2005) Marked Reduction of the Alpha-Fetoprotein Levels Among Individuals With Chronic Hepatitis C, Following Peg-Interferon and Ribavirin Treatment. Journal of Clinical Gastroenterology 39:10, 923-924
CrossRef673
J. Encke, J. Findeklee, J. Geib, E. Pfaff, W. Stremmel. (2005) Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clinical and Experimental Immunology 142:2, 362-369
CrossRef674
Jordi Bruix, Morris Sherman. (2005) Management of hepatocellular carcinoma. Hepatology 42:5, 1208-1236
CrossRef675
Gordon McLennan, Erik N.K. Cressman, Yonghua Xu, Dianbo Zhang, Mandar R. Jagtap, Hiremagular N. Jayaram. (2005) The Effect of Benzamide Riboside on the VX2 Model of Liver Cancer in Rabbits. Journal of Vascular and Interventional Radiology 16:11, 1499-1504
CrossRef676
Pierce K. Chow. (2005) Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma. Cancer Treatment Reviews 31:6, 491-495
CrossRef677
V. Sypsa, G. Touloumi, G. V. Papatheodoridis, N. C. Tassopoulos, I. Ketikoglou, I. Vafiadis, G. Hatzis, D. Tsantoulas, E. Akriviadis, S. Koutsounas, A. Hatzakis. (2005) Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. Journal of Viral Hepatitis 12:5, 543-550
CrossRef678
Sameera Ezzat, Mohamed Abdel-Hamid, Soheir Abdel-Latif Eissa, Nadia Mokhtar, Nargis Albert Labib, Laila El-Ghorory, Nabiel Nasmi Mikhail, Amany Abdel-Hamid, Tamer Hifnawy, G. Thomas Strickland, Christopher A. Loffredo. (2005) Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. International Journal of Hygiene and Environmental Health 208:5, 329-339
CrossRef679
Jens Encke, Thomas Kraus, Arianeb Mehrabi, Wolfgang Stremmel, Peter Sauer. (2005) Treatment of Hepatitis C Virus Reinfection after Liver Transplantation. Transplantation 80:Supplement, S125-S127
CrossRef680
Ivan Borbath, Renaud Lhommel, Laila Bittich, Pierre Goffette, Laurence Annet, Bernard E. Van Beers, Marie-Alix Bonny, Stanislas Pauwels, Yves Horsmans. (2005) 131I-Labelled-iodized oil for palliative treatment of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 17:9, 905-910
CrossRef681
Colin W Shepard, Lyn Finelli, Miriam J Alter. (2005) Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 5:9, 558-567
CrossRef682
Jianguang Ji, Kari Hemminki. (2005) Variation in the risk for liver and gallbladder cancers in socioeconomic and occupational groups in Sweden with etiological implications. International Archives of Occupational and Environmental Health 78:8, 641-649
CrossRef683
Taichi Shimazu, Yoshitaka Tsubono, Shinichi Kuriyama, Kaori Ohmori, Yayoi Koizumi, Yoshikazu Nishino, Daisuke Shibuya, Ichiro Tsuji. (2005) Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan. International Journal of Cancer 116:1, 150-154
CrossRef684
Yasuhiro Kuramitsu, Kazuyuki Nakamura. (2005) Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Review of Proteomics 2:4, 589-601
CrossRef685
Jia-Horng Kao, Ding-Shinn Chen. (2005) Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver International 25:4, 696-703
CrossRef686
Fumio Imazeki, Osamu Yokosuka, Kenichi Fukai, Shigenobu Kawai, Tatsuo Kanda, Hiroshige Kojima, Hiromitsu Saisho. (2005) Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C.. Liver International 25:4, 772-778
CrossRef687
W. Ray Kim, Gregory J. Gores, Joanne T. Benson, Terry M. Therneau, L. Joseph Melton. (2005) Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States. Gastroenterology 129:2, 486-493
CrossRef688
Jian Zhou, Yong-Sheng Xiao, Zhao-You Tang, Jia Fan, Zhi-Quan Wu, Yan Zhao, Qiong Xue, Zao-Zhuo Shen, Yin-Kun Liu, Sheng-Long Ye. (2005) Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration. Journal of Cancer Research and Clinical Oncology 131:8, 547-551
CrossRef689
TAKASHI ISHIKAWA, YASUSHI FUKUSHIMA, YUJIRO SHIOBARA, TSUYOSHI KISHIMOTO, SAKIKO TANNO, IKUO SHOJI, TETSURO SUZUKI, TAMANO MATSUI, YASUSHI SHIMADA, TAKAAKI OHYAMA, RYOZO NAGAI, TATSUO MIYAMURA. (2005) Outbreak of hepatitis C virus infection in an outpatient clinic. Journal of Gastroenterology and Hepatology 20:7, 1087-1093
CrossRef690
Jean-Pierre E. N. Pierie, Alona Muzikansky, Kenneth K. Tanabe, Mark J. Ott. (2005) The Outcome of Surgical Resection Versus Assignment to the Liver Transplant Waiting List for Hepatocellular Carcinoma. Annals of Surgical Oncology 12:7, 552-560
CrossRef691
Bachir Taouli, Jeffrey S. K Goh, Ying Lu, Aliya Qayyum, Benjamin M Yeh, Raphael B Merriman, Fergus V Coakley. (2005) Growth Rate of Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 29:4, 425-429
CrossRef692
Thomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre-Henri Bernard, Olivier Boillot, Karim Boudjema, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Dhumeaux, Daniel Cherqui, Christophe Duvoux. (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transplantation 11:7, 767-775
CrossRef693
Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Ryosuke Tateishi, Tomonori Fujishima, Takashi Ishikawa, Yukihiro Koike, Haruhiko Yoshida, Takao Kawabe, Masao Omata. (2005) A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma. Gastroenterology 129:1, 122-130
CrossRef694
Uwe Weickert, Andrea Buttmann, Ralf Jakobs, Dieter Schilling, Axel Eickhoff, J??rgen Ferdinand Riemann. (2005) Diagnosis of Liver Cirrhosis. Journal of Clinical Gastroenterology 39:6, 529-532
CrossRef695
Sherif A. El-Kafrawy, Mohamed Abdel-Hamid, Mai El-Daly, Ola Nada, Alaa Ismail, Sameera Ezzat, Soheir Abdel-Latif, Amany Abdel-Hamid, Peter G. Shields, Christopher Loffredo. (2005) p53 Mutations in hepatocellular carcinoma patients in Egypt. International Journal of Hygiene and Environmental Health 208:4, 263-270
CrossRef696
Shuang-Jian Qiu, Lina Lu, Chunping Qiao, LiangFu Wang, Zhong Wang, Xiao Xiao, Shiguang Qian, John J. Fung, Sheng-Long Ye, C. Andrew Bonham. (2005) Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. Journal of Cancer Research and Clinical Oncology 131:7, 429-438
CrossRef697
Jean-Francois Geschwind, Eleni Liapi. (2005) Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?. Nature Clinical Practice Gastroenterology & Hepatology 2:7, 302-303
CrossRef698
K NG. (2005) Radiofrequency ablation for malignant liver tumor. Surgical Oncology 14:1, 41-52
CrossRef699
HIRONORI TANAKA, YOSHIAKI IWASAKI, KAZUHIRO NOUSO, YOSHIYUKI KOBAYASHI, SHIN-ICHIRO NAKAMURA, EIJI MATSUMOTO, NOBUYUKI TOSHIKUNI, TOSHIHIKO KANEYOSHI, TOSHIYA OHSAWA, KOUICHI TAKAGUCHI, KOZO FUJIO, TOMONORI SENOH, TOHRU OHNISHI, KOHSAKU SAKAGUCHI, YASUSHI SHIRATORI. (2005) Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 20:6, 850-856
CrossRef700
Hector Rodriguez-Luna, Hugo E. Vargas, Thomas Byrne, Jorge Rakela. (2005) Artificial Neural Network and Tissue Genotyping of Hepatocellular Carcinoma in Liver-Transplant Recipients: Prediction of Recurrence. Transplantation 79:12, 1737-1740
CrossRef701
Katsuhiro Matoba, Norio Iizuka, Toshikazu Gondo, Tokuhiro Ishihara, Hisafumi Yamada-Okabe, Takao Tamesa, Norikazu Takemoto, Kiichiro Hashimoto, Kazuhiko Sakamoto, Takanobu Miyamoto, Shunji Uchimura, Yoshihiko Hamamoto, Masaaki Oka. (2005) Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. International Journal of Cancer 115:2, 231-240
CrossRef702
WILLIAM KEMP, STEPHEN PIANKO, SHARA NGUYEN, MICHAEL J BAILEY, STUART K ROBERTS. (2005) Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease. Journal of Gastroenterology and Hepatology 20:6, 873-881
CrossRef703
Gerald B. Sharp, Frederic Lagarde, Terumi Mizuno, Catherine Sauvaget, Toshiyuki Fukuhara, Naomi Allen, Gen Suzuki, Shoji Tokuoka. (2005) Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan. International Journal of Cancer 115:2, 290-295
CrossRef704
Jorge A Marrero. (2005) Hepatocellular carcinoma. Current Opinion in Gastroenterology 21:3, 308-312
CrossRef705
Taro Takami, Shuji Terai, Yuichiro Yokoyama, Haruko Tanimoto, Kunihiko Tajima, Koichi Uchida, Takahiro Yamasaki, Isao Sakaida, Hiroshi Nishina, Snorri S. Thorgeirsson, Kiwamu Okita. (2005) Human Homologue of Maid Is a Useful Marker Protein in Hepatocarcinogenesis. Gastroenterology 128:5, 1369-1380
CrossRef706
Shengyuan Luo, William Cassidy, Lennox Jeffers, K. Rajender Reddy, Christine Bruno, Charles D. Howell. (2005) Interferon-Stimulated Gene Expression in Black and White Hepatitis C Patients During Peginterferon Alfa-2a Combination Therapy. Clinical Gastroenterology and Hepatology 3:5, 499-506
CrossRef707
M. Sala, M. Varela, A. Forner, J. Bruix. (2005) Diagnóstico temprano del cáncer de hígado. Gastroenterología y Hepatología 28:5, 292-297
CrossRef708
Darius Moradpour, Hubert E. Blum. (2005) Pathogenesis of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 17:5, 477-483
CrossRef709
Lucas McCormack, Henrik Petrowsky, Pierre-Alain Clavien. (2005) Surgical therapy of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 17:5, 497-503
CrossRef710
Mathew A Van Deusen, Eddie K Abdalla, Jean-Nicolas Vauthey, Mark S Roh. (2005) Staging classifications for hepatocellular carcinoma. Expert Review of Molecular Diagnostics 5:3, 377-383
CrossRef711
YI-HSIANG HUANG, CHIEN-HUNG CHEN, TING-TSUNG CHANG, SHINN-CHERNG CHEN, SHEN-YUNG WANG, HSUAN-SHU LEE, PIN-WEN LIN, GUAN-TARN HUANG, JIN-CHUAN SHEU, HONG-MING TSAI, PUI-CHING LEE, GAR-YANG CHAU, WING-YIU LUI, SHOU-DONG LEE, JAW-CHING WU. (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. Journal of Gastroenterology and Hepatology 20:5, 765-771
CrossRef712
Koji Hashimoto, Yasuharu Ikeda, Daisuke Korenaga, Kazuo Tanoue, Motoharu Hamatake, Katsumi Kawasaki, Terutoshi Yamaoka, Yasue Iwatani, Kohei Akazawa, Kenji Takenaka. (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:9, 1856-1864
CrossRef713
Mark Danta, Eleanor Barnes, Geoffrey Dusheiko. (2005) The surveillance and diagnosis of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 17:5, 491-496
CrossRef714
David S. K. Lu, Nam C. Yu, Steven S. Raman, Charles Lassman, Myron J. Tong, Carolyn Britten, Francisco Durazo, Sammy Saab, Steven Han, Richard Finn, Jonathan R. Hiatt, Ronald W. Busuttil. (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41:5, 1130-1137
CrossRef715
David Schottenfeld, Jennifer L. Beebe-Dimmer. (2005) ADVANCES IN CANCER EPIDEMIOLOGY: Understanding Causal Mechanisms and the Evidence for Implementing Interventions. Annual Review of Public Health 26:1, 37-60
CrossRef716
Kazuyasu Fujii, Tadashi Kondo, Hideki Yokoo, Tesshi Yamada, Keiji Iwatsuki, Setsuo Hirohashi. (2005) Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. PROTEOMICS 5:5, 1411-1422
CrossRef717
Wilco A Slijkhuis, Linda Stadheim, Ziad M Hassoun, Ugochukwu C Nzeako, Walter K Kremers, Jayant A Talwalkar, Gregory J Gores. (2005) Octreotide Therapy for Advanced Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 39:4, 333-338
CrossRef718
Gernot Zollner, Martin Wagner, Peter Fickert, Dagmar Silbert, Andrea Fuchsbichler, Kurt Zatloukal, Helmut Denk, Michael Trauner. (2005) Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver International 25:2, 367-379
CrossRef719
Esther Unitt, Simon M. Rushbrook, Aileen Marshall, Susan Davies, Paul Gibbs, Lesley S. Morris, Nicholas Coleman, Graeme J. M. Alexander. (2005) Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells. Hepatology 41:4, 722-730
CrossRef720
Daniel H Palmer, Syed A Hussain, Philip J Johnson. (2005) Gene- and immunotherapy for hepatocellular carcinoma. Expert Opinion on Biological Therapy 5:4, 507-523
CrossRef721
Motonari Takashima, Yasuhiro Kuramitsu, Yuichiro Yokoyama, Norio Iizuka, Masanori Fujimoto, Takashi Nishisaka, Kiwamu Okita, Masaaki Oka, Kazuyuki Nakamura. (2005) Overexpression of alpha enolase in hepatitis?C virus-related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis. PROTEOMICS 5:6, 1686-1692
CrossRef722
CHYI-FENG JAN, CHIEN-JEN CHEN, HSIU-HSI CHEN. (2005) Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience. Journal of Gastroenterology and Hepatology 20:4, 521-526
CrossRef723
Eldad Bialecki, Adrian Di Bisceglie. (2005) Diagnosis of hepatocellular carcinoma. HPB: Official Journal of The International Hepato Pancreato Biliary Association 7:1, 26-34
CrossRef724
Rafael Ba
CrossRef725
Samuel Daniel. (2005) Chronic Hepatitis C Treatment Patterns in African American Patients: An Update. The American Journal of Gastroenterology 100:3, 716-722
CrossRef726
Michael J Grace, David L Cutler, Ronald W Bordens. (2005) Pegylated IFNs for chronic hepatitis C: an update. Expert Opinion on Drug Delivery 2:2, 219-226
CrossRef727
Chen Li, Ye-Xiong Tan, Hu Zhou, Shi-Jian Ding, Su-Jun Li, Dan-jun Ma, Xiao-bo Man, Yi Hong, Lei Zhang, Long Li, Qi-Chang Xia, Jia-Rui Wu, Hong-Yang Wang, Rong Zeng. (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. PROTEOMICS 5:4, 1125-1139
CrossRef728
E. Ellen Schwegler, Lisa Cazares, Laura F. Steel, Bao-Ling Adam, David A. Johnson, O. John Semmes, Timothy M. Block, Jorge A. Marrero, Richard R. Drake. (2005) SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41:3, 634-642
CrossRef729
Y.-H. Huang, C.-H. Chen, T.-T. Chang, S.-C. Chen, J.-H. Chiang, H.-S. Lee, P.-W. Lin, G.-T. Huang, J.-C. Sheu, H.-M. Tsai, P.-C. Lee, T.-I. Huo, S.-D. Lee, J.-C. Wu. (2005) The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage. Alimentary Pharmacology and Therapeutics 21:6, 687-694
CrossRef730
Calogero Cammà, Anna Licata, Giuseppe Cabibbo, Federica Latteri, Antonio Craxì. (2005) Treatment of hepatitis C: critical appraisal of the evidence. Expert Opinion on Pharmacotherapy 6:3, 399-408
CrossRef731
Mitchell S. Cappell. (2005) Screening, prevention, and treatment of esophageal, gastric, and hepatic malignancies. Medical Clinics of North America 89:2, xi-xiv
CrossRef732
Mindie H. Nguyen, Emmet B. Keeffe. (2005) General management. Best Practice & Research Clinical Gastroenterology 19:1, 161-174
CrossRef733
Charles Cha, Ronald P. DeMatteo. (2005) Molecular mechanisms in hepatocellular carcinoma development. Best Practice & Research Clinical Gastroenterology 19:1, 25-37
CrossRef734
Ihab R. Kamel, Eleni Liapi, Elliot K. Fishman. (2005) Multidetector CT of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 19:1, 63-89
CrossRef735
L. M. Mofenson, J. Oleske, L. Serchuck, R. Van Dyke, C. Wilfert. (2005) Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clinical Infectious Diseases 40:Supplement 1, S1-S84
CrossRef736
Hubert E. Blum. (2005) Treatment of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 19:1, 129-145
CrossRef737
James E. Goin, Riad Salem, Brian I. Carr, Janet E. Dancey, Michael C. Soulen, Jean-Francois H. Geschwind, Kathleen Goin, Mark Van Buskirk, Kenneth Thurston. (2005) Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: A Risk-Stratification Analysis. Journal of Vascular and Interventional Radiology 16:2, 195-203
CrossRef738
L. C. Miller. (2005) International Adoption: Infectious Diseases Issues. Clinical Infectious Diseases 40:2, 286-293
CrossRef739
Albert Y. Lin, Nathalie Brophy, George A. Fisher, Sam So, Christopher Biggs, Torunn I. Yock, Lee Levitt. (2005) Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer 103:1, 119-125
CrossRef740
Jennifer R. Kramer, Thomas P. Giordano, Julianne Souchek, Peter Richardson, Lu-Yu Hwang, Hashem B. El-Serag. (2005) The Effect of HIV Coinfection on the Risk of Cirrhosis and Hepatocellular Carcinoma in U.S. Veterans with Hepatitis C. The American Journal of Gastroenterology 100:1, 56-63
CrossRef741
Derek Patel, Norah A. Terrault, Francis Y. Yao, Nathan M. Bass, Uri Ladabaum. (2005) Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus–related cirrhosis. Clinical Gastroenterology and Hepatology 3:1, 75-84
CrossRef742
Katsunori Shinozaki, Oliver Ebert, Savio L.C. Woo. (2005) Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV. Hepatology 41:1, 196-203
CrossRef743
Lihua Wang, Marc S. Levin. (2005) Suppression of FGF signaling: A putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma. Gastroenterology 128:1, 228-231
CrossRef744
Namiki Izumi, Asahina Yasuhiro, Masayuki Kurosaki, Yuko Onuki, Yuki Nishimura, Kazunari Inoue, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi, Masakatsu Uchihara, Shozo Miyake. (2005) Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C. Intervirology 48:1, 59-63
CrossRef745
Yasuhiro Sakaguchi, Masatoshi Kudo, Toyokazu Fukunaga, Yasunori Minami, Hobyung Chung, Toshihiko Kawasaki. (2005) Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma. Intervirology 48:1, 64-70
CrossRef746
Ryosuke Tateishi, Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Yukihiro Koike, Tomonori Fujishima, Haruhiko Yoshida, Takao Kawabe, Masao Omata. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 103:6, 1201
CrossRef747
Maximilian Schoniger-Hekele, Sabine Hanel, Fritz Wrba, Christian Muller. (2005) Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver International 25:1, 62
CrossRef748
Hideo Tanaka, Hideaki Tsukuma, Hajime Yamano, Akira Oshima, Hirotoshi Shibata. (2004) Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. International Journal of Cancer 112:6, 1075-1080
CrossRef749
Masatoshi Akamatsu, Haruhiko Yoshida, Shuntaro Obi, Shinpei Sato, Yukihiro Koike, Tomonori Fujishima, Ryosuke Tateishi, Masatoshi Imamura, Keisuke Hamamura, Takuma Teratani, Shuichiro Shiina, Takashi Ishikawa, Masao Omata. (2004) Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Liver International 24:6, 625-629
CrossRef750
James P O'Beirne, Phillip M Harrison. (2004) The role of the immune system in the control of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 16:12, 1257-1260
CrossRef751
Daniel H Palmer, Syed A Hussain, Philip J Johnson. (2004) Systemic therapies for hepatocellular carcinoma. Expert Opinion on Investigational Drugs 13:12, 1555-1568
CrossRef752
Josep M. Llovet. (2004) Treatment of hepatocellular carcinoma. Current Treatment Options in Gastroenterology 7:6, 431-441
CrossRef753
E Schausberger, K Hufnagl, W Parzefall, C Gerner, D Kandioler-Eckersberger, F Wrba, M Klimpfinger, R Schulte-Hermann, B Grasl-Kraupp. (2004) Inherent growth advantage of (pre)malignant hepatocytes associated with nuclear translocation of pro-transforming growth factor α. British Journal of Cancer 91:11, 1955-1963
CrossRef754
Brian H. Lang, Ronnie T. Poon, Sheung T. Fan, John Wong. (2004) Outcomes of Patients with Hepatocellular Carcinoma Presenting with Variceal Bleeding. The American Journal of Gastroenterology 99:11, 2158-2165
CrossRef755
David A. Bush, Donald J. Hillebrand, James M. Slater, Jerry D. Slater. (2004) High-Dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 127:5, S189-S193
CrossRef756
Giovanna Fattovich, Tommaso Stroffolini, Irene Zagni, Francesco Donato. (2004) Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127:5, S35-S50
CrossRef757
Bachir Taouli, Mariela Losada, Agnes Holland, Glenn Krinsky. (2004) Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 127:5, S144-S152
CrossRef758
Weihua Qiu, Bingsen Zhou, Hongzhi Zou, Xiyong Liu, Peiguo G. Chu, Richard Lopez, Jennifer Shih, Christopher Chung, Yun Yen. (2004) Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 β Promoter in Human Hepatocellular Carcinoma. The American Journal of Pathology 165:5, 1689-1699
CrossRef759
Hashem B. El-Serag. (2004) Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 127:5, S27-S34
CrossRef760
Yun Kyung Kang, Seong Woo Hong, Hyucksang Lee, Woo Ho Kim. (2004) Overexpression of clusterin in human hepatocellular carcinoma. Human Pathology 35:11, 1340-1346
CrossRef761
Jordi Bruix, Margarita Sala, Josep M. Llovet. (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127:5, S179-S188
CrossRef762
Jean Francois H. Geschwind, Riad Salem, Brian I. Carr, Michael C. Soulen, Kenneth G. Thurston, Kathleen A. Goin, Mark van Buskirk, Carol A. Roberts, James E. Goin. (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127:5, S194-S205
CrossRef763
Jessica A. Davila, Robert O. Morgan, Yasser Shaib, Katherine A. McGlynn, Hashem B. El–Serag. (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 127:5, 1372-1380
CrossRef764
Leonard B. Seeff. (2004) Introduction: The burden of hepatocellular carcinoma. Gastroenterology 127:5, S1-S4
CrossRef765
F.Xavier Bosch, Josepa Ribes, Mireia Díaz, Ramon Cléries. (2004) Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127:5, S5-S16
CrossRef766
Russell H. Wiesner, Richard B. Freeman, David C. Mulligan. (2004) Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 127:5, S261-S267
CrossRef767
Jessica Y. Leung, Andrew X. Zhu, Fredric D. Gordon, Daniel S. Pratt, Abigail Mithoefer, Kathryn Garrigan, Adam Terella, Martin Hertl, A. Benedict Cosimi, Raymond T. Chung. (2004) Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study. Liver Transplantation 10:11, 1343-1354
CrossRef768
Doris B. Strader. (2004) Hepatitis C virus among african-american persons. Current Hepatitis Reports 3:4, 129-135
CrossRef769
Daniel B. Brown, Christopher E. Fundakowski, Mauricio Lisker-Melman, Jeffrey S. Crippin, Thomas K. Pilgram, William Chapman, Michael D. Darcy. (2004) Comparison of MELD and Child-Pugh Scores to Predict Survival after Chemoembolization for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 15:11, 1209-1218
CrossRef770
Xin Chen, John Higgins, Siu-Tim Cheung, Rui Li, Veronica Mason, Kelli Montgomery, Sheung-Tat Fan, Matt van de Rijn, Samuel So. (2004) Novel endothelial cell markers in hepatocellular carcinoma. Modern Pathology 17:10, 1198-1210
CrossRef771
Yi-Hsiang Huang, Chien-Hung Chen, Ting-Tsung Chang, Shinn-Cherng Chen, Shen-Yung Wang, Pui-Ching Lee, Hsuan-Shu Lee, Pin-Wen Lin, Guan-Tarn Huang, Jin-Chuan Sheu, Hong-Ming Tsai, Gar-Yang Chau, Jen-Huei Chiang, Wing-Yiu Lui, Shou-Dong Lee, Jaw-Ching Wu. (2004) The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver International 24:5, 419-424
CrossRef772
Barbara A. Piasecki, James D. Lewis, K. Rajender Reddy, Scarlett L. Bellamy, Steven B. Porter, Robert M. Weinrieb, Donald D. Stieritz, Kyong-Mi Chang. (2004) Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40:4, 892-899
CrossRef773
YUMIKO NAGAO, MICHIO SATA. (2004) Hepatitis C virus and lichen planus. Journal of Gastroenterology and Hepatology 19:10, 1101-1113
CrossRef774
James E Pingpank. (2004) Therapy for Unresectable Hepatocellular Carcinoma. The Cancer Journal 10:5, 291-293
CrossRef775
Umberto Cillo, Filippo Navaglia, Alessandro Vitale, Alfiero Molari, Daniela Basso, Marco Bassanello, Alberto Brolese, Giacomo Zanus, Umberto Montin, Francesco D'Amico, Francesco Antonio Ciarleglio, Amedeo Carraro, Alessio Bridda, Patrizia Burra, Paolo Carraro, Mario Plebani, Davide Francesco D'Amico. (2004) Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clinica Chimica Acta 347:1-2, 129-138
CrossRef776
Mindie H. Nguyen, Alice S. Whittemore, Ruel T. Garcia, Saraa A. Tawfeek, Jing Ning, Suzanna Lam, Teresa L. Wright, Emmet B. Keeffe. (2004) Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clinical Gastroenterology and Hepatology 2:9, 820-824
CrossRef777
Ju-Seog Lee, In-Sun Chu, Jeonghoon Heo, Diego F. Calvisi, Zongtang Sun, Tania Roskams, Anne Durnez, Anthony J. Demetris, Snorri S. Thorgeirsson. (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:3, 667-676
CrossRef778
Juan I. Arenas, Hugo E. Vargas. (2004) Hepatitis C virus antiviral therapy in patients with cirrhosis. Gastroenterology Clinics of North America 33:3, 549-562
CrossRef779
M. Anzola. (2004) Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. Journal of Viral Hepatitis 11:5, 383-393
CrossRef780
Josepa Ribes, Ramon Cl??ries, Joan Borr??s, Jaume Galceran, F Xavier Bosch. (2004) Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980???1997 in Catalonia, Spain. European Journal of Gastroenterology & Hepatology 16:9, 865-872
CrossRef781
Kamran Ahrar, Robert A. Newman, Jihai Pang, Mary K. Vijjeswarapu, Michael J. Wallace, Kenneth C. Wright. (2004) 2004 Dr. Gary J. Becker Young Investigator Award: Relative Thermosensitivity of Cytotoxic Drugs Used in Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology 15:9, 901-905
CrossRef782
Eva Negri, D'Anna Little, Mauro Boiocchi, Carlo La Vecchia, Silvia Franceschi. (2004) B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: A systematic review. International Journal of Cancer 111:1, 1-8
CrossRef783
Hector Rodriguez-Luna, Vijayan Balan, Pratima Sharma, Thomas Byrne, David Mulligan, Jorge Rakela, Hugo E. Vargas. (2004) Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver Transplantation. Transplantation 78:4, 580-583
CrossRef784
Ronnie T. Poon. (2004) Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma. The American Journal of Gastroenterology 99:8, 1488-1489
CrossRef785
Teh-Ia Huo, Jaw-Ching Wu, Wing-Yiu Lui, Yi-Hsiang Huang, Pui-Ching Lee, Jen-Huei Chiang, Full-Young Chang, Shou-Dong Lee. (2004) Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment. The American Journal of Gastroenterology 99:8, 1479-1487
CrossRef786
Damien Jeantet, Isabelle Chemin, Bernard Mandrand, Albert Tran, Fabien Zoulim, Philippe Merle, Christian Trepo, Alan Kay. (2004) Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. Journal of Medical Virology 73:4, 508-515
CrossRef787
K. Kulkarni, E. Barcak, H. El-Serag, R. Goodgame. (2004) The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Alimentary Pharmacology and Therapeutics 20:4, 445-450
CrossRef788
Andrea E. Reid, Maria Resnick, YuChiao Chang, Nathan Buerstatte, Joel S. Weissman. (2004) Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transplantation 10:7, 834-841
CrossRef789
Francis Y. Yao, John P. Roberts. (2004) Applying expanded criteria to liver transplantation for hepatocellular carcinoma: Too much too soon, or is now the time?. Liver Transplantation 10:7, 919-921
CrossRef790
Kirti Shetty, Kate Timmins, Colleen Brensinger, Emma E. Furth, Sushil Rattan, Weijing Sun, Mark Rosen, Michael Soulen, Abraham Shaked, K. Rajender Reddy, Kim M. Olthoff. (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transplantation 10:7, 911-918
CrossRef791
Renato Talamini, Maurizio Montella, Marina Crovatto, Luigino Dal Maso, Anna Crispo, Eva Negri, Michele Spina, Antonio Pinto, Antonino Carbone, Silvia Franceschi. (2004) Non-Hodgkin's lymphoma and hepatitis C virus: A case-control study from northern and southern Italy. International Journal of Cancer 110:3, 380-385
CrossRef792
Teh-Ia Huo, Jaw-Ching Wu, Pui-Ching Lee, Full-Young Chang, Shou-Dong Lee. (2004) Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver International 24:3, 210-215
CrossRef793
Diane L. Reidy, Jonathan D. Schwartz. (2004) Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials???I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma. Anti-Cancer Drugs 15:5, 427-437
CrossRef794
O. S. Lin, E. B. Keeffe, G. D. Sanders, D. K. Owens. (2004) Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Alimentary Pharmacology and Therapeutics 19:11, 1159-1172
CrossRef795
Linda L Wong, Kathryn Tanaka, Lansdale Lau, Steven Komura. (2004) Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clinical Transplantation 18:3, 227-234
CrossRef796
Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama, Yasuhiro Sone, Makoto Tanikawa, Yasuhiro Hisanaga, Kazuhiko Hayashi, Takashi Honda, Shusuke Kitabatake, Teiji Kuzuya, Koji Nonogaki, Toshifumi Kasugai, Junichi Shimizu. (2004) Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000. Cancer 100:11, 2415-2421
CrossRef797
Beatrice Gerard, Harry Bleiberg. (2004) Treatment of hepatocarcinoma. Current Oncology Reports 6:3, 184-191
CrossRef798
Kester Crosse, Onuora G. Umeadi, Frank A. Anania, Jacqueline Laurin, John Papadimitriou, Cinthia Drachenberg, Charles D. Howell. (2004) Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clinical Gastroenterology and Hepatology 2:6, 463-468
CrossRef799
Lennox J. Jeffers, William Cassidy, Charles D. Howell, Sylvia Hu, K. Rajender Reddy. (2004) Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology 39:6, 1702-1708
CrossRef800
Valeria R. Mas, Daniel G. Maluf, Richard Stravitz, Catherine I. Dumur, Bradly Clark, Cheryl Rodgers, Andrea Ferreira-Gonzalez, Robert A. Fisher. (2004) Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: Genes involved in tumor progression. Liver Transplantation 10:5, 607-620
CrossRef801
David H. Van Thiel, Sherri Yong, S. David Li, Marc Kennedy, John Brems. (2004) The development ofde novo hepatocellular carcinoma in patients on a liver transplant list: Frequency, size, and assessment of current screening methods. Liver Transplantation 10:5, 631-637
CrossRef802
Luis J. Lopez, Jorge A. Marrero. (2004) Hepatocellular carcinoma. Current Opinion in Gastroenterology 20:3, 248-253
CrossRef803
W.-T. Chen, G.-Y. Chau, W.-Y. Lui, S.-H. Tsay, K.-L. King, C.-C. Loong, C.-W. Wu. (2004) Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. European Journal of Surgical Oncology (EJSO) 30:4, 414-420
CrossRef804
Noriyo Yamashiki, Jeffrey J. Gaynor, Tomoaki Kato, K. Rajender Reddy, Abhasnee Sobhonslidsuk, David Levi, Seigo Nishida, Juan Madariaga, Jose Nery, Eugene R. Schiff, Andreas G. Tzakis. (2004) Competing Risks Analysis of Predictors of Delisting Owing to Tumor Progression in Liver Transplant Candidates with Hepatocellular Carcinoma. American Journal of Transplantation 4:5, 774-781
CrossRef805
JEAN-MARIE PERON, BETTINA COUDERC, PHILIPPE ROCHAIX, VICTORINE DOUIN-ECHINARD, AMANI ASNACIOS, ANNY SOUQUE, JEAN-JACQUES VOIGT, LOUIS BUSCAIL, JEAN-PIERRE VINEL, GILLES FAVRE. (2004) Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12. Journal of Gastroenterology and Hepatology 19:4, 388-396
CrossRef806
C.-M. Lam, A. O. O. Chan, P. Ho, I. O.-L. Ng, C. M. Lo, C. L. Liu, R. T. P. Poon, S. T. Fan. (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Alimentary Pharmacology and Therapeutics 19:7, 771-777
CrossRef807
Masataka Date, Kazuhide Fukuchi, Yoshihisa Namiki, Akihiko Okumura, Shosuke Morita, Hiroshi Takahashi, Kiyoshi Ohura. (2004) Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells. Liver International 24:2, 142-148
CrossRef808
Linda L Wong, Naoky Tsai, Whitney Limm, Livingston Wong. (2004) Liver transplant for hepatocellular cancer: a treatment for the select few. Clinical Transplantation 18:2, 205-210
CrossRef809
James R. Jacob, Agnes Sterczer, Ilia A. Toshkov, Amy E. Yeager, Brent E. Korba, Paul J. Cote, Marie-Annick Buendia, John L. Gerin, Bud C. Tennant. (2004) Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors. Hepatology 39:4, 1008-1016
CrossRef810
Wenqian Yang, Haiying Fan, Xingming Gao, Shouhai Gao, Vishnu Vardhan Reddy Karnati, Weijuan Ni, W.Borden Hooks, John Carson, Brent Weston, Binghe Wang. (2004) The First Fluorescent Diboronic Acid Sensor Specific for Hepatocellular Carcinoma Cells Expressing Sialyl Lewis X. Chemistry & Biology 11:4, 439-448
CrossRef811
Ronnie Tung-Ping Poon, Kelvin Kwok-Chai Ng, Chi-Ming Lam, Victor Ai, Jimmy Yuen, Sheung-Tat Fan. (2004) Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma. Annals of Surgical Oncology 11:3, 281-289
CrossRef812
Thomas R. OʼBrien, Gregory Kirk, Mingdong Zhang. (2004) Hepatocellular Carcinoma. The Cancer Journal 10:2, 67-73
CrossRef813
Yamini K. Maddala, Linda Stadheim, James C. Andrews, Lawrence J. Burgart, Charles B. Rosen, Walter K. Kremers, Gregory Gores. (2004) Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transplantation 10:3, 449-455
CrossRef814
ADRIANA PEREZ, MONICA ANZALDUA, JOSEPH MCCORMICK, SUSAN FISHER-HOCH. (2004) High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population. Journal of Gastroenterology and Hepatology 19:3, 289-295
CrossRef815
Dai Nakae, Fumiyuki Uematsu, Hideki Kishida, Osamu Kusuoka, Shin-ichi Katsuda, Midori Yoshida, Masakazu Takahashi, Akihiko Maekawa, Ayumi Denda, Yoichi Konishi, Yashige Kotake, Robert A Floyd. (2004) Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, l-amino acid-defined diet. Cancer Letters 206:1, 1-13
CrossRef816
D. Lavanchy. (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 11:2, 97-107
CrossRef817
Jerome H. Liu, Pauline W. Chen, Steven M. Asch, Ronald W. Busuttil, Clifford Y. Ko. (2004) Surgery for Hepatocellular Carcinoma: Does It Improve Survival?. Annals of Surgical Oncology 11:3, 298-303
CrossRef818
Nicholas N. Nissen, Emanuel Cavazzoni, Tram T. Tran, Fred P. Poordad. (2004) Emerging Role of Transplantation for Primary Liver Cancers. The Cancer Journal 10:2, 88-96
CrossRef819
Timothy M. Pawlik, Charles R. Scoggins, Melanie B. Thomas, Jean-Nicolas Vauthey. (2004) Advances in the Surgical Management of Liver Malignancies. The Cancer Journal 10:2, 74-87
CrossRef820
Hashem B. El-serag, Thomas Tran, James E. Everhart. (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:2, 460-468
CrossRef821
Stuart J. Knechtle. (2004) Challenging Choices. Annals of Surgery 239:2, 160-161
CrossRef822
Adrian M. Di Bisceglie. (2004) What every hepatologist should know about endocrinology: Obesity, diabetes, and liver disease. Gastroenterology 126:2, 604-606
CrossRef823
Gabriel E. Gondolesi, Sasan Roayaie, Luis Muñoz, Leona Kim-Schluger, Thomas Schiano, Thomas M. Fishbein, Sukru Emre, Charles M. Miller, Myron E. Schwartz. (2004) Adult Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma. Annals of Surgery 239:2, 142-149
CrossRef824
Adrian M. Di Bisceglie, Steven Strasberg. (2004) A common staging system for hepatocellular carcinoma. Hepatology 39:2, 550-551
CrossRef825
Daniel Jaeck, Philippe Bachellier, Elie Oussoultzoglou, Jean-Christophe Weber, Philippe Wolf. (2004) Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overview. Liver Transplantation 10:S2, S58-S63
CrossRef826
Timothy M. Pawlik, Nestor F. Esnaola, Jean-Nicolas Vauthey. (2004) Surgical treatment of hepatocellular carcinoma: Similar long-term results despite geographic variations. Liver Transplantation 10:S2, S74-S80
CrossRef827
A. O. O. Chan, M. F. Yuen, C. M. Lam, C. Y. Fong, B. C. Y. Wong, C. L. Lai. (2004) Prevalence and characteristics of familial hepatocellular carcinoma caused by chronic hepatitis B infection in Hong Kong. Alimentary Pharmacology and Therapeutics 19:4, 401-406
CrossRef828
Kazuo Okumoto, Etsuko Hattori, Kazuko Tamura, Shinichi Kiso, Hisayoshi Watanabe, Koji Saito, Takafumi Saito, Hitoshi Togashi, Sumio Kawata. (2004) Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma. Liver International 24:1, 21-28
CrossRef829
Sirenda Vong, Beth P. Bell. (2004) Chronic liver disease mortality in the United States, 1990-1998. Hepatology 39:2, 476-483
CrossRef830
B.D. Roebuck. (2004) Hyperplasia, partial hepatectomy, and the carcinogenicity of aflatoxin B1. Journal of Cellular Biochemistry 91:2, 243-249
CrossRef831
Jin Woo Kim, Qinghai Ye, Marshonna Forgues, Yidong Chen, Anuradha Budhu, Jessica Sime, Lorne J. Hofseth, Rashmi Kaul, Xin Wei Wang. (2004) Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 39:2, 518-527
CrossRef832
Francisco Martínez Baca-López, Erick Ramírez-Arias, Ana Lilia Rayas-Gómez, Enrique Alfredo Bernal-Ruiz, Guillermo Saturno-Chiu. (2004) Hepatocellular carcinoma with invasion into right cardiac cavities: report of a case and literature review. Journal of the American Society of Echocardiography 17:2, 192-194
CrossRef833
Pratima Sharma, Vijayan Balan, Jose L. Hernandez, Ann M. Harper, Erick B. Edwards, Hector Rodriguez-Luna, Thomas Byrne, Hugo E. Vargas, David Mulligan, Jorge Rakela, Russell H. Wiesner. (2004) Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transplantation 10:1, 36-41
CrossRef834
Laurie Blendis, Morris Sherman. (2004) Hepatocellular Carcinoma. American Journal of Cancer 3:6, 349-368
CrossRef835
Paul Ruff. (2004) Therapeutic Options in Hepatocellular Carcinoma. American Journal of Cancer 3:2, 119-131
CrossRef836
Yasuhiro Kuramitsu, Kazuyuki Nakamura. (2004) Proteomics for hepatocellular carcinoma. SEIBUTSU BUTSURI KAGAKU 48:3, 93-97
CrossRef837
Jaquelyn Fleckenstein. (2004) Chronic hepatitis C in african americans and other minority groups. Current Gastroenterology Reports 6:1, 66-70
CrossRef838
Paul H. Hayashi, James F. Trotter, Lisa Forman, Marcelo Kugelmas, Tracy Steinberg, Paul Russ, Michael Wachs, Thomas Bak, Igal Kam, Gregory T. Everson. (2004) Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transplantation 10:1, 42-48
CrossRef839
Christopher D. Costanza, Khaled Selim. 2004. Hepatocellular Carcinoma (HCC). , 340-346.
CrossRef840
Jong-Hyun Kim, Kyung-Ran You, In Hee Kim, Baik-Hwan Cho, Chan-Young Kim, Dae-Ghon Kim. (2004) Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology 39:1, 129-138
CrossRef841
Richard B. Freeman, Russell H. Wiesner, Erick Edwards, Ann Harper, Robert Merion, Robert Wolfe, . (2004) Results of the first year of the new liver allocation plan. Liver Transplantation 10:1, 7-15
CrossRef842
Richard B. Freeman. (2004) Liver allocation for HCC: A moving target. Liver Transplantation 10:1, 49-51
CrossRef843
M. Kanazir, Mirjana Jarebinski, Dragan Delic, Ivan Boricic, Zorana Gledovic, Tatjana Pekmezovic. (2004) Primary liver cancer mortality in Belgrade population. Acta chirurgica iugoslavica 51:3, 105-110
CrossRef844
Jorge Filmus, Mariana Capurro. (2004) Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma. Molecular Diagnosis 8:4, 207-212
CrossRef845
Will J. Fecht, Alex S. Befeler. (2004) Hepatocellular carcinoma: Updates in primary prevention. Current Gastroenterology Reports 6:1, 37-43
CrossRef846
Teresa Pollicino, Giovanni Squadrito, Giovanni Cerenzia, Irene Cacciola, Giuseppina Raffa, Antonio Craxı̀, Fabio Farinati, Gabriele Missale, Antonina Smedile, Claudio Tiribelli, Erica Villa, Giovanni Raimondo. (2004) Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126:1, 102-110
CrossRef847
H Xu. (2004) Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clinical Radiology 59:1, 53-61
CrossRef848
Jacques Belghiti, Alexandre Cortes, Eddie K. Abdalla, Jean-Marc Régimbeau, Kurumboor Prakash, François Durand, Daniele Sommacale, Federica Dondero, Mickael Lesurtel, Alain Sauvanet, Olivier Farges, Reza Kianmanesh. (2003) Resection Prior to Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 238:6, 885-893
CrossRef849
Josep M Llovet, Andrew Burroughs, Jordi Bruix. (2003) Hepatocellular carcinoma. The Lancet 362:9399, 1907-1917
CrossRef850
Jonathan M. Schwartz, John M. Ham. (2003) Treatment of hepatocellular carcinoma. Current Treatment Options in Gastroenterology 6:6, 465-472
CrossRef851
Masataka Date, Kazuhide Fukuchi, Shosuke Morita, Hiroshi Takahashi, Kiyoshi Ohura. (2003) 15-deoxy-Delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. Liver International 23:6, 460-466
CrossRef852
John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan. (2003) Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 4:12, 2175-2185
CrossRef853
Massimo Colombo. (2003) Hepatitis C infection and hepatocellular carcinoma. Current Hepatitis Reports 2:4, 166-172
CrossRef854
Thierry Poynard, Man-Fung Yuen, Vlad Ratzin, Ching Lung Lai. (2003) Viral hepatitis C. The Lancet 362:9401, 2095-2100
CrossRef855
Teh-Ia Huo, Jaw-Ching Wu, Wing-Yu Lui, Pui-Ching Lee, Yi-Hsiang Huang, Gar-Yang Chau, Shyh-Haw Tsay, Full-Young Chang, Shou-Dong Lee. (2003) Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. European Journal of Gastroenterology & Hepatology 15:11, 1203-1208
CrossRef856
Lawrence E Harrison, Baburao Koneru, Phil Baramipour, Adrian Fisher, Alison Barone, Dorian Wilson, Andrew Dela Torre, Kyunghee C Cho, Daniel Contractor, Maria Korogodsky. (2003) Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. Journal of the American College of Surgeons 197:5, 759-764
CrossRef857
J.-L. Raoul, M. Messner, E. Boucher, J.-F. Bretagne, J.-P. Campion, K. Boudjema. (2003) Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of131I-labelled lipiodol. British Journal of Surgery 90:11, 1379-1383
CrossRef858
Cornelis Verhoef, Raymond GJ Pot, Rob A de Man, Pieter E Zondervan, Ernst J Kuipers, Jan NM IJzermans, Johannes G Kusters. (2003) Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 15:11, 1171-1174
CrossRef859
Charles Cha, Yuman Fong, William R Jarnagin, Leslie H Blumgart, Ronald P DeMatteo. (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. Journal of the American College of Surgeons 197:5, 753-758
CrossRef860
Vincent Donckier, Jean Luc Van Laethem, Daniel Van Gansbeke, Brigitte Ickx, Pierre Lingier, Jean Closset, Issam El Nakadi, Pascale Feron, Nathalie Boon, Nadine Bourgeois, Michael Adler, Michel Gelin. (2003) New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. Journal of Surgical Oncology 84:1, 36-44
CrossRef861
Adrian M. Bisceglie, Andre C. Lyra, Myron Schwartz, Rajender K. Reddy, Paul Martin, Gregory Gores, Anna S. F. Lok, Khozema B. Hussain, Robert Gish, David H. Thiel, Zobair Younossi, Myron Tong, Tarek Hassanein, Luis Balart, Jacquelyn Fleckenstein, Stephen Flamm, Andres Blei, Alex S. Befeler, . (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. The American Journal of Gastroenterology 98:9, 2060-2063
CrossRef862
Hironori Koga. (2003) Hepatocellular carcinoma: Is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?. Cancer 98:4, 661-667
CrossRef863
Takuya Miyagi, Tetsuo Takehara, Tomohide Tatsumi, Tatsuya Kanto, Takahiro Suzuki, Masahisa Jinushi, Yoshiko Sugimoto, Yutaka Sasaki, Masatsugu Hori, Norio Hayashi. (2003) CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. International Journal of Cancer 106:1, 81-89
CrossRef864
C. Verhoef, J. W. Kuiper, J. Heisterkamp, R. A. de Man, P. M. T. Pattynama, J. N. M. IJzermans. (2003) Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma. British Journal of Surgery 90:8, 950-955
CrossRef865
X S Hao, P P Wang, K X Chen, Q Li, M He, S B Yu, Z Y Guo, A Perruccio, T Rohan. (2003) Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population. European Journal of Cancer Prevention 12:4, 273-279
CrossRef866
S. Kummar, N.Q. Shafi. (2003) Metastatic Hepatocellular Carcinoma. Clinical Oncology 15:5, 288-294
CrossRef867
Jean-Francois H. Geschwind, Douglas E. Ramsey, Michael A. Choti, Paul J. Thuluvath, Michael S. Huncharek. (2003) Chemoembolization of Hepatocellular Carcinoma. American Journal of Clinical Oncology 26:4, 344-349
CrossRef868
Jorge Ortiz, Radi Zaki, David Reich, Cosme Manzarbeitia. (2003) Commentary. Journal of Surgical Oncology 83:3, 179-179
CrossRef869
Guillermo Marı́n-Hargreaves, Daniel Azoulay, Henri Bismuth. (2003) Hepatocellular carcinoma: surgical indications and results. Critical Reviews in Oncology/Hematology 47:1, 13-27
CrossRef870
Salvatore Leonardi, Milena La Spina, Mario La Rosa, Gino Schilir
CrossRef871
Junko Tanaka, Hiromitsu Kumada, Kenji Ikeda, Kazuaki Chayama, Masaaki Mizui, Kunihiko Hino, Keiko Katayama, Junko Kumagai, Yutaka Komiya, Yuzo Miyakawa, Hiroshi Yoshizawa. (2003) Natural histories of hepatitis C virus infection in men and women simulated by the Markov model. Journal of Medical Virology 70:3, 378-386
CrossRef872
Andrew X. Zhu, Raymond T. Chung. (2003) Hepatic steatosis in patients with chronic hepatitis C virus infection. Cancer 97:12, 2948-2950
CrossRef873
Kazuyuki Ohata, Keisuke Hamasaki, Kan Toriyama, Kojiro Matsumoto, Akira Saeki, Kenji Yanagi, Seigou Abiru, Yuichi Nakagawa, Masaya Shigeno, Seiji Miyazoe, Tatsuki Ichikawa, Hiroki Ishikawa, Kazuhiko Nakao, Katsumi Eguchi. (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97:12, 3036-3043
CrossRef874
Weihua Qiu, Donald David, Bingsen Zhou, Peiguo G. Chu, Bohe Zhang, Mengchao Wu, Jiacheng Xiao, Tianquan Han, Zhenggang Zhu, Tianxiang Wang, Xiyong Liu, Richard Lopez, Paul Frankel, Ambrose Jong, Yun Yen. (2003) Down-Regulation of Growth Arrest DNA Damage-Inducible Gene 45β Expression Is Associated with Human Hepatocellular Carcinoma. The American Journal of Pathology 162:6, 1961-1974
CrossRef875
E GARIN, S LAFFONT, Y ROLLAND, D OLIVIÉ, J LECLOIREC, J-Y HERRY, E BOUCHER, J-L RAOUL, P BOURGUET. (2003) Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma. Nuclear Medicine Communications 24:6, 671-678
CrossRef876
S. Gaiani, N. Celli, L. Cecilioni, F. Piscaglia, L. Bolondi. (2003) Percutaneous treatment of hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 17:s2, 103-110
CrossRef877
Jean-Dean Liu, Ying-Jan Wang, Chien-Ho Chen, Cheng-Fei Yu, Li-Ching Chen, Jen-Kun Lin, Yu-Chih Liang, Shyr-Yi Lin, Yuan-Soon Ho. (2003) Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Molecular Carcinogenesis 37:1, 39-50
CrossRef878
Jessica A Davila, Nancy J Petersena, Harlan A Nelson, Hashem B El-Serag. (2003) Geographic variation within the United States in the incidence of hepatocellular carcinoma. Journal of Clinical Epidemiology 56:5, 487-493
CrossRef879
Jorge A. Marrero. (2003) Hepatocellular carcinoma. Current Opinion in Gastroenterology 19:3, 243-249
CrossRef880
Martin, Greg S., Mannino, David M., Eaton, Stephanie, Moss, Marc, . (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. New England Journal of Medicine 348:16, 1546-1554
Full Text881
Marie Ann Bailey, Elizabeth M Brunt. (2003) Hepatocellular carcinoma: predisposing conditions and precursor lesions. Hematology/Oncology Clinics of North America 17:2, 625-646
CrossRef882
Gary L. Davis. (2003) Treatment of chronic hepatitis C: Improved combination therapy. Current Hepatitis Reports 2:1, 40-46
CrossRef883
Frank Staib, S. Perwez Hussain, Lorne J. Hofseth, Xin W. Wang, Curtis C. Harris. (2003) TP53 and liver carcinogenesis. Human Mutation 21:3, 201-216
CrossRef884
C. B. O'Suilleabhain, R. T. P. Poon, J. L. Yong, G. C. Ooi, W. K. Tso, S. T. Fan. (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. British Journal of Surgery 90:3, 325-331
CrossRef885
KAZUFUMI DOHMEN, HIROHISA SHIGEMATSU, KOJI IRIE, HIROMI ISHIBASHI. (2003) Longer survival in female than male with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 18:3, 267-272
CrossRef886
D. Maluf, R. A. Fisher, T. Maroney, A. Cotterell, A. Fulcher, J. Tisnado, M. Contos, V. Luketic, R. Stravitz, M. Shiffman, R. Sterling, M. Posner. (2003) Non-Resective Ablation and Liver Transplantation in Patients with Cirrhosis and Hepatocellular Carcinoma (HCC): Safety and Efficacy. American Journal of Transplantation 3:3, 312-317
CrossRef887
Ronnie Tung-Ping Poon, Sheung Tat Fan, Irene Oi-Lin Ng, John Wong. (2003) Prognosis After Hepatic Resection for Stage IVA Hepatocellular Carcinoma. Annals of Surgery 237:3, 376-383
CrossRef888
Shamim Akhter, Huifeng Liu, Ramesh Prabhu, Cynthia DeLucca, Frank Bastian, Robert F Garry, Myron Schwartz, Swan N Thung, Srikanta Dash. (2003) Epstein–Barr virus and human hepatocellular carcinoma. Cancer Letters 192:1, 49-57
CrossRef889
W. Y. Lau, Thomas W. T. Leung, Simon C. H. Yu, Stephen K. W. Ho. (2003) Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma. Annals of Surgery 237:2, 171-179
CrossRef890
Charles S. Lieber. (2003) Hepatitis C and Alcohol. Journal of Clinical Gastroenterology 36:2, 100-102
CrossRef891
Pilar Taur??, Josep Fuster, Anabel Blasi, Julia Martinez-Ocon, Teresa Anglada, Joan Beltran, Jaume Balust, Javier Tercero, Juan-Carlos Garcia-Valdecasas. (2003) Postoperative Pain Relief After Hepatic Resection in Cirrhotic Patients: The Efficacy of a Single Small Dose of Ketamine Plus Morphine Epidurally. Anesthesia & Analgesia 96:2, 475-480
CrossRef892
Pilar Taurá, Josep Fuster, Anabel Blasi, Julia Martinez-Ocon, Teresa Anglada, Joan Beltran, Jaume Balust, Javier Tercero, Juan-Carlos Garcia-Valdecasas. (2003) Postoperative Pain Relief After Hepatic Resection in Cirrhotic Patients: The Efficacy of a Single Small Dose of Ketamine Plus Morphine Epidurally. Anesthesia & Analgesia 96:2, 475-480
CrossRef893
R. H. Wiesner, J. Rakela, M. B. Ishitani, D. C. Mulligan, J. R. Spivey, J. L. Steers, R. A. F. Krom. (2003) Recent Advances in Liver Transplantation. Mayo Clinic Proceedings 78:2, 197-210
CrossRef894
N. W. W. Choong, S. Asfandiyar, L. R. Roberts. (2003) 67-Year-Old Man With Hepatitis C Infection and Abdominal Distention. Mayo Clinic Proceedings 78:2, 217-220
CrossRef895
G. L. Grazi, M. Cescon, M. Ravaioli, G. Ercolani, A. Gardini, M. Del Gaudio, G. Vetrone, A. Cavallari. (2003) Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Alimentary Pharmacology and Therapeutics 17:s2, 119
CrossRef896
Ihab R Kamel, David A Bluemke. (2003) MR imaging of liver tumors. Radiologic Clinics of North America 41:1, 51-65
CrossRef897
René Adam, Daniel Azoulay, Denis Castaing, Rony Eshkenazy, Gérard Pascal, Kentaro Hashizume, Didier Samuel, Henri Bismuth. (2003) Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis. Transactions of the ... Meeting of the American Surgical Association 121, 201-212
CrossRef898
Charles H. Cha, Leyo Ruo, Yuman Fong, William R. Jarnagin, Jinru Shia, Leslie H. Blumgart, Ronald P. DeMatteo. (2003) Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation. Transactions of the ... Meeting of the American Surgical Association 121, 9-17
CrossRef899
Nestor F. Esnaola, Nadeem Mirza, Gregory Y. Lauwers, Iwao Ikai, Jean-Marc Regimbeau, Jacques Belghiti, Yoshio Yamaoka, Steven A. Curley, Lee M. Ellis, David M. Nagorney, Jean-Nicolas Vauthey. (2003) Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and Japan. Annals of Surgery 238:5, 711
CrossRef900
Yi Wang, Meng-Chao Wu, Jonathan S. T. Sham, Weigou Zhang, Wei-Qing Wu, Xin-Yuan Guan. (2002) Prognostic significance ofc-myc andAIB1 amplification in hepatocellular carcinoma. Cancer 95:11, 2346-2352
CrossRef901
Jorge A. Marrero, Robert J. Fontana, Grace L. Su, Hari S. Conjeevaram, Dawn M. Emick, Anna S. Lok. (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States. Hepatology 36:6, 1349-1354
CrossRef902
Yujin Hoshida, Yasushi Shiratori, Masao Omata. (2002) Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma. Liver International 22:6, 479-485
CrossRef903
HUBERT E BLUM, DARIUS MORADPOUR. (2002) Viral pathogenesis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 17:s3, S413-S420
CrossRef904
Jessica A. Davila, Hashem B. El-Serag. (2002) Cholangiocarcinoma: the "other" liver cancer on the rise122. The American Journal of Gastroenterology 97:12, 3199-3200
CrossRef905
Michael C Kew. (2002) Epidemiology of hepatocellular carcinoma. Toxicology 181-182, 35-38
CrossRef906
Hashem B. El-Serag. (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S1, S74-S83
CrossRef907
Mindie H. Nguyen, Emmet B. Keeffe. (2002) Screening for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 35, S86-S91
CrossRef908
Hashem B. El-Serag. (2002) Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 35, S72-S78
CrossRef909
Walter Reinisch, Margareta Holub, Andreas Katz, Andreas Herneth, Cornelia Lichtenberger, Maximilian Schoniger-Hekele, Thomas Waldhoer, Georg Oberhuber, Peter Ferenci, Alfred Gangl, Christian Mueller. (2002) Prospective Pilot Study of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-γ in Patients With Inoperable Hepatocellular Carcinoma. Journal of Immunotherapy 25:6, 489-499
CrossRef910
Charles Cha, Ronald P. DeMatteo, Leslie H. Blumgart. (2002) Surgery and Ablative Therapy for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 35, S130-S137
CrossRef911
Marie Annick Buendia. (2002) Genetic alterations in hepatoblastoma and hepatocellular carcinoma: Common and distinctive aspects. Medical and Pediatric Oncology 39:5, 530-535
CrossRef912
Nicholas N. Nissen, Paul Martin. (2002) Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 35, S79-S85
CrossRef913
Leonard B. Seeff. (2002) Natural history of chronic hepatitis C. Hepatology 36:S1, S35-S46
CrossRef914
Robert A Fisher, Timothy P Maroney, Ann S Fulcher, Daniel Maluf, John A Clay, Luke G Wolfe, Sherfield Dawson, Adrian Cotterell, R Todd Stravitz, Velimir A Luketic, Mitchell Shiffman, Richard K Sterling, Marc P Posner. (2002) Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation. Clinical Transplantation 16:s7, 52-58
CrossRef915
Jonathan D Schwartz, Myron Schwartz, John Mandeli, Max Sung. (2002) Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. The Lancet Oncology 3:10, 593-603
CrossRef916
Yu-Jing Zhang, Habibul Ahsan, Yu Chen, Ruth M. Lunn, Li-Yu Wang, Shu-Yuan Chen, Po-Huang Lee, Chien-Jen Chen, Regina M. Santella. (2002) High frequency of promoter hypermethylation ofRASSF1A andp16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Molecular Carcinogenesis 35:2, 85-92
CrossRef917
J GESCHWIND. (2002) Chemoembolization for Hepatocellular Carcinoma: Where Does the Truth Lie?. Journal of Vascular and Interventional Radiology 13:10, 991-994
CrossRef918
Susanne Beckebaum, Vito R. Cicinnati, Guido Gerken. (2002) DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?. Reviews in Medical Virology 12:5, 297-319
CrossRef919
K. Hino, A. Kitase, Y. Satoh, D. Fujiwara, Y. Yamaguchi, M. Korenaga, Y. Shingai, T. Konishi, S. Yamashita, K. Uchida, K. Mori, H. Hanada, T. Kodama, K. Nukui, K. Okita. (2002) Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. Journal of Viral Hepatitis 9:5, 370-376
CrossRef920
Avram J. Smukler, Lee Ratner. (2002) Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Current Opinion in Oncology 14:5, 538-542
CrossRef921
Ronnie Tung-Ping Poon, Sheung-Tat Fan, Criostoir B O’Suilleabhain, John Wong. (2002) Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy1 1No competing interests declared.. Journal of the American College of Surgeons 195:3, 311-318
CrossRef922
Peter L Pedersen, Saroj Mathupala, Annette Rempel, J.F Geschwind, Young Hee Ko. (2002) Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1555:1-3, 14-20
CrossRef923
Manal M. Hassan, Adam Frome, Yehuda Z. Patt, Hashem B. El-Serag. (2002) Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United States. Journal of Clinical Gastroenterology 35:3, 266-269
CrossRef924
A. AL-NAHHAS, A. PADHY. (2002) Symposium on therapeutic intervention in nuclear medicine - an introduction. Nuclear Medicine Communications 23:9, 827-828
CrossRef925
A DIBISCEGLIE. (2002) Epidemiology and Clinical Presentation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S169-S171
CrossRef926
W RILLING, A DROOZ. (2002) Multidisciplinary Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S259-S263
CrossRef927
I KAMEL, D BLUEMKE. (2002) Imaging Evaluation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S173-S183
CrossRef928
A KOTEISH, P THULUVATH. (2002) Screening for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S185-S190
CrossRef929
Takuma Teratani, Takashi Ishikawa, Yasushi Shiratori, Shuichiro Shiina, Haruhiko Yoshida, Masatoshi Imamura, Shuntaro Obi, Shinpei Sato, Keisuke Hamamura, Masao Omata. (2002) Hepatocellular carcinoma in elderly patients. Cancer 95:4, 816-823
CrossRef930
Eiji Ando, Masatoshi Tanaka, Fumihiko Yamashita, Ryoko Kuromatsu, Shigeru Yutani, Kazuta Fukumori, Shuji Sumie, Yoichi Yano, Koji Okuda, Michio Sata. (2002) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer 95:3, 588-595
CrossRef931
J. Gournay, J. Tchuenbou, C. Richou, C. Masliah, F. Lerat, B. Dupas, T. Martin, J. F. Nouel, M. Schnee, P. Montigny, A. D'Alincourt, A. Hamy, J. Paineau, J. -C. Le Neel, J. Le Borgne, J. P. Galmiche. (2002) Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis. Alimentary Pharmacology and Therapeutics 16:8, 1529-1538
CrossRef932
G. W. McCaughan, D. J. Koorey, S. I. Strasser. (2002) Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal 32:8, 394-400
CrossRef933
Liang, T. Jake, Ghany, Marc, . (2002) Hepatitis B e Antigen — The Dangerous Endgame of Hepatitis B. New England Journal of Medicine 347:3, 208-210
Full Text934
Orazia M Granata, Giuseppe Carruba, Giuseppe Montalto, Monica Miele, Vincenzo Bellavia, Giuseppe Modica, Charles H Blomquist, Luigi A.M Castagnetta. (2002) Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness. Molecular and Cellular Endocrinology 193:1-2, 51-58
CrossRef935
Erica Villa, Alessandra Colantoni, Antonella Grottola, Ilva Ferretti, Paola Buttafoco, Helga Bertani, Nicola De Maria, Federico Manenti. (2002) Variant estrogen receptors and their role in liver disease. Molecular and Cellular Endocrinology 193:1-2, 65-69
CrossRef936
Bao-En Wang, Wei-Min Ma, Ali Sulaiman, Sjaifoellah Noer, Suwignyo Sumoharjo, Didacus Sumarsidi, Badri Nath Tandon, Kuniaki Nakao, Shunji Mishiro, Yuzo Miyakawa, Yoshihiro Akahane, Hiroshi Suzuki. (2002) Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: Survey of 414 patients from four countries. Journal of Medical Virology 67:3, 394-400
CrossRef937
IAN RABINOWITZ, ROBERT TELEPAK, FA-CHYI LEE. (2002) Octreotide Scans Are Positive in a Subset of Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine 27:7, 499-502
CrossRef938
Charles S. Fuchs, Jeffrey W. Clark, David P. Ryan, Mathew H. Kulke, Haesook Kim, Craig C. Earle, Michele Vincitore, Robert J. Mayer, Keith E. Stuart. (2002) A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma. Cancer 94:12, 3186-3191
CrossRef939
Jerome Seidenfeld, Allan Korn, Naomi Aronson. (2002) Radiofrequency ablation of unresectable primary liver cancer1 1No competing interests declared.. Journal of the American College of Surgeons 194:6, 813-828
CrossRef940
Dar-In Tai, Chien-Hung Chen, Ting-Tsung Chang, Shinn-Cherng Chen, Li-Ying Liao, Chung-Huang Kuo, YangYuan Chen, Gran-Hum Chen, Sien-Sing Yang, Huang-Shang Tang, Hsien Hong Lin, Deng-Yn Lin, Sing Kai Lo, Jeng-Ming Du, Kwo-Chuan Lin, Chi-Sin Changchien, Wen-Yu Chang, Jin-Chuan Sheu, Yun-Fan Liaw, Ding-Shinn Chen, Juei-Low Sung. (2002) Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection. Journal of Gastroenterology and Hepatology 17:6, 682-689
CrossRef941
S. Einav, M.J. Koziel, S. Einav. (2002) Immunopathogenesis of hepatitis C virus in the immunosuppressed host. Transplant Infectious Disease 4:2, 85-92
CrossRef942
GIUSEPPE MONTALTO, MELCHIORRE CERVELLO, LYDIA GIANNITRAPANI, FABIO DANTONA, ANGELA TERRANOVA, LUIGI A. M. CASTAGNETTA. (2002) Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma. Annals of the New York Academy of Sciences 963:1, 13-20
CrossRef943
Lora E Fleming, Carlos Rivero, John Burns, Chris Williams, Judy A Bean, Kathleen A Shea, John Stinn. (2002) Blue green algal (cyanobacterial) toxins, surface drinking water, and liver cancer in Florida. Harmful Algae 1:2, 157-168
CrossRef944
Marie Ann Bailey, Elizabeth M Brunt. (2002) Hepatocellular carcinoma: predisposing conditions and precursor lesions. Gastroenterology Clinics of North America 31:2, 641-662
CrossRef945
Mary Ann Huang, Jorge A. Marrero. (2002) Hepatocellular carcinoma. Current Opinion in Gastroenterology 18:3, 345-350
CrossRef946
Jeffrey D. Wayne, Gregory Y. Lauwers, Iwao Ikai, Dorota A. Doherty, Jacques Belghiti, Yoshio Yamaoka, Jean-Marc Regimbeau, David M. Nagorney, Kim-Anh Do, Lee M. Ellis, Steven A. Curley, Raphael E. Pollock, Jean-Nicolas Vauthey. (2002) Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas. Annals of Surgery 235:5, 722-731
CrossRef947
Alex S. Befeler, Adrian M. Di Bisceglie. (2002) Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 122:6, 1609-1619
CrossRef948
Ronnie Tung-Ping Poon, Sheung-Tat Fan, Flora Hau-Fung Tsang, John Wong. (2002) Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective. Annals of Surgery 235:4, 466-486
CrossRef949
Sasan Roayaie, Jason S. Frischer, Sukru H. Emre, Thomas M. Fishbein, Patricia A. Sheiner, Max Sung, Charles M. Miller, Myron E. Schwartz. (2002) Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters. Annals of Surgery 235:4, 533-539
CrossRef950
Thomas W. T. Leung, Amanda M. Y. Tang, Benny Zee, W. Y. Lau, Paul B. S. Lai, K. L. Leung, Joseph T. F. Lau, Simon C. H. Yu, Philip J. Johnson. (2002) Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system. Cancer 94:6, 1760-1769
CrossRef951
Ronnie Tung-Ping Poon, Sheung Tat Fan, Chung Mau Lo, Chi Leung Liu, John Wong. (2002) Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function. Annals of Surgery 235:3, 373-382
CrossRef952
C. La Vecchia, E. Negri, C. Pelucchi. (2002) The rise and fall in primary liver cancer mortality in Italy. Digestive and Liver Disease 34:3, 169-171
CrossRef953
Linda L Wong. (2002) Current status of liver transplantation for hepatocellular cancer. The American Journal of Surgery 183:3, 309-316
CrossRef954
Christoph Herold, Thomas Reck, Peter Fischler, Rudolf Ott, Martin Radespiel-Troeger, Marion Ganslmayer, Werner Hohenberger, Eckhart G. Hahn, Detlef Schuppan. (2002) Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre. Liver International 22:1, 23-28
CrossRef955
MASAO OMATA, YOSHIYUKI DAN, BRUNO DANIELE, RUBEN PLENTZ, KARL LENHARD RUDOLPH, MICHAEL MANNS, TEERHA PIRATVISUTH, DING S CHEN, RYOSUKE TATEISHI, ANUCHIT CHUTAPUTTI. (2002) Clinical features, etiology, and survival of hepatocellular carcinoma among different countries. Journal of Gastroenterology and Hepatology 17, S40-S49
CrossRef956
Lisa H Butterfield, Antoni Ribas. (2002) Immunotherapy of hepatocellular carcinoma. Expert Opinion on Biological Therapy 2:2, 123-133
CrossRef957
Peter L.M. Jansen. (2002) Liver disease in the elderly. Best Practice & Research Clinical Gastroenterology 16:1, 149-158
CrossRef958
Russell H. Wiesner. (2002) Medical Aspects of Liver Transplantation. Journal of Vascular and Interventional Radiology 13:2, P41-P48
CrossRef959
Jia-Horng Kao, Ding-Shinn Chen. (2002) Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma. International Journal of Cancer 97:3, 269-271
CrossRef960
Thomas W. T. Leung, Amanda M. Y. Tang, Benny Zee, Simon C. H. Yu, Paul B. S. Lai, Wan Yee Lau, Philip J. Johnson. (2002) Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Cancer 94:2, 421-427
CrossRef961
S. Pol, A. Vallet-Pichard, H. Fontaine. (2002) Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy. Journal of Viral Hepatitis 9:1, 1-8
CrossRef962
Paul R. Engstrom. 2002. Hepatocellular Carcinoma (HCC). , 363-371.
CrossRef963
M. Bourliere, J. M. Barberin, M. Rotily, V. Guagliardo, I. Portal, L. Lecomte, S. Benali, C. Boustiere, H. Perrier, M. Jullien, G. Lambot, R. Loyer, O. LeBars, R. Daniel, H. Khiri, P. Halfon. (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis 9:1, 62-70
CrossRef964
Masahiro Gotoh, Michiie Sakamoto, Kengo Kanetaka, Makoto Chuuma, Setsuo Hirohashi. (2002) Overexpression of osteopontin in hepatocellular carcinoma. Pathology International 52:1, 19-24
CrossRef965
Claudio A. Redaelli, Jean-François Dufour, Markus Wagner, Martin Schilling, Jürg Hüsler, Lukas Krähenbühl, Markus W. Büchler, Jürg Reichen. (2002) Preoperative Galactose Elimination Capacity Predicts Complications and Survival After Hepatic Resection. Annals of Surgery 235:1, 77-85
CrossRef966
Gregory Y. Lauwers, Benoit Terris, Ulysses J. Balis, Kenneth P. Batts, Jean-Marc Regimbeau, Yuchiao Chang, Fiona Graeme-Cook, Hirohiko Yamabe, Iwao Ikai, Karen R. Cleary, Shiro Fujita, Jean-Francois Flejou, Lawrence R. Zukerberg, David M. Nagorney, Jacques Belghiti, Yoshio Yamaoka, Jean-Nicolas Vauthey. (2002) Prognostic Histologic Indicators of Curatively Resected Hepatocellular Carcinomas. The American Journal of Surgical Pathology 26:1, 25-34
CrossRef967
M. Harris, P. Gibbs, J. Cebon, R. Jones, R. Sewell, T. Schelleman, P. Angus. (2001) Hepatocellular carcinoma and chemoembolization. Internal Medicine Journal 31:9, 517-522
CrossRef968
Masataka Okuno, Soichi Kojima, Hisataka Moriwaki. (2001) Chemoprevention of hepatocellular carcinoma: Concept, progress and perspectives. Journal of Gastroenterology and Hepatology 16:12, 1329-1335
CrossRef969
Tram T. Tran, Paul Martin. (2001) Chronic hepatitis C. Current Treatment Options in Gastroenterology 4:6, 503-510
CrossRef970
Dave Li, Tonya Mallory, Shinji Satomura. (2001) AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clinica Chimica Acta 313:1-2, 15-19
CrossRef971
Luisa Benvegnù, Alfredo Alberti. (2001) Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Research 52:2, 199-207
CrossRef972
Katherine A. McGlynn, Lilian Tsao, Ann W. Hsing, Susan S. Devesa, Joseph F. Fraumeni. (2001) International trends and patterns of primary liver cancer. International Journal of Cancer 94:2, 290-296
CrossRef973
Gerald B. Sharp, John B. Cologne, Toshiyuki Fukuhara, Hideyo Itakura, Masami Yamamoto, Shoji Tokuoka. (2001) Temporal changes in liver cancer incidence rates in Japan: Accounting for death certificate inaccuracies and improving diagnostic techniques. International Journal of Cancer 93:5, 751-758
CrossRef974
Steve J. Cheng, Daniel S. Pratt, Richard B. Freeman, Marshall M. Kaplan, John B. Wong. (2001) LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1. Transplantation 72:5, 861-868
CrossRef975
P P Anthony. (2001) Hepatocellular carcinoma: an overview. Histopathology 39:2, 109-118
CrossRef976
Yasushi Shiratori, Haruhiko Yoshida, Masao Omata. (2001) Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Review of Anticancer Therapy 1:2, 277-290
CrossRef977
Davis, Gary L., , Rodrigue, James R., . (2001) Treatment of Chronic Hepatitis C in Active Drug Users. New England Journal of Medicine 345:3, 215-217
Full Text978
Anna S. Lok, E. Jenny Heathcote, Jay H. Hoofnagle. (2001) Management of hepatitis B: 2000—Summary of a workshop. Gastroenterology 120:7, 1828-1853
CrossRef979
W. Ray Kim. (2001) Models predicting the natural history of cirrhosis and need for liver transplantation. Current Opinion in Organ Transplantation 6:2, 107-113
CrossRef980
Manish M. Chokshi, Jorge A. Marrero. (2001) Hepatocellular carcinoma. Current Opinion in Gastroenterology 17:3, 276-280
CrossRef981
Myron J Tong, Lawrence M Blatt, Vincent WC Kao. (2001) Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. Journal of Gastroenterology and Hepatology 16:5, 553-559
CrossRef982
Kathleen A. Shea, Lora E. Fleming, James D. Wilkinson, Brad Wohler-Torres, Jill A. McKinnon. (2001) Hepatocellular carcinoma incidence in Florida. Cancer 91:5, 1046-1051
CrossRef983
Makoto Ohashi, Fumihiko Kanai, Keisuke Tateishi, Hiroyoshi Taniguchi, Paola A. Marignani, Yoko Yoshida, Yasushi Shiratori, Hirofumi Hamada, Masao Omata. (2001) Target Gene Therapy for α-Fetoprotein-Producing Hepatocellular Carcinoma by E1B55k-Attenuated Adenovirus. Biochemical and Biophysical Research Communications 282:2, 529-535
CrossRef984
Namiki Izumi, Yasuhiro Asahina, Osamu Noguchi, Masakatsu Uchihara, Nobuhiko Kanazawa, Jun Itakura, Yoshiro Himeno, Shozo Miyake, Takahiro Sakai, Nobuyuki Enomoto. (2001) Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 91:5, 949-956
CrossRef985
A Quaglia, S Bhattacharjya, A P Dhillon. (2001) Limitations of the histopathogical diagnosis and prognostic assessment of hepatocellular carcinoma. Histopathology 38:2, 167-174
CrossRef986
(2001) Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health 91:1, 31-37
CrossRef987
Blair Jarvis, Caroline M. Perry. (2001) Management of Chronic Hepatitis B. Disease Management and Health Outcomes 9:4, 215-234
CrossRef988
Javier Garcia-Samaniego, Manuel Rodriguez, Juan Berenguer, Rafael Rodriguez-Rosado, Jorge Carbo, Victor Asensi, Vicente Soriano. (2001) Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. The American Journal of Gastroenterology 96:1, 179-183
CrossRef989
Christopher N. H. Jenkins, Chau Buu, Wendy Berger, Do T. Son. (2001) Liver carcinoma prevention among Asian Pacific Islanders. Cancer 91:S1, 252-256
CrossRef990
Bhupinder S. Anand. (2001) Drug Treatment of the Complications of Cirrhosis in the Older Adult. Drugs & Aging 18:8, 575-585
CrossRef991
Josep M Llovet, Jordi Bruix. (2000) Early diagnosis and treatment of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 14:6, 991-1008
CrossRef992
Audrey Smith Rogers, Jane C. Lindsey, Donna C. Futterman, Bonnie Zimmer, Sue Ellen Abdalian, Lawrence J. D'Angelo. (2000) Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks. AIDS Patient Care and STDs 14:12, 651-657
CrossRef993
G. W. McCaughan, S. I. Strasser. (2000) Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype. Australian and New Zealand Journal of Medicine 30:6, 644-646
CrossRef994
E. J.S. Kunkel. (2000) Depression in Korean Immigrants With Hepatitis B and Related Liver Diseases. Psychosomatics 41:6, 472-480
CrossRef995
Gregory T. Everson. (2000) Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transplantation 6:6B, s2-s10
CrossRef996
N.V Rajeshkumar, Ramadasan Kuttan. (2000) Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. Journal of Ethnopharmacology 73:1-2, 215-219
CrossRef997
Jeannie L. Callum, Peter H. Pinkerton, Ahmed S. Coovadia, Anne E. Thomson, Frankie Dewsbury. (2000) An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients. Transfusion 40:10, 1169-1175
CrossRef998
(2000) Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health 90:10, 1562-1569
CrossRef999
Alan P. Venook. (2000) Hepatocellular carcinoma. Current Treatment Options in Oncology 1:5, 407-414
CrossRef1000
Rosenberg, Cook, Lanza. (2000) Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population. Journal of Viral Hepatitis 7:5, 361-367
CrossRef1001
Shuichi Okada, Toru Abo. (2000) Spontaneous regression of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 15:9, 965-966
CrossRef1002
Mark E. Reeves, Ronald P. DeMatteo. (2000) Genes and viruses in hepatobiliary neoplasia. Seminars in Surgical Oncology 19:2, 84-93
CrossRef1003
Usha Dutta. (2000) Treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 15:8, 822-824
CrossRef1004
J. Encke, J.R. Wands. (2000) Ethanol Inhibition: The Humoral and Cellular Immune Response to Hepatitis C Virus NS5 Protein After Genetic Immunization. Alcoholism: Clinical and Experimental Research 24:7, 1063-1067
CrossRef1005
Emily K. Bergsland, Alan P. Venook. (2000) Hepatocellular carcinoma. Current Opinion in Oncology 12:4, 357-361
CrossRef1006
Chih-Yen Chen, Gar-Yang Chau, Sang-Hue Yen, Yu-Hsi Hsieh, Yee Chao, Kwan-Hwa Chi, Chung-Pin Li, Full-Young Chang, Shou-Dong Lee. (2000) Life-threatening haemorrhage from a sternal metastatic hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 15:6, 684-687
CrossRef1007
John T. Edwards, Graeme A. Macdonald. (2000) Hepatocellular carcinoma. Current Opinion in Gastroenterology 16:3, 275-281
CrossRef1008
Berwyn E. Clarke. (2000) New drugs for hepatitis C virus (HCV). Best Practice & Research Clinical Gastroenterology 14:2, 293-305
CrossRef1009
Thierry Poynard, Vlad Ratziu, Yves Benhamou, Pierre Opolon, Patrice Cacoub, Pierre Bedossa. (2000) Natural history of HCV infection. Best Practice & Research Clinical Gastroenterology 14:2, 211-228
CrossRef1010
Philippe Monteyne, Francis E André. (2000) Is there a causal link between hepatitis B vaccination and multiple sclerosis?. Vaccine 18:19, 1994-2001
CrossRef1011
Massimo Colombo. (2000) Hepatocellular carcinoma in patients with HCV. Best Practice & Research Clinical Gastroenterology 14:2, 327-339
CrossRef1012
Leonhard Mohr, Srinivas Shankara, Seung-Kew Yoon, Tim U. Krohne, Michael Geissler, Bruce Roberts, Hubert E. Blum, Jack R. Wands. (2000) Gene therapy of hepatocellular carcinomain vitro andin vivo in nude mice by adenoviral transfer of theescherichia coli purine nucleoside phosphorylase gene. Hepatology 31:3, 606-614
CrossRef1013
William G. Cance, Andrew K. Stewart, Herman R. Menck. (2000) The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas. Cancer 88:4, 912-920
CrossRef1014
Gary L. Davis. (2000) Current therapy for chronic hepatitis C. Gastroenterology 118:2, S104-S114
CrossRef1015
Man-Fung Yuen, Chi-Chung Cheng, I. J. Lauder, Shui-Kam Lam, Clara Gaik Ooi, Ching-Lung Lai. (2000) Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31:2, 330-335
CrossRef1016
J. Wallis Marsh, Igor Dvorchik, C. Andrew Bonham, Shunzaburo Iwatsuki. (2000) Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?. Cancer 88:3, 538-543
CrossRef1017
Josep M. Llovet, Margarita Sala, Llu
CrossRef1018
Daniel Azoulay, Denis Castaing, Jinane Krissat, Alloua Smail, Guillermo Marin Hargreaves, Antoinette Lemoine, Jean-Fran??ois Emile, Henri Bismuth. (2000) Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver. Annals of Surgery 232:5, 665
CrossRef1019
Francesco Fiore, Paolo Vallone, Paolo Ricchi, Rosa Tambaro, Bruno Daniele, Fabio Sandomenico, Rocco De Vivo, Corrado Civiletti, Francesco Izzo, Sandro Pignata, Mario Ziviello. (2000) Levovist-enhanced Doppler Sonography Versus Spiral Computed Tomography to Evaluate Response to Percutaneous Ethanol Injection in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 31:2, 164
CrossRef1020
Janet Van Cleave, Pamela Devine, Pam Odom-Ball. (1999) Multidisciplinary Care of Hepatocellular Carcinoma. Cancer Practice 7:6, 302-308
CrossRef1021
Etienne M. Sokal, Flavia Bortolotti. (1999) Update on prevention and treatment of viral hepatitis in children. Current Opinion in Pediatrics 11:5, 384-389
CrossRef1022
Robert C. Kurtz. (1999) Hepatocellular carcinoma and coinfection with hepatitis B and C. Cancer 86:5, 741-743
CrossRef1023
Adil M. Choudhary, Ingram Roberts, Tarun Gupta. (1999) Changing Patterns of Hepatocellular Carcinoma. The American Journal of Gastroenterology 94:9, 2571-2572
CrossRef1024
(1999) The Rising Incidence of Hepatocellular Carcinoma. New England Journal of Medicine 341:6, 451-452
Full Text1025
Ince, Nedim, Wands, Jack R., . (1999) The Increasing Incidence of Hepatocellular Carcinoma. New England Journal of Medicine 340:10, 798-799
Full Text
- Letters
